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Abstract 
α-Cyanocarbanion complexes are an interesting class of complexes that contain a 
nitrile ligand featuring a deprotonated α-carbon. Chapter 1 gives an overview of the 
various synthetic methods, bonding modes and applications that have been 
established in the literature. Of particular interest is the role these complexes have 
as intermediates in the formation of various different compounds including the 
synthetically versatile β-hydroxynitriles. 
One example of a catalyst that can be used to synthesise a range of β-
hydroxynitriles from the corresponding aldehydes under base free conditions is the 
POCOP pincer complex [{2,6-(iPr2PO)2C6H3}Ni(CH2CN)]. DFT calculations outlined 
in Chapter 2 indicated some of the key features of the complex in relation to its 
catalytic performance. These were that the –CH2CN ligand isomerises to yield the 
active N-bound catalyst in solution, the trans donation effect of the phenyl ring 
lowers the energy of the transition state of the reaction and the rate determining 
transition state involves a 5 coordinate intermediate and therefore the steric 
hindrance of the phosphine substituent influences the performance. 
Chapter 3 describes a series of bis(NHC) palladium(II) complexes (NHC =  
N-heterocyclic carbene) of the type [{(RIm)2CH2}Pd(NCMe)2][PF6]2 with different  
N-substituents which were reacted with NaOH in CH3CN. Two different products 
were formed under similar conditions. [{(RIm)2CH2}Pd(CH2CN)2] was observed for 
both the R = Me and 2,4,6-trimethyphenyl (Mes) substituent while 
[{([RIm]2CH2)Pd(µ–CH2CN)}2][PF6]2 was observed for both the R = Mes and  
2,6-diisopropylphenyl substituent. The two initial products that were not formed 
under these conditions could be synthesised under modified conditions. Complexes 
of the type [{(MesIm)2CH2}Pd(NCR)2][PF6]2 where R = CH2CH3 and CH2CH2CH3 
were also synthesised, however, subsequent conversion to the corresponding 
[{(RIm)2CH2}Pd(CHRCN)2] was not successful. 
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In Chapter 4 a range of NHC-containing pincer complexes were synthesised due to 
their close structural similarity to the successful POCOP complex and therefore may 
result in successful catalytic applications under similar reaction conditions. These 
complexes contain two NHC ligands bridged by either a pyridine or phenyl ring. 
[CNCiPrPd(CH2CN)][SbF6] was synthesised from the corresponding NCMe complex 
following the same method used for the bis(NHC) complexes. 
[C^C^CMePd(NCMe)][SbF6] was prepared from the previously reported Br complex. 
However attempts to form the corresponding –CH2CN complex were not fruitful. 
A number of alternative synthetic approaches were attempted for the desired non 
methylene linked phenyl based complex using various ligand modifications. Initially 
reactions were based on the pro-ligands of the type [1,3-{(R)ImH}2Ph]X2 where  
R = CH3 and X = I or R = nBu and X = Br were reacted in various approaches, 
however, due to the difficulty of the three C–H metallations an alternative pathway 
was pursued. This strategy investigated the preparation of a phenyl–OTf based  
pro-ligand, however, due to difficulties in synthesising the pro-ligand an alternative 
approach was needed. 
A series of pro-ligands of the type [2,6-(RImH)21-BrPh]X2 where R = CH3 and X = I 
or R = nBu, Ad and X = Br were synthesised from 2-bromo-1,3-difluorobenzene. The 
desired [CCCnBuPdBr] was then successfully prepared from the corresponding  
pro-ligand in good yield. This provided an alternative synthetic pathway to that 
previously developed for these complexes, although the yield was lower, the lack of 
a zirconium transfer reagent and the use of air-stable starting materials and higher 
atom efficiency make this method advantageous to previous literature methods. The 
catalytically relevant –NCMe derivative was synthesised, however, the attempted 
formation of the –CH2CN ligated complex was not successful. [CCCnBuNiCl] was 
also synthesised from the corresponding pro-ligand which then was reacted further 
to form the catalytically relevant NiNCMe complex. 
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The catalytic studies described in Chapter 5 explored the C–C coupling of 
benzaldehyde and CH3CN to yield 3-hydroxy-3-phenylpropionitrile. Various 
bis(NHC) and NHC containing pincer –CH2CN complexes were tested, however, no 
reaction was observed. For the pincer complexes in which the –CH2CN complex 
could not be succesfully synthesised, the –NCMe complex was used as a pre-
catalyst in solution with a catalytic amount of NaOH to prepare the required complex 
in situ. However, the yield of the product was identical to the background reaction 
performed in the absence of the transition metal catalyst.  
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Figure 1.1: Three of the most common methods for the synthesis of α-
cyanocarbanions. 
Chapter 1: Introduction 
1.1 Introduction to α-Cyanocarbanion Complexes: 
-Cyanocarbanion complexes represent an interesting class of complexes that 
contain a nitrile ligand featuring a deprotonated α-carbon. The interest is due to the 
various synthetic methods, bonding modes and applications that have been 
established in the literature. Since the first crystal structure of an -cyanocarbanion 
complex was reported in 1970[1] applications for these complexes have mostly 
surrounded the development of catalysts for the synthesis of nitrile-based small 
molecules.[2] These complexes have also been observed as key intermediates in the 
reaction of acrylonitrile with various substrates in phosphination, amination and 
copolymerisation processes amongst others.[3] Due to the often distinct synthetic 
approaches and applications of cyanoanions where a negative charge on the  
α-carbon is stabilised by further conjugation, such complexes will not be discussed 
in the introduction.[4] 
1.2 Synthesis of α-Cyanocarbanion Complexes: 
A wide variety of methods for the synthesis of α-cyanocarbanion complexes have 
been developed. However, the most common strategies employed are: (i) the 
oxidative addition of an -halogenated nitrile to a metal complex; (ii) the salt 
metathesis of a preformed α-cyanocarbanion metal complex onto the corresponding 
desired metal halide complex and (iii) the reaction of a transition metal complex, 
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base and alkyl nitrile (Figure 1.1). Synthesis via decarboxylation will also be 
discussed. 
A number of less common synthetic approaches that will not be specifically 
discussed[5] include electrochemical generation of the desired ligand from 
BrCH2CN,[6] the use of O2 as a C-H bond cleavage mediator,[7] acrylonitrile insertion 
into a metal–ligand bond[3d, 8] and crystal isomerisation via heat or light with the alkyl 
ligand isomerising between different carbons on the alkyl chain to form the  
-cyanocarbanion.[9] 
1.2.1 Oxidative Addition:  
Oxidative addition was the first method developed for the synthesis of  
α-cyanocarbanions with the addition of ClCH2CN to Pd(PPh3)4.[10] This oxidative 
addition can proceed from XCH2CN where X is a halide[10, 11] or hydrogen.[12] A  
4-coordinate rhodium(I) complex was used to synthesise the desired 6-coordinate 
rhodium(III) complex by oxidative addition of ICH2CN in CH2Cl2 (Figure 1.2).[11a]  
A rhodium(III) complex that readily undergoes reductive elimination was used as a 
starting material to form the desired rhodium(III) -cyanocarbanion.[13] These 
rhodium starting material complexes (1 & 2) have been shown to readily reductively 
eliminate to form the corresponding unsaturated rhodium(I) fragment [TpMeRh(PR3)] 
(3). Thus, 1 & 2 were reacted with acetonitrile allowing C–H activation to form the 
desired rhodium(III) complex (Figure 1.3).[13a]  
Figure 1.2: Oxidative addition of ICH2CN. 
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Oxidative addition has been shown to have applications with metal clusters.[11b, 11c, 
11e] Typically, in these reactions the halide and CR2CN segments ultimately bind to 
different metals in the cluster increasing their oxidation state by one. An example is 
using Br–CH2CN to oxidatively add to a digold(I) ylide to form the corresponding 
gold(II) ylide (Figure 1.4).[11e] 
 
Figure 1.4: Synthesis of a gold(II) ylide via oxidative addition of bromoacetonitrile 
in benzene. 
Figure 1.3: Synthesis of Rh complexes via oxidative addition from a complex that 
readily undergoes reductive elimination. 
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1.2.2 Salt Metathesis: 
The second fundamental synthesis strategy [14] is salt metathesis, which involves the 
reaction of a preformed alkali metal salt with the corresponding metal halide to form 
the desired α-cyanocarbanion complex. Typically the alkali metal salt are not 
characterised,[14, 15] however, lithium ketenimine salts were characterised (a 
structural isomer of the CH2CN ligands presented in Section 1.2.1, the binding 
modes of these complexes will subsequently be discussed, vide infra) from the 
reaction of diphenyl acetonitrile with nBuLi. Salt metathesis was then performed with 
the corresponding indium(III) and gallium(III) halide complexes (Figure 1.5).[16] 
1.2.3 Base-assisted Deprotonation of Nitriles: 
The most common of these approaches feature the reaction of a metal complex with 
a base and a nitrile. Variants of the metal precursor complex have been used with 
the base,[17] parent nitrile[15b, 18] or halogen[18a, 18b, 19] bound to the metal centre. A 
wide selection of bases have been used for these reactions including milder bases 
like preformed M‒OH,[17a-d, 18a] NaOH[20] and KOtBu[18b, 18c, 19a-c, 21] and stronger bases 
such as NaH[19e] and nBuLi.[18d] The α-hydrogen can also be removed utilising bulky 
free carbenes.[22] 
Figure 1.5: Transmetallation of ketenimine salt from the corresponding lithium salt. 
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Figure 1.7: Synthesis of Cu– and Ni–CH2CN complexes 4 from the corresponding  
M–OH complexes in CH3CN. 
Initial work using base-assisted deprotonation involved the use of stronger  
pre-coordinated bases. This was first utilised by Boche and co-workers[23] while 
analysing the mechanism for the reaction of LDA with phenylacetonitrile in which 
they observed a monoketenimine intermediate (Figure 1.6). 
However, an unexpected property of these complexes is the ability of NaOH and 
other week bases to deprotonate unactivated nitriles, such as acetonitrile, despite 
their high pKa. This is likely due to activation of the nitrile via coordination on the 
metal. Although the pKa of acetonitrile is 31.3 in DMSO[24] and 25 in water,[25] NaOH 
and KOtBu have been successfully utilised as bases.[18b, 18c, 19a-c, 20, 21] K2CO3 can be 
used to activate nitriles like methyl cyanoacetate.[26]  
Tolman and co-workers demonstrated the formation of α-cyanocarbanion 
complexes 4 from either the corresponding Cu–OH or Ni‒OH complexes in CH3CN 
(Figure 1.7).[17a] Three possible reaction mechanisms were proposed for the 
deprotonation of the nitrile ligand, all which were consistent with the kinetic data, 
Figure 1.6: Synthesis of a monoketenimine from phenylacetonitrile. 
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however, no DFT studies were performed to support which mechanism is operative 
for this deprotonation (Figure 1.8). 
 
The hydration of nitriles to form carboxamides in the presence of hydroxides has 
also been observed.[27] Ir‒OH complexes have been employed in a similar manner, 
however, the resulting nitrile-derived organometallic products were shown to be 
dependent on the nitrile substituent (Figure 1.9). When R is an aromatic group the 
carboxamide product 5 is formed exclusively. However, when R = methyl a mixture 
of both hydration product 5 and -deprotonated product 6 were formed. Additionally, 
when R = CHPh2 ketenimine complex 7 was the sole product. The hydrolysis versus 
deprotonation products are believed to be competing reactions with the 
deprotonation only possible with an -hydrogen while the hydrolysis reaction is not 
preferential with the large steric bulk of R = CHPh2. For the formation of complex 7, 
Figure 1.8: Possible reaction mechanisms for the synthesis of 4. 
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the corresponding iridium triflate catalyst was shown to accelerate the rate of the 
reaction.[17c] 
1.2.4 Synthesis via Decarboxylation of Cyanoacetate: 
Complexes of α-cyanocarbanions can also be formed via decarboxylation.[28] 
Cyanomethylcopper(I) was synthesised from the corresponding copper(I) and 
copper(II) cyanoacetates. When copper(II) was used, in addition to the formation of 
cyanomethylcopper(I) and the evolution of CO2, succinonitrile was also 
observed.[28b]  
Figure 1.10: Synthesis of copper α-cyanocarbanion via decarboxylation. 
 
1.3 Bonding of α-Cyanocarbanions: 
Various bonding modes have been observed for complexes bearing -deprotonated 
alkylnitrile ligands (Figure 1.11). The most common are M‒CR2CN (I) and 
M‒NCCR2 (III). These bonding modes can be distinguished via X-ray 
Figure 1.9: Synthesis of various nitrile products, R = CHPh2, CH3 and Ph. 
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crystallography, and in some cases NMR and IR spectroscopic techniques due to 
their unique characteristics. 
1.3.1 Crystallographic and Spectroscopic Data for Binding Modes I–IV: 
Studies have been performed on these complexes in attempt to assign bonding 
modes, however, without X-ray crystal structure analysis often the nature of the 
binding cannot conclusively be assigned.[29] Representative spectroscopic data for 
complexes displaying each of the four predominant bonding modes I–IV (Figure 
1.11) is presented in Table 1.1. These complexes were selected due to the 
availability of complete characterisation data. 
[Ni(IMes)(CH2CN)Cp] adopts bonding mode I (Figure 1.12)[18c] displaying a C‒Cα 
bond length of 1.429(3) Å typical of a C(sp)‒C(sp3) single bond and the C‒N bond 
length of 1.147(3) Å is as expected of a C≡N bond. Similarly, the example of 
bonding mode II, [Cp(OC)2Fe(CH2CN)Re(CO)5][BF4],[30] has bond lengths typical of 
a C≡N bond and a C(sp)–C(sp3) single bond (Figure 1.13).  
 
Figure 1.11: Predominant different bonding modes of α-cyanocarbanion. 
 
 complexes 
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 M–CR2CN (I) M–CR2CN–M (II) M–N=C=CR2 (III) M2–N=C=CR2 (IV) 
Example used [Ni(IMes)(CH2CN)Cp][18c] [Cp(OC)2Fe(CH2CN)Re(CO)5]BF4[30] [Cp*(PMe3)Ir{N=C=C(Ph)2}Ph][17c] [{([Ph]2C=C=N)InMe2(THF)}2][16] 
Bond lengths 
Cα‒C (Å) 1.429(3) 1.447a 1.377(7) 1.350(5)-1.358(5) 
C‒N (Å) 1.147(3) 1.144a 1.168(6) 1.188(5)-1.201(5) 
Bond angles 
Cα‒C‒N (°) 178.5(6) 178.9(10) 178.9(5) 178.5(4)-179.4(4) 
M‒Cα‒C (°) 112.5(2) 111.7(7)   
C‒N‒M (°)  178.2(7) 163.5(4) 124.6(3)-129.2(3) 
M‒N‒M (°)    103.4(1)-106.1(1) 
NMR and IR spectroscopy 
1H NMR resonance 
(ppm) 
–0.08b 1.59c   
13C NMR resonance 
Cα (ppm) 
–42.0b –31.9c 142.6d 55.0e 
13C NMR resonance 
C (ppm) 
132.7b 140.2c 129.5d 141.2e 
IR band (cm-1) 2188 2251 2105 2167 
Table 1.1: Key spectroscopic data for binding modes I-IV. a incorrectly reported in original paper, values were obtained from CCDC. b in CDCl3. 
c in acetone-d6. d in C6D6. e in THF-d8. 
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Most complexes featuring binding mode II are bi- and tri-nuclear species[3d, 15a, 31] 
and a variety of homo- and hetero-metallic examples are known. When the bridging 
ligand is involved in metallocyclic ring formation, the geometries of the complexes 
are distorted from that noted in [Cp(OC)2Fe(CH2CN)Re(CO)5][BF4] as discussed in 
Table 1.1 to accommodate the influence of the ring formation. An example of this 
effect is [{(ONOtBu)Ir(PPh3)(μ-CH2CN)}2][32c] (ONO
tBu =  
2,2'-(4-t-butyl-2,6-pyridinediyl)bis(4,6-bis(t-butyl)phenoxide)) with a N‒C‒Cα angle of 
171.7(2) °, an average C‒N‒M angle of 157.1 ° and a M‒Cα‒C angle of  
105.13(16) °.  
Figure 1.13: Molecular structure of [Cp(OC)2Fe(CH2CN)Re(CO)5][BF4], hydrogen 
atoms not on the nitrile ligand have been omitted for clarity. 
 
Figure 1.12: Molecular structure of [Ni(IMes)(CH2CN)Cp], hydrogen atoms not on 
the nitrile ligand have been omitted for clarity. 
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In contrast, for bonding mode III the X-ray crystal structure of 
[Cp*(PMe3)Ir{N=C=C(Ph)2}Ph][17c] (Figure 1.15) reveals a systematic shift in the 
bond lengths of the ligand with a lengthening of the C‒N bond and a shortening of 
the C‒Cα bond in comparison to binding mode I. This is consistent with a greater 
contribution of the ketenimine resonance form of the ligand (Figure 1.14). The C–N 
bond length is lengthened to 1.168(6) Å, still within the range of a typical CN triple 
bond, while the C–Cα bond length is substantially shorter at 1.377(7) Å. These 
lengths are consistent with other complexes displaying binding mode III.[5f, 15c, 32] 
Similarly, for bonding mode IV, the X-ray crystal structure of 
[{([Ph]2C=C=N)InMe2(THF)}2][16] (Figure 1.16) contains further characteristics of the 
ketenimine resonance form in comparison to bonding mode III (Figure 1.14).  
 
 
Figure 1.15: Molecular structure of [Cp*(PMe3)Ir{N=C=C(Ph)2}Ph], hydrogen atoms 
removed for clarity 
 
Figure 1.14: Resonance forms of ketenimine ligand. 
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There is only one non aromatic nitrile ligand of binding mode III as observed by 
Hartwig for [Pd(DiPrPF){NCC(Me2)}(C6H4-4-tBu)].[15a] The N‒C bond distance of  
1.21 Å is lengthened and the C‒C bond distance of 1.35 Å is shortened in 
comparison with the aromatic ketenimine ligand [Cp*(PMe3)Ir{N=C=C(Ph)2}Ph], 
possibly indicating greater contribution of the ketenimine resonance form (Figure 
1.14). 
The 1H NMR resonances of the Cα protons of complexes with binding modes I & II 
typically range between 0–2 ppm[12a, 13a, 18c, 30, 33] while the few examples of bonding 
mode III with an α-hydrogen typically have a downfield shift in resonances to 
between 2.5–6 ppm.[15c, 32a, 34] Similarly, the 13C NMR resonances of the Cα are the 
most contrasting between the binding modes with the downfield shift in resonance 
for bonding modes III in comparison to I. The Cα resonance is typically between –40 
and –21 ppm[12a, 13a, 18c, 30, 33] for binding mode I. However, for binding mode III this 
signal is usually further downfield with resonances typically observed between  
36.7–142.6 ppm.[32a, 32b, 34] These downfield shifts in both the 13C NMR and 1H NMR 
spectra are consistent with an increased contribution from the ketenimine 
resonance form (Figure 1.14). The C‒N IR band also is trending towards lower 
Figure 1.16: Molecular structure of [{([Ph]2C=C=N)InMe2(THF)}2], hydrogen atoms 
removed for clarity. 
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wave numbers for bonding modes III & IV, with the Cα‒C bands typically not 
assigned for these complexes. These spectroscopic data are consistent with greater 
contribution from the ketenimine resonance for complexes of binding modes III and 
IV (Figure 1.14). 
Although rare, a few other bonding modes have been observed due to the 
involvement of the various π-bonds and lone pairs in the ligand system. One was 
discovered with lanthanum and cerium, which appears to be a hybrid between 
bonding mode II and III with the lanthanide coordinated to both the α-carbon atom 
and the nitrogen while the bond distances for the C‒Cα and the C‒N bonds are 
similar to that observed with bonding mode III.[35] Utilising an α-stabilised carbanion, 
a sodium ketenimine complex was formed (bonding mode III), however due the 
propensity of sodium to aggregate it also interacted with both the nitrogen atom and 
the α-carbon atom of other nitrile ligands (Figure 1.17).[36] Deprotonated 
malononitrile with conjugation across both nitrile substituents similarly binds via 
binding mode I,[37] II[17d] and III[38] depending on the complex. However, when 
conjugation is increased to tricyanomethane, bonding is exclusively seen on the 
nitrogen due to the increased conjugation.[4] 
1.3.2 Relationship Between the Binding Modes: 
The relationship between bonding mode I and III was first observerd by Naota and 
co-workers who synthesised a series of ruthenium complexes. They introduced an 
Figure 1.17: Bonding of the sodium aggregate [(PhSO2CHCN)Na·THF]. 
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electron withdrawing α-sulfonyl group that has minimal resonance influence onto the 
nitrile ligand and successfully observed both bonding modes I and III with a series of 
ruthenium complexes. Some of these complexes were then shown to interconvert 
between the two binding modes upon heating in benzene (Figure 1.18).[39] 
Figure 1.18: Interconversion between binding mode I and III. 
An intermediate of bonding mode III was later postulated in the synthesis of a 
molybdenum α-cyanocarbanion complex as supported by IR spectroscopy (Figure 
1.19). The presence of ketenimine intermediate 8 was assigned due to the presence 
of two strong νCO bands and a weak band at 2178 cm–1 assigned to the ketenimine 
ligand.[15e]  
 
Mechanistic data[31a, 39b] and DFT studies[39b, 40] indicate that the transformation 
between isomers of type III and I occurs via two different mechanisms with an 
intramolecular slippage process occurring for both the C- to N- and N- to C- 
interconversions while a self assembly intermolecular process has also been 
observed for the C- to N- interconversion (Figure 1.20). The presence of a complex 
of binding mode II as an intermediate was verified by NMR spectroscopic 
Figure 1.19: Isomerisation of α-cyanocarbanion as supported by IR spectroscopy.  
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studies.[31a, 39b] DFT calculations performed on the formation of a nickel  
α-cyanocarbanion complex from the reaction of the corresponding acetonitrile salt 
with KOtBu, proposed that the reaction also proceeded via a ketenimine 
intermediate before isomerising to the related carbanion of bonding mode I.[18c] 
 
The preference for the various bonding modes that are observed ultimately seems 
to depend on a number of factors. Bonding mode IV has been exclusively observed 
with Group 1 and 13 metals.[16, 23, 41] Group 1 metals also form complexes of bonding 
mode III depending on the co-ligands.[42] The rationalisation for other classes of 
complexes can be more complicated. Recent work has suggested that the 
electronegativity of the metal preferences the formation of the N- versus C- bound 
ligand.[43] Although complexes of bonding mode I typically contain metals with higher 
electronegativity,[7, 8, 11b, 13a, 15e, 17a, 18a, 18d, 19a, 19b, 33, 44] there are also complexes of 
metals with lower electronegativity (< 1.8 on the Pauling scale)[45] that exhibit 
binding mode I.[15d, 17e] Similarly, complexes of bonding mode III typically have lower 
electronegativity,[5f, 15c, 16, 32a, 46] however, complexes with this binding mode have 
been observed for metals with higher electronegativities (> 2.0 on the Pauling 
scale[45]).[15a, 17c, 34]  
Steric effects influence the binding modes observed for α-cyanocarbanion 
complexes with binding modes I and III typically featuring different steric bulk of the 
Figure 1.20: Isomerisation of α-cyanocarbanion nitrile ligand. 
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R-substituents. Generally, nitriles featuring low steric bulk, often with at least one  
α-substituent being hydrogen, favour bonding mode I.[9a, 15a, 18a, 47] While ligands in 
which at least one α-substituent is a phenyl group prefer bonding mode III.[15a, 15c, 32a] 
Bonding mode II aggregation typically occurs when bonding via the α-carbon atom 
is preferential and there is an open coordination site on the metal allowing 
aggregation to arise by bridging, or when an additional metal complex is present 
that has propensity to bind to N-donors. This is supported by work done by Piers 
and co-workers where bonding mode II was initially observed, however, upon the 
addition of PPh3 or PMe3, bonding mode I was observed with a break-up of the 
aggregate.[3d] Conversely, the reaction of a palladium complex of bonding mode I 
containing a chloride co-ligand with Ag[BF4] leading to the formation of a dinuclear 
complex having bonding mode II.[48] 
Naota and co-workers observed the impact of the steric hindrance of the ancillary 
ligand on the binding mode. A range of ruthenium complexes with phosphine  
co-ligands of various cone angles were synthesised.[39] Bonding mode I was 
observed with phosphine co-ligands featuring smaller cone angles while for 
phosphine ligands with larger cone angles bonding mode III was exclusively 
observed. The authors also noticed a solvent effect on the reaction; when the 
reaction was performed in EtOH/toluene (1:1) the complex of bonding mode III was 
exclusively formed. However, when the reaction was undertaken in EtOH/hexane 
(1:1) a 59:41 mixture of bonding mode I:III was observed.[39a] 
This work was supported by the synthesis of a series of palladium complexes with 
hydrotris(pyrazolyl)borato (Tp) ligands. The presence of an iPr substituent on the Tp 
ligand, favoured bonding mode III exclusively. However, with a Me substituent on 
the Tp ligand, complexes of both bonding modes III and I were formed. Experiments 
showed that bonding mode III is the kinetic product while bonding mode I is the 
thermodynamic product of this reaction, as discussed earlier.[49] 
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Hartwig and co-workers subsequently synthesised a series of phosphine-ligated 
palladium complexes and reacted them with a potassium nitrile complex via salt 
metathesis (Figure 1.21). Due to the steric bulk and electronic variation of the 
phosphine and nitrile ligand they successfully observed complexes of the three 
different bonding modes I–III. The variation in bonding modes between complex 13 
and 14 could be due to electronic stabilisation by the Ph substituents of 13, 
however, this is inconsistent with other R substituents. Thus, the difference in 
binding mode is likely due to the increased steric hindrance of the second R 
substituent. The preference in binding is also impacted by the variation in ancillary 
ligand consistent with those discussed above.[15a] 
In cases where the binding mode of complexes where the Cα substituents are 
hydrogens and crystallographically identified disorder or high thermal motion limits 
accurate bonding mode determination, the M‒X‒C angle can be used to 
differentiate between bonding mode I and III due to the near linear M–N–C angle 
and the close to ideal tetrahedral M–C–C angle (Table 1.1). 
Figure 1.21: Synthesis of Pd complexes with various binding modes. 
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1.4 Reactivity of α-Cyanocarbanions: 
α-Cyanocarbanion complexes have been utilised for three primary modes of 
reactivity. The first is the formation of alkylnitriles via catalytic C‒C bond formation 
reactions, developed by the pioneering work by Murahashi and co-workers in the 
late 1980s. These researchers identified various aldol and Michael reactions of 
nitriles,[3c, 50] while this Introduction will focus on recently discovered applications. 
Alkylnitriles are useful compounds in organic synthesis due to the nitrile moiety, 
which can be functionalised further. α‒Cyanocarbanion ligands are also interesting 
due to their propensity to react with other ligands including nitriles on the metal to 
form novel C‒C coupling products. These complexes are also key intermediates in 
the reaction of acrylonitrile with various substrates including polymerisation and 
hydrophosphination reactions and thus have been studied to understand more 
about these reactions, their catalytic cycles and to improve yields. There are also a 
number of less common applications that won’t be focused on, such as α-
cyanocarbanion complexes reacting with CO2 to form the cyanoacetate,[51] 
enantioselective alkylation of an α-cyanocarbanion ligand,[52] organocobaloxime 
complexes which have applications as Vitamin B12 mimics and undergo crystalline 
state reactions[9a, 53] and the application in the activation of O2.[7] 
1.4.1 Coupling of Deprotonated Nitrile Ligands: 
The cyclotrimerisation of nitriles to form 6-membered heterocyclic rings have been 
observed affording various heterocycles depending on the conditions. It is well 
established that the reaction of KOMe[54] or KOtBu (Figure 1.22)[55] with neat CH3CN 
forms 4-amino-2,6-dimethylpyrimidine. 
 
  
 
Figure 1.22: Synthesis of 4-amino-2,6-dimethylpyrimidine. 
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However, in addition to the formation of pyrimidines, [Pd(TMEDA)(C6H5)(OH)][17b] 
and [{(C6F5)2Pd(µ-OH)}2]2–[17d] have been used to catalyse the formation of  
4,6-diamino-2-cyanomethyl-3,5-pyridinedicarbonitrile from malononitrile (Figure 
1.23). 
Acetonitrile can also be trimerised with gallium and indium complexes in the 
presence of CsF[56] or via a Rh‒CH2CN bond[44a] to form a 6-membered metallacycle 
(Figure 1.24). The rhodium metallacylce is thought to be formed by the insertion of 
two equivalents of acetonitrile into the Rh‒CH2CN bond and tautomerisation of the 
cyanomethylene protons to form a cyanoNacNac ligand.[44a] 
In addition, there are a number of complexes where dimerisation of  
-cyanocarbanion ligands occurs. In one example, by Rosenthal and co-workers, it 
is suggested that the reaction proceeded via a ketenimine intermediate to form a 
compound containing two zirconocene units which are connected by 5-membered 
bridges which occur via the C–C coupling of two nitrile ligands, one bound through 
the α-carbon atom and the second bound through the nitrile carbon atom (Figure 
Figure 1.23: Cyclotrimerisation of malononitrile with [Pd(TMEDA)(C6H5)(OH)]. 
 
Figure 1.24: Trimerisation of acetonitrile on a rhodium complex. 
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1.25).[15c] Analogous dimerisation was also observed in an intramolecular fashion 
with a zirconium adiponitrile complex.[57] 
 The dimerisation of -cyanocarbanion ligands via C–C coupling of the α-carbon 
atom and the carbon atom of the nitrile has also formed an alternative isomer of that 
observed by Rosenthal.[5f, 46b, 49] Intermediate 18 is postulated as analogous 
products were observed for the reaction of barium and magnesium with 
diphenylacetonitrile. Complex 19 was isolated and its structure confirmed via X-ray 
crystallography. Hydrolysis of 19 was observed in the NMR sample yielding  
3-aminocrotonitrile (Figure 1.26).[46b] 
In addition to dimerisation between the α-carbon atom and nitrile carbon atom, 
dimerisation between two α-carbon atoms has been observed with platinum 
clusters[11b] and via reductive elimination from a nickel phosphine complex under an 
atmosphere of O2 (Figure 1.27).[15f] 
Figure 1.25: C–C coupling via an α-cyanocarbanion intermediate. 
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A zinc α-cyanocarbanion complex was synthesised by reacting a Zn alkoxide with 
acetonitrile. Given the lower pKa of acetone compared to acetonitrile (20[58] vs 25[25]) 
the authors attempted to react the alkoxide with acetone, however, no reaction was 
observed. An alternative synthetic method was attempted for deprotonation where 
they reacted the cyanocarbanion complex with acetone. Unexpectedly, this ligand 
coupled with the acetone to form the β-ketoiminate complex (Figure 1.28).[17e]  
Figure 1.26: Synthesis of 3-aminocrotononitrile via a strontium complex. 
 
Figure 1.27: Generation of succinonitrile from a Ni phosphine complex. 
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1.4.2 Acrylonitrile Coupling Reactions: 
Acrylonitrile is a useful starting material for various transition metal-catalysed 
reactions including hydrophosphination and copolymerisation and it is believed that 
many of these reactions proceed via α-cyanocarbanion complex intermediates. In 
this section, a number of papers are highlighted which observed these 
intermediates and used this information to understand the reaction mechanisms and 
optimise yields. 
Metallacycle 21 was synthesised from the addition of alkenes from the precursor 20. 
This key intermediate and studies that indicated that the Ru–C bond can be broken 
Figure 1.29: Hydrophosphination of alkenes 
 
Figure 1.28: Synthesis of ketoiminate zinc complex. 
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in the presence of a base were used to develop a related catalyst (22). 22 was 
shown to be effective in synthesising the linear hydrophosphination product 
exclusively, a specificity that has not previously been obtained (Figure 1.29).[3a] 
Nickel and platinum PCP-type complexes (PCP = 2,6-(R2PCH2)2C6H3, R = Ph, Cy) 
have applications in the hydroamination of acrylonitrile. In 2002, the mechanism for 
the formation of the hydroamination product using catalyst 23 was analysed. Due to 
the slow reaction rate the reaction was monitored by 31P{1H}NMR spectroscopy and 
two species (24 & 25) were observed (15 and 45 % yield in 2 days at 45 °C). Their 
identities were confirmed by independent syntheses. In addition to this, to elucidate 
Figure 1.30: Proposed catalytic cycle of the hydroamination of acrylonitrile. 
 
Chapter 1 
24 
 
the possible mechanism for the liberation of the product, intermediate 26 was 
synthesised and possible reaction pathways were analysed. In addition, the 
liberation of the by-product [NH3(p-Tol)]BPh4 was observed supporting the 
mechanism proposed in Figure 1.30.[3b] Since then further work has utilised a range 
of Ni–PCP and Ni–POCOP ligands (POCOP = 2,6-(iPr2PO)2C6H3) also producing 
the same hydroamination product.[59] However, further work is required to support 
the mechanism as this work proposes an alternative mechanism in which the nickel 
acts a Lewis acid.[60] 
Piers and co-workers[3d] investigated the insertion of acrylonitrile into palladium 
methyl bonds and the importance of this work in understanding the mechanism of 
polymer formation using polar monomers. Previously, polymers and copolymers 
integrating polar monomers were prepared via less controlled methods than 
transition metal catalysis such as radical-initiated polymerisations.[61] The authors 
studied the factors that affected the formation of acrylonitrile-based polymers and 
found that the barriers to insertion are not the issue but the dominance of 
coordination of polar functional groups must be overcome to enable more effective 
polymerisation. Due to this dominance of the coordination of the polar functional 
group, they reported no success in the reaction of it with ethylene or carbon 
monoxide, a key reaction step to form the desired polymers.[3d] However, since then 
subsequent work employing alternative catalysts has overcome these problems.[62]  
1.4.3 C-C Activation of Acetonitrile: 
In addition to C‒H activation of acetonitrile there are a number of complexes that 
then further react via C‒CN bond activation to form nitrile and methyl ligands by 
C‒C bond cleavage.[5h, 13] One example employs a rhodium complex to achieve the 
selective cleavage of C–H and C–C bonds.[13b] Both were observed with acetonitrile 
depending on the reaction conditions (Figure 1.31). However, in the case of 
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benzonitrile C‒C bond activation occurred exclusively due to the lack of -hydrogen 
atoms.[13b]  
1.4.4 Synthesis of Alkylnitrile Compounds: 
The applications of -cyanocarbanion complexes in catalysis to form alkylnitrile 
compounds were covered in a recent review by Palomo et al.[2] and are an important 
class of complexes that are found as structural motifs in a number of natural 
products[63] and pharmaceuticals,[64] as well as being synthetically useful 
intermediates. These compounds are typically α-aryl nitriles or β-hydroxy, β-amino 
and β-ketonitriles.  
Alkylnitriles have been successfully synthesised via organic methodologies using a 
strong base to deprotonate the α-position,[65] substituting an electron withdrawing 
group onto the α-substituted aromatic ring, reducing the pKa of the α-carbon[66] or 
the use of synthetic equivalents most commonly TMSCH2CN[67] and silyl 
ketenimines.[68] However, the metal-catalysed formation of alkylnitriles provides 
synthetic advantages due to the high functional group tolerance and atom efficiency 
that has not been achieved under organic reaction conditions. 
Hartwig and co-workers developed a palladium-catalysed arylation of 
alkylnitriles.[15a] Their work tolerated a variety of aryl bromides and was compatible 
Figure 1.31: C-CN activation of acetonitrile with a rhodium catalyst. 
 
hν 
hν 
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with secondary nitriles. When R'' = hydrogen disubstitution of the aryl substituent 
was exclusively observed over 16 h in 60 % yield (Figure 1.32). By using a 
trimethylsilyl functionality on the α-carbon further studies enabled the monoarylation 
of compounds where R' and/or R'' are hydrogen.[69] Since then, the reaction was 
performed using a chiral palladium catalyst yielding asymmetric α-arylated 
alkylnitriles in 80‒95 % ee.[70] 
Figure 1.32: Synthesis of α-arylnitriles 
 
There are a number of synthetic methods for the formation of β-substituted nitriles. 
Based off Hartwig’s work, a range of β-ketonitriles were synthesised using an in situ 
generated palladium catalyst under a CO atmosphere (Figure 1.33).[71] 
Figure 1.33: Synthesis of β-aryl-β-ketonitriles 
Decarboxylative Mannich-type reactions are one synthetic method used to generate  
β-aminonitriles. Initial reactions looked at the performance with and without an  
α-substitution of a carboxylic acid and showed that this substitution greatly 
increased the diastereomeric ratio and ee of the product observed (Figure 1.34).[72] 
Figure 1.34: Synthesis of β-aminonitriles from imines 
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β-Hydroxy, β-amino and β-ketonitriles have also been successfully synthesised from 
the corresponding ketone or imine and a non-activated nitrile. There are a number 
of these reports in the literature and some of the most promising examples will be 
presented below. Both β-hydroxy[73] and β-aminonitriles[74] have been successfully 
synthesised asymmetrically with the use of chiral catalysts. Previously, the 
synthesis of chiral α,α-dichloro-β-aminonitriles has been challenging due to the low 
thermal stability of α,α-dichlorocarbanions. These compounds were successfully 
formed by reaction dichloroacetonitrile with a variety of imines in high yields and 
enantioselectivities (Figure 1.35). The proposed catalytic cycle involves an  
α-cyanocarbanion complex of bonding mode III.[75]  
Figure 1.35: Synthesis of α,α-dichloro-β-aminonitriles using a chiral palladium 
catalyst 
A nickel PNP type complex was used to catalyse the formation of a range of  
β-hydroxynitrile compounds using a –OTf based catalyst in the presence of DBU 
(Figure 1.36, 28). The authors proposed a mechanism involving a ketenimine 
intermediate. Interestingly, when the corresponding Ni–CH2CN complex was used 
no reaction was observed suggesting that this species is not a competent catalyst. 
The authors postulated that this was due to either the ketenimine isomer being 
Figure 1.36: Preparation of β-hydroxynitriles via a PNP catalyst 
 
Chapter 1 
28 
 
stabilised in the reaction mixture via hydrogen-bonding with the protonated DBU, 
(DBUH)+, or that the reaction of the ketenimine with the aldehyde is much faster 
than the isomerisation to the –CH2CN ligand.[76] 
The synthesis of alkylnitrile compounds via catalytic processes typically requires the 
addition of a base, which can lower the functional group tolerance of the 
methodology. Notably, Guan and co-workers utilised a preformed -cyanocarbanion 
complex to catalyse the formation of β-hydroxynitriles from aldehydes without the 
addition of a base (Figure 1.37). The proposed catalytic cycle (Figure 1.38) involves 
the reversible addition of the aldehyde to the carbon-bound α-cyanocarbanion 
complex 29 forming the alkoxide intermediate 30. It is claimed that a dπ-pπ 
Figure 1.37: Synthesis of β-hydoxynitrile compounds via a Ni–POCOP catalyst 
Figure 1.38: Proposed mechanism for β-hydroxynitrile synthesis via catalyst 29 
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repulsion of the Ni–O bond promotes the reformation of the active catalyst despite 
the fact that it is energetically unfavourable.[15b] The mechanism proposed is further 
examined in Chapter 2 accompanied by DFT calculations. 
1.5 Summary and Outlook: 
α-Cyanocarbanion complexes are key intermediates for the synthesis of a range of 
small molecules from β-hydroxynitriles to reactions such as hydrophosphination 
reactions. These complexes can be synthesised using a variety of methods 
primarily via the use of a base to deprotonate a nitrile, oxidative addition and salt 
metathesis. DFT studies indicate that transformations between the two main binding 
modes occur via an intramolecular or a metal slippage process and the binding 
mode observed is influenced by the steric hindrance of the ligands. 
1.6 Project Scope: 
Ongoing studies on α-cyanocarbanion complexes highlight these species as key 
intermediates in various synthetic processes with recent promising examples 
including the base-free synthesis of β-hydroxynitriles. Further work is needed to 
understand the mechanisms for the formation and isomerisation of these complexes 
and the roles of the binding modes in catalysis. 
The project scope is based on previous work in which members of the Gardiner 
group serendipitously synthesised palladium bis(NHC) α-cyanocarbanion 
complexes of bonding mode I and II (Figure 1.39).[77] This finding, combined with the 
applications of α-cyano carbanion complexes in the synthesis of β-hydroxynitriles[2] 
and the extensive applications that palladium NHC complexes have in carbon-
carbon cross reactions[78] formed the basis of potential catalytic applications of these 
compounds. 
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Figure 1.39: Synthesis of α-cyanocarbanion complexes from the corresponding 
acetonitrile complex 
 
Areas of interest of NHC based α-cyanocarbanion complexes to the scope of the 
project include: 
1. Chapter 2 will focus on the most promising published system for the 
synthesis of β-hydroxynitriles[15b], outlining the DFT calculations performed 
as part of this study as well as the synthesis of some related complexes (31, 
Figure 1.40). 
2. A range of bis(NHC) complexes with α-cyanocarbanion ligands will be 
discussed in Chapter 3. 
3. A range of NHC containing pincer complexes based on the information 
discussed in Chapters 2 & 3 will be discussed in Chapter 4 including a new 
synthetic pathway for the formation of complexes of the type 33 (Figure 1.40, 
32, 33).  
4. Chapter 5 outlines catalyst screening employing the complexes described in 
Figure 1.40: General classes of complexes to be studied E = N/C 
Chapter 1 
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Chapters 2-4 for the synthesis of β-hydroxynitriles.  
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Chapter 2: Ni POCOP complexes 
2.1 Introduction to POCOP Complexes: 
The phosphine-based pincer complexes of the type PCP have been studied 
extensively and have been shown to have applications in various areas of catalysis 
including Mizoroki–Heck and Suzuki–Miyaura coupling reactions.[1] POCOP style 
complexes were developed in 2000[2] after noticing that phosphite ligands were 
much more active in Mizoroki–Heck reactions than the corresponding phosphine 
ligands.[3] These replaced the methylene linker of the PCP complexes with an 
electron withdrawing alkoxy group substituted to the phosphine ligand. These 
complexes were shown to be effective in the Mizoroki–Heck reaction and can be 
synthesised in two steps from commercially available starting materials in an 86% 
overall yield.[2] 
Since then the POCOP complexes have found applications in a wide variety of 
catalytic applications. These include Kharasch additions,[4] hydrosilylation of 
aldehydes,[5] homocoupling of benzyl halides,[6] dimerisation of terminal alkynes,[7] 
aromatic C–H borylation[8] and alkane dehydrogenation.[9]  
In addition to this, α-cyanocarbanions have been proposed as an intermediate for a 
number of POCOP catalysis reactions. This includes the hydroamination reaction 
discussed in Chapter 1[10] and Michael addition reactions.[4] However, at this stage, 
no DFT calculations have been performed on these complexes to support the 
bonding mode of the intermediate. 
The most interesting work from the perspective of this study is work published by 
Guan et al.[11] featuring a preformed α-cyanocarbanion complex in the catalytic 
formation of β-hydroxynitriles (Scheme 2.1). A discussion on the mechanism 
proposed by these authors is detailed in Chapter 1. 
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2.2 Results and Discussion: 
2.2.1 DFT Calculations on Guan’s Catalysis:  
Since the work performed by Guan and co-workers, collaborators Alireza Ariafard 
and Allan Canty performed DFT studies to better understand the reaction and the 
impact of steric and electronic variations of the supporting ligands had on the 
catalytic cycle. This information was vital for the subsequent development of 
complexes presented later in this thesis and is thus discussed in detail here. The 
DFT methodology will not be discussed in detail but more information can be found 
in the paper.[12]  
Guan proposed that the –CH2CN ligated complex was the active catalyst while other 
similar reactions proposed the isomerised ligand of –NCCH2 as the active 
catalyst.[13] Therefore, the energies of the two were compared for the addition of the 
aldehyde. 
Two initial mechanisms were investigated for the insertion of the aldehyde. Pathway 
(a) was that proposed by Guan et al. with complex 1 representing the active catalyst 
and 2 being the intermediate. However, the energy for TS1-2 makes this path not 
favoured relative to the alternative pathways investigated. Thus, an alternative 
mechanism (b) was proposed. The proposed mechanism involves the 
intramolecular slippage process as described by Naota et al.[14] (discussed in detail 
in chapter 1.3.2) that transforms the ligand from bonding mode I to III. This is 
Scheme 2.1: Synthesis of β-hydoxynitrile compounds via a Ni–POCOP catalyst. 
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followed by the addition of the alkoxide to the α-carbon to form the remote alkoxide 
intermediate 4 (Scheme 2.2). 
Scheme 2.2: Computed energy profile for pathway a and b of proposed 
mechanism. 
 
As 2 is a common proposed intermediate by Guan and related catalysis papers[13c, 
15] the catalytic cycle pathway (c) was analysed with the rearrangement from the  
N–bound remote alkoxide intermediate (4) to the proposed O–bound alkoxide 
intermediate 2. However, the energy for the TS2-3 makes this path unfeasible. Thus, 
it appears that the O–bound alkoxide is not an intermediate in the reaction and that 
the reaction instead proceeds by the N–bound remote alkoxide intermediate 4 
(Scheme 2.3). 
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Scheme 2.3: Computed energy profile for pathway c of proposed mechanism. 
 
The initial calculations were performed for the transformation of the alkoxide 
intermediate to the active ketenimine catalyst via pathway (d). As Guan et al. 
suggested that they did not scrupulously exclude water from the reaction, the 
calculations were also performed with the incorporation of a H2O dimer. This was 
shown to reduce the energy of the five coordinate transition state TS5-6 and TS7-8 
from 31.2 to 23.6 kcal/mol. The calculations then showed a reformation of the active 
catalyst 3 and the β-hydroxynitrile product (Scheme 2.4). 
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Scheme 2.4: Computed energy profile for pathway d and e of proposed 
mechanism. 
 
Thus, the overall catalytic cycle is proposed below. An activation energy of  
28.5 kcal/mol for the first formation of the product was calculated, however, the 
effective activation energy for the second cycle onwards is 23.6 kcal/mol. This is 
because the activation energy of 28.5 kcal/mol is required to form the active catalyst 
however, this complex is reformed at the end of the catalytic cycle and therefore 
TS7-8 is the highest energy for subsequent cycles (Scheme 2.5). 
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Scheme 2.5: Catalytic cycle proposed for the formation of β-hydoxynitriles using 
catalyst 1. 
 
Steric and electronic influences of the ligand on the activation energy of the catalytic 
cycle were then investigated by modification of the POCOP catalyst to give insight 
into some of the important characteristics of these complexes. The first modification 
performed was changing the central phenyl ring to a pyrrole ring. Due to the weaker 
trans influence the energetics for both the intramolecular isomerisation and the  
five-coordinate transition state is higher than that observed for the corresponding 
phenyl ring (Scheme 2.6). 
ΔGǂ = 28.5 kcal/mol 
ΔGǂ = 23.6 kcal/mol 
Effective activation 
energy of the 
second cycle 
onwards 
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Scheme 2.6: Catalytic cycle when central phenyl is replaced with a pyrrole. 
 
The catalytic cycle was also modified to look at the effect of increasing the steric 
bulk to tBu from iPr. When Guan et al. used the corresponding tBu ligand no 
conversion was observed. The calculations indicate that the 5-coordinate transition 
state energy is increased to 28.8 kcal/mol, which may account for the observation 
that no reaction was observed (Scheme 2.7).[11]  
 
ΔGǂ = 33.9 kcal/mol 
ΔGǂ = 28.4 kcal/mol 
Effective activation 
energy of the second 
cycle onwards 
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Scheme 2.7: Catalytic cycle when the steric bulk is increased from iPr to tBu. 
 
The important conclusions from the DFT calculations performed which may assist in 
understanding the effect that the pincer ligand has on the catalytic cycle are 
summarised below; 
a) The C–bound isomer is not the active catalyst and instead the N–bound 
catalyst is the active catalyst. 
b) The trans donor effect of the phenyl ring is important in lowering the energy 
of the transition state of the isomerisation to the N-bound active catalyst and 
the 5-coordinate transition state. 
c) Due to the presence of the 5-coordinate transition state, increasing the steric 
bulk to a tBu ligand prevents the reaction from proceeding. 
ΔGǂ = 30.1 kcal/mol 
ΔGǂ = 28.8 kcal/mol 
Effective activation 
energy of the second 
cycle onwards 
Chapter 2 
49 
 
2.2.2 Attempted Synthesis of [{2,6-(iPr2PO)2C6H3}Ni(CH2CN)]: 
A series of catalytically relevant Ni POCOP complexes were synthesised to 
compare their catalytic activity to previously known catalysts (as discussed in 
Chapter 5). [{2,6-(iPr2PO)2C6H3}Ni(NCMe)][SbF6] (I) was synthesised following a 
modified published procedure[10] by reacting [{2,6-(iPr2PO)2C6H3}NiBr] and Ag[SbF6] 
in CH3CN at room temperature for 17 h with the exclusion of light (Scheme 2.8). The 
structure was confirmed by X-ray crystallography and supported by 1H and 13C NMR 
spectroscopy with a 1H NMR resonance at 2.20 ppm consistent with the CH3 from 
the formation of the –NCMe ligand. 
The metrics of the crystal structure of [{2,6-(iPr2PO)2C6H3}Ni(NCMe)][SbF6] is 
consistent with the previously published [{2,6-(iPr2PO)2C6H3}Ni(NCMe)][OTf] 
complex which had Ni–C bond distances of 1.881(2)–1.883(2) Å and Ni–N bond 
distances of 1.874(2)–1.884(2) Å (Figure 2.1).[4] 
Scheme 2.8: Synthesis of [{2,6-(iPr2PO)2C6H3}Ni(NCMe)][SbF6] (I). 
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Figure 2.2: X-ray molecular structure of cation [{2,6-(iPr2PO)2C6H3}Ni(NCMe)]+ of I. 
Thermal ellipsoids are shown at the 50 % probability level. Only one of 
the three [{2,6-(iPr2PO)2C6H3}Ni(NCMe)] complexes in the asymmetric 
unit is displayed and all phosphine substituent hydrogen atoms and 
[SbF6] counter anions are removed for clarity. Range of selected bond 
lengths (Å) and angles (°): Ni–C 1.885(3)–1.888(3), Ni–P  
2.1635(8)–2.1755(8), Ni–N 1.876(2)–1.884(2), P–Ni–P 162.92(3)–
164.32(3), N–Ni–P 95.34(7)–101.30(7), N–Ni–C 173.89(11)–174.01(11), 
C–Ni–P 81.81(8)–82.24(8). 
One of the three crystallographically independent complexes in the lattice had a 
distorted geometry with N-Ni-P angles of 95.34(7) and 101.30(7) ° in contrast to 
97.32(7)–98.70(7) ° observed for the other two complexes. This is consistent with a 
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distortion of the –NCMe ligand due to the steric bulk of the iPr2P substituent (Figure 
2.2). 
Figure 2.2: X-ray molecular structure of cation [{2,6-(iPr2PO)2C6H3}Ni(NCMe)]+ of I. 
Thermal ellipsoids are shown at the 50 % probability level. The one 
complex of three in the lattice with a distorted geometry is shown. 
 
A number of approaches were explored in an attempt to prepare Guan’s catalyst 
[{2,6-(iPr2PO)2C6H3}Ni(CH2CN)] (1). The previously reported two synthetic methods 
were attempted under modified conditions.[11] 1 was reported to be an air stable 
complex both as a solid and as a solution in toluene. 
[{2,6-(iPr2PO)2C6H3}Ni(NCMe)][SbF6] was reacted with [LiN(SiMe3)2] in THF. When 
the 1H NMR spectrum was recorded in CDCl3 the resonances were consistent with  
[{2,6-(iPr2PO)2C6H3}NiCl] indicating decomposition in the presence of CDCl3. 
Similarly, when the product was purified on the bench top the product decomposed 
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from one major product to various products by 1H NMR spectroscopy. When the 
purification was performed in a glove box, various products were observed by 1H 
NMR spectroscopy and thus purification was not possible. An alternative method 
was pursued in a desire to synthesise the reported complex. 
Alternatively, [{2,6-(iPr2PO)2C6H3}Ni(NCMe)][SbF6] was reacted with NaOH in 
CH3CN. Although initially a yellow powder was observed, when the powder was left 
standing over the weekend exposed to air the product had decomposed to a green 
solid with multiple products observed by 1H NMR spectroscopy. Thus this synthesis 
method, discussed further in Chapter 3 used for the formation of the bis(NHC)  
–CH2CN complexes is not suitable here. 
[{2,6-(iPr2PO)2C6H3}NiBr] was reacted with in situ generated [LiCH2CN] in THF 
however recrystallisation attempts did not yield the desired product as judged by 1H 
NMR spectroscopy. Similarly, [{2,6-(iPr2PO)2C6H3}NiCl] was reacted with in situ 
generated [LiCH2CN] in THF forming an inseparable mixture. 
Due to the difficulty in synthesising the desired [{2,6-(iPr2PO)2C6H3}Ni(CH2CN)] (1) 
catalyst, [{2,6-(iPr2PO)2C6H3}NiCl] and [{2,6-(iPr2PO)2C6H3}NiBr] were both reacted 
with NaOH in THF in an attempt to form [{2,6-(iPr2PO)2C6H3}Ni(OH)] following a 
modified published procedure developed for the related PCP complexes.[16] This 
complex would have been used for the synthesis of β-hydroxynitriles as an 
alternative to 1, however, a range of products were observed by 1H NMR 
spectroscopy and purification was not possible. 
2.3 Experimental: 
2.3.1 General Considerations: 
All air sensitive reactions were performed under an atmosphere of high purity argon 
using standard Schlenk techniques. Glassware was heated under vacuum and 
back-filled with argon to ensure the exclusion of oxygen and moisture in the 
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reactions. Ag[SbF6] was purchased from Sigma-Aldrich and used as received. 
NaOH was purchased from Chem Supply and dried under vacuum at 200 °C. 
[LiN(SiMe3)2] (1.0 M in THF) was purchased from Aldrich and stored in an ampoule. 
Anhydrous CH3CN was obtained by passage through an Innovative Technologies 
Solvent Purifier and stored in an ampoule over 3 Å molecular sieves. All other 
anhydrous solvents were obtained by passage through an Innovative Technologies 
Solvent Purifier and stored in an ampoule over a mirror of sodium.  
[{2,6-(iPr2PO)2C6H3}NiBr],[4] [{2,6-(iPr2PO)2C6H3}NiCl][4] and [LiCH2CN][11] were all 
synthesised according to literature procedures. 
2.3.2 Instrumentation: 
NMR spectroscopic studies were carried out on a Bruker Avance III HD 400 MHz 
Wide Bore Spectrometer with a 5 mm BBFO probe at room temperature (293 K) or 
120 °C (393 K) where indicated or a Bruker Avance III HD 600 MHz spectrometer 
with a 5 mm TCI-cyroprobeat 300 K, in DMSO-d6. DMSO-d6 was used as received. 
1H NMR spectra were obtained at 399.58 MHz, 13C NMR spectra were recorded at 
150.89 MHz and 31P NMR spectra were recorded at 161.75 MHz. 1H NMR spectra 
were referenced to the residual 1H resonance of the residual solvent peak while 13C 
NMR spectra were referenced to a deuterated 13C resonance. 
Elemental analyses were conducted by Dr. Thomas Rodemann at the Central 
Science Laboratory at the University of Tasmania using a Carlo Erba EA1108 
Elemental Analyser. 
X-ray crystallographic data for I was collected at –173 °C on crystals mounted on a 
Hampton Scientific cryoloop on a Bruker AXS D8 Quest with a Cu Kα source. The 
structure was solved by direct methods with SHELXT, refined using full-matrix least-
squares routines against F2 with SHELXL-97,[17] and visualised using Olex2.[18] All 
non-hydrogen atoms were refined anisotropically. All hydrogen atoms were placed 
in calculated positions and refined using a riding model with fixed C–H distances of 
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0.95 Å (sp2CH), 1.00 Å (sp3CH) and 0.98 Å (CH3). The thermal parameters of all 
hydrogen atoms were estimated as Uiso(H) = 1.2Ueq(C), except for CH3 where 
Uiso(H) = 1.5Ueq(C). Cif file available on request. 
2.3.3 Preparation of [{2,6-(iPr2PO)2C6H3}Ni(NCMe)][SbF6] (I): 
A modified published procedure was employed.[10] [{2,6-(iPr2PO)2C6H3}NiBr]  
(0.098 g, 2.04x10-4 mol), Ag[SbF6] (0.087 g, 2.54x10-4 mol) and CH3CN (5 mL) were 
combined in a Schlenk flask and stirred overnight at room temperature with the 
exclusion of light for 17 h. CH3CN was removed under vacuum and the product was 
dissolved in CH3CN and filtered through a glass fibre filter pipette. The ensuing solid 
was then recrystallised via vapour diffusion of diethyl ether into a near saturated 
solution in CH3CN yielding orange crystals (41 % yield, 0.057 g). 
1H NMR (400 MHz, d6-DMSO): δ 7.03 (t, 1H, J = 8.0 Hz, p-CH), 6.44 (d, 2H, J =  
8.0 Hz, m-CH), 2.55–2.58 (m, 4H, iPr CH), 2.20 (d, 3H, J = 2.5 Hz, NCMe),  
1.28–1.40 ppm (m, 24H, iPr CH3). 
13C NMR (150 MHz, d6-DMSO): δ 169.0 (t, JPC = 8.9 Hz, o-C), 131.0 (p-CH), 122.6 
(bs, as defined by HMBC, NCMe), 117.8 (bs, confirmed by HMBC, Ni–C), 106.3 (t, 
JPC = 5.7 Hz, m-CH), 28.1 (t, JPC = 11.9 Hz, iPr CH), 17.7 (iPr CH3), 16.9 (iPr CH3), 
2.2 ppm (NCMe). 
31P NMR (161.8 MHz, d6-DMSO): δ 186.7 ppm 
Anal. Calc. for C20NH34O2P2NiSbF6: C, 35.49; H, 5.06; N, 2.07; Found: C, 35.01; H, 
5.21; N, 1.89 %  
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Chapter 3: Synthesis of bis(NHC) α-Cyanocarbanion 
Complexes 
3.1 Introduction to bis(NHC) α-Cyanocarbanion Complexes: 
Bis(NHC) (bis N-heterocyclic carbene) complexes of type 1 have been shown to be 
active in the copolymerisation of CO and ethene to form polyketones.[1] However, 
the yields and TON are much lower than that observed with the comparable 
bisphosphine palladium(II) catalysts used for the previously commercialised Shell 
process.[2] Thus, previous work by the Gardiner group studied these complexes 
under catalytically relevant conditions to understand if the performance of these 
catalysts can be improved. Reacting the [bis(NHC)Pd(NCMe)2][PF6]2 complex (1) 
with Na2CO3 in MeOH led to the generation of two novel Pd2(I) hydride species 
(Scheme 3.1).[3] 
Scheme 3.1: Synthesis of Pd2(I) hydride species under catalytically relevant 
conditions. 
 
In the initial DFT calculations of the reaction in Scheme 3.1 a key proposed reaction 
step was the abstraction and reductive elimination of a hydride from Pd2(II) 
dihydride intermediate by methoxide (Scheme 3.2) yielding the observed Pd2(I) 
hydride complexes. Palladium(II) hydride species have been proposed as 
intermediates for the synthesis of polyketones,[2] however, they have been very 
infrequently observed under catalytically relevant conditions. Attempts were made to 
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trap some of the reactive Pd(II) hydride intermediates via the reaction of 1 with a 
more sterically hindered alkoxide and the corresponding alcohol as a solvent.[4]  
Scheme 3.2: Deprotonation and reductive elimination step of the mechanism from 
the dipalladium(II) hydride complex to the dipalladium(I) hydride 
complex. 
 
During this work,[4] an unexpected product was observed when the solvent was 
changed from the corresponding alcohol of the base to CH3CN due to the practical 
issues of the melting point of tBuOH being 25 °C. When 1a, NaOtBu and CH3CN 
were reacted, the deprotonation of the acetonitrile ligand was observed forming two 
different complexes (Scheme 3.3). These two complexes are related; complex IIa 
involves two deprotonated acetonitrile molecules per Pd bis(NHC) motif, while 
complex IIIa is a dinuclear complex with a 1:1 ratio of the deprotonated acetonitrile 
molecule and Pd bis(NHC) motif. These complexes were shown to exhibit bonding 
Scheme 3.3: Synthesis of bis(NHC) supported α-cyanocarbanion complexes of 
different binding modes. 
Chapter 3 
59 
 
modes I and II (See Figure 1.11, Chapter 1) by X-ray crystallography but were not 
further characterised prior to this project commencing (bonding modes are 
discussed in depth in the introduction in Section 1.3). 
Interest in further studying these complexes was prompted by their potential 
catalytic applications in the formation of β-hydroxynitriles[5] and to understand more 
about the unexpected synthesis of these complexes given the high pKa of 
acetonitrile. With a pKa of 31.3 in DMSO[6] and 25 in water,[7] acetonitrile was not 
expected to readily react with NaOtBu under these conditions. 
3.2 Results and Discussion: 
3.2.1 Synthesis of [{(MesIm)2CH2}Pd(CH2CN)2] (IIa) and  
[{([MesIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (IIIa): 
The used of NaOtBu for the synthesis of IIa and IIIa was identified as an issue due 
to the formation of an unexpected by-product. A background reaction was observed 
when NaOtBu was stirred with CH3CN at 70°C for 16 h yielding three products: the 
E & Z isomer of 3-aminocrotononitrile (IV) and 4-amino-2,6-dimethylpyrimidine (V) 
(Scheme 3.4). The formation of IV was supported by 1H NMR spectroscopy which 
displayed resonances at 4.85 and 4.99 ppm consistent with the formation of the 
amine and previous literature values.[8] The 1H NMR resonance at 6.07 ppm 
supported the formation of V and was consistent with previous literature reports.[9]  
Scheme 3.4: Unintended synthesis of 3-aminocrotononitrile IV and  
4-amino-2,6-dimethylpyrimidine V. 
The formation of the E- and Z-isomer of 3-aminocrotononitrile is thought to result 
from the dimerisation of acetonitrile which had been observed under similar 
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conditions.[8] This dimer is suggested as an intermediate in the formation of V, a 
trimerisation product from acetonitrile, with previous studies involving the reaction of 
IV with Me4NOH.5H2O in CH3CN yielding 4-amino-2,6-dimethylpyrimidine (V).[10] 
The synthesis of 4-amino-2,6-dimethylpyrimidine (V), has been previously observed 
from acetonitrile[9, 11] using KOtBu at 165 °C in a microwave.[9] These milder 
conditions have not previously been recorded and are interesting due to the 
previous reports for the synthesis of V requiring elevated temperatures.[9, 11]  
The mechanism proposed for the dimerisation and trimerisation of acetonitrile is 
modified from that proposed by Murahashi who observed dimerisation of acetonitrile 
with NaOtBu acting as a catalyst instead of iridium (Scheme 3.5).[12]  
Scheme 3.5: Proposed reaction mechanism for the synthesis of  
3-aminocrotononitrile IV and 4-amino-2,6-dimethylpyrimidine V. 
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Due to the success that was observed with copper,[13] nickel[13] and iridium[14] 
hydroxide complexes in the synthesis of α-cyanocarbanions discussed in Chapter 1, 
NaOH was chosen as an alternative base for the reaction. 
NaOH was shown to have the same performance as NaOtBu forming the desired  
–CH2CN product with no formation of a carboxamide product which has been 
observed under similar conditions.[14-15] 
Reacting [{(MesIm)2CH2}Pd(NCMe)2][PF6]2 with NaOH in CH3CN at 60 °C for 24 h 
yielded [{(MesIm)2CH2}Pd(CH2CN)2] (IIa) or [{([MesIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 
(IIIa) depending on the reaction conditions (Scheme 3.6). The specificity between 
the two products IIa and IIIa will be discussed later in the Chapter when other  
N-substituents have been considered. 
Scheme 3.6: Synthesis of two different α-cyanocarbanion complexes 
[{(MesIm)2CH2}Pd(CH2CN)2] (IIa) and  
[{([MesIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (IIIa). 
 
When 6.3 equiv. of NaOH was used IIa was synthesised in a quantitative yield. 
There are a number of possible reasons for the high yield obtained. This could be 
due to the contamination with IIIa which was difficult to separate from IIa. The 
identity of [{(MesIm)2CH2}Pd(CH2CN)2] (IIa) was supported by 1H NMR 
spectroscopy with a resonance at 0.36 ppm consistent with the formation of an  
α-cyanocarbanion of bonding mode I. The product was spectroscopically identical to 
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that previously reported in the Gardiner group.[4] An ESI-MS was obtained of the 
product with a m/z consistent with the formation of IIa. 
When 3.5 equiv of NaOH was used IIIa was synthesised in a 45 % yield. The 
formation of the desired product was supported by 1H NMR spectroscopy in  
d6-DMSO at 120 °C with a resonance at 0.31 ppm corresponding to the CH2CN 
ligand and 4 inequivalent imidazol-2-ylidene resonances. This is consistent with the 
two imidazol-2-ylidene rings becoming inequivalent due to two different trans 
ligands consistent with a Pd–C and Pd–N bond from the µ-CH2CN ligands. At room 
temperature there are two resonances at 6.29 and 6.52 ppm consistent with the 
methylene linker of the bis(NHC) ligand observed as a AB spin system which is 
consistent with the retention of a boat conformation for the C3N2Pd ring with ring 
flipping that is slow on the NMR time scale.[16] 
The X-ray crystal structure of [{([MesIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (IIIa) is 
consistent with that reported for similar complexes, including the starting material 
[{(MesIm)2CH2}Pd(NCMe)2][PF6]2. A boat shape geometry is observed for the 
C3N2Pd ring with Pd–CNHC distances of 1.991(5) Å for the ligand trans to the 
nitrogen and 2.050(5) Å for the ligand trans to the carbon and angles of the NHC 
plane to the PdL4 plane at 24.60(10) and 33.28(10) °. Consistent with other 
complexes of binding mode II as discussed in the introduction, the bond order of the 
two deprotonated nitrile ligands are consistent with a N–C triple bond with a length 
of 1.143(6) Å and a C–C bond length of 1.422(6) Å consistent with a single bond 
between a sp and sp3 centre. There is also a C(8)–N(5)–Pd(1) angle of 163.0(4) ° 
distorted from the ideal linear angle to accommodate the formation of the Pd2N2C4 
metallocyclic ring of the dinuclear species. The C(8)‒C(9)‒Pd(1) angle of 109.8(3) ° 
is close to the ideal tetrahedral angle (Figure 3.1, Table 3.1). 
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Complex: 1a[1, 17] IIa[4] IIIa 1b[1] IIb IIIba 1c[18] IIca IIIc 
Pd-Ccarbene distance (Å) 1.983(4), 
1.984(4) 
2.039(4)–
2.065(3) 
1.991(5), 
2.050(5) 
1.966(2), 
1.972(3) 
2.023(9), 
2.037(10) 
 1.979(3), 
1.984(3) 
 2.065(3), 
2.013(3) 
Ccarbene-Pd-Ccarbene angle 
(°) 
85.87(17) 86.59(14), 
86.79(14) 
87.5(2) 84.05(11) 85.4(4)  87.68(11)  88.28(11) 
Ccarbene-N-R angle (°) 127.2(3), 
128.1(4) 
125.7(3)–
126.7(3) 
126.1(4), 
126.6(4) 
125.8(2), 
126.3(3) 
124.8(9), 
126.6(9) 
 127.2(2), 
129.6(2) 
 127.6(2), 
130.5(2) 
Im/PdC2L2 dihedral angle 
(°) 
37.7(2), 
35.92(14) 
37.18(13)–
37.94(13) 
34.8(4), 
31.6(4) 
42.4252(4), 
42.7953(5) 
40.6(4), 
39.6(4) 
 27.59(9), 
28.45(9) 
 24.60(10),  
33.28(10) 
Av. distance from Im 
plane for CN-substituent and 
Pd (Å) 
0.045 0.103 0.0538 0.0446 0.0648  0.083  0.230 
Distance of CH2 from 
PdC2L2 plane (Å) 
1.537(7) 1.551(5) 1.394(8) 1.596030(14) 1.642(14)  1.255(4)  1.246(4) 
Pd-C-C angle (°)  108.6(2)–
118.4(3) 
109.8(3)  110.2(7), 
110.3(7) 
   110.7(2) 
Pd-N-C angle (°) 167.8(4), 
168.4(4) 
 163.0(4) 172.8(2), 
179.4(2) 
  165.6(2), 
166.0(2) 
 164.9(2) 
N≡C-C angle (°) 178.2(5), 
179.1(5) 
177.3(4), 
179.5(4) 
176.6(5) 178.8(3), 
179.2(3) 
175.4(11), 
177.6(12) 
 178.2(3), 
178.8(3) 
 175.3(3) 
1H NMR shift of CH2/3 
(ppm) 
2.49b 0.36c 0.31b 2.08b 1.04c 1.26-
1.32c 
2.05b 0.30b 0.46c 
13C NMR shift of CH2/3 
(ppm) 
1.6b –15.0c –12.4b 1.6b –13.5c –14.1c 1.9b –10.5b –14.3c 
Table 3.1: Key crystallographic and NMR data for [{(MesIm)2CH2}Pd(NCMe)2][PF6]2 (1a), [{(MesIm)2CH2}Pd(CH2CN)2] (IIa),  
[{([MesIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (IIIa), [{(MeIm)2CH2}Pd(NCMe)2][BF4]2 (1b), [{(MeIm)2CH2}Pd(CH2CN)2] (IIb), 
[{([MeIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (IIIb), [{(dippIm)2CH2}Pd(NCMe)2][PF6]2 (1c), [{(dippIm)2CH2}Pd(CH2CN)2] (IIc) and 
[{([dippIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (IIIc). a X-ray crystal structure not obtained b NMR spectra performed in d6-DMSO. c NMR 
spectra performed in CD3CN. 
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A detailed comparison of all the compounds presented in Table 3.1 will be 
performed later in this Chapter when all the complexes presented in the Table have 
been discussed. 
 Figure 3.1: X-ray molecular structure of cation [{([MesIm]2CH2)Pd(µ-CH2CN)}2]2+ of 
IIIa. Thermal ellipsoids are shown at the 50% probability level. 2 [PF6]- 
counter ions and 2 CH3CN lattice solvent molecules omitted for clarity. 
All mesityl hydrogen atoms removed for clarity. Selected bond lengths 
(Å) and angles (°): Pd(1)‒N(5) 2.030(4), Pd(1)‒C(1) 1.991(5), 
Pd(1)‒C(5) 2.050(5), Pd(1)‒C(9) 2.136(5), N(5)‒C(8) 1.143(6), 
C(8)‒C(9) 1.422(6), N(5)‒Pd(1)‒C(5) 92.07(18), N(5)‒Pd(1)‒C(9) 
89.53(18), C(1)‒Pd(1)‒C(5) 87.5(2), C(1)‒Pd(1)‒C(9) 90.91(19), 
C(8)‒N(5)‒Pd(1) 163.0(4), N(5)‒C(8)‒C(9) 176.6(5), C(8)‒C(9)‒Pd(1) 
109.8(3). 
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While in DMSO-d6 the 1H NMR spectroscopy of  
[{([MesIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (IIIa) is consistent with the presence of the 
dinuclear complex with a 1:1 ratio of the deprotonated acetonitrile molecule and Pd 
bis(NHC) motif, as described above. Analysis of the 1H NMR spectra of IIIa in 
CD3CN provides insight into the different influence on solvent intervened 
monomer/dimer equilibria. At room temperature two products were observed, 
complexes A and B in a 1.8:1 ratio. The two species both exhibit 1H NMR 
resonances characteristic of a bis(NHC) ligand bound to a palladium with the two 
NHC rings within each complex being inequivalent imidazol-2-ylidene rings due to 
the presence of two inequivalent trans ligands (Figure 3.2, Green). The integration 
ratios support both complex A and B having one CH2CN ligand per Pd bis(NHC) 
motif. 2D NMR spectroscopy allowed the assignment of resonances for complex A 
and B. The NMR spectra were compared with IIa and 1a suggesting that neither of 
these products were present in solution (Figure 3.2). The full assignment and 
behaviour in solution will be presented after the discussion of the identity of 
complexes A and B in solution. 
Figure 3.2: 1H NMR spectra of [{([MesIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (IIIa, green), 
[{(MesIm)2CH2}Pd(NCMe)2][PF6]2 (1a, red) and 
[{(MesIm)2CH2}Pd(CH2CN)2] (IIa, blue). 
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In order to make partial structural assignment for the two complexes in solution a 
Diffusion Ordered Spectroscopy (DOSY) NMR experiment was recorded of a 
CD3CN solution containing a mixture of 1a and IIIa. The addition of 
[{(MesIm)2CH2}Pd(NCMe)2][PF6]2 (1a) in the solution served as an internal standard 
as the molecular weight, and thus diffusion coefficient of its cation 
[{(MesIm)2CH2}Pd(NCMe)2]2+ was roughly equivalent to the fragment of IIIa 
[([MesIm]2CH2)Pd(CH2CN)]+ if the species was cleaved in solution. The NMR 
spectrum was recorded of the mixture of 1a and IIIa suggesting that the complexes 
were unaltered in solution and that an equilibrium between the internal standard and 
the two complexes A and B in solution does not occur (Figure 3.3). 
Figure 3.3: 1H NMR spectra of [{(MesIm)2CH2}Pd(NCMe)2][PF6]2 (1a, green), 
[{([MesIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (IIIa, red) and the solution of 1a 
and IIIa combined (blue). 
Analysis of the DOSY experiment (Figure 3.4) indicates that the diffusion coefficient 
of 1a (black dots) and complex B (green dots) are close and thus have a similar 
molecular weight while the diffusion coefficient of complex A (red dots) is lower and 
thus it has a higher molecular weight. 
It is proposed that complex A corresponds to the dimer observed in the crystal 
structure in solution while this species is also cleaved in solution to form complex B 
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with an NCMe ligand complexing to the open coordination site. The similarity in 
chemical shifts between complexes A and B support complex B having a CH2CN 
ligand being of bonding mode I (Scheme 3.7). An ESI-MS was recorded of the 
solution of IIIa in an attempt to observe a molecular ion consistent with the 
assignment for complex B, however, due to the dissociation of Pd–N bonds under 
even mild conditions only the fragment [{(MesIm)2CH2}Pd(CH2CN)]+ was observed. 
This is consistent with the ESI-MS of [{(dippIm)2CH2}Pd(NCMe)2]]PF6]2 in which 
both [{(dippIm)2CH2}Pd]2+ and [{(dippIm)2CH2}Pd(NCMe)]2+ were observed.[18] 
Figure 3.4: DOSY NMR spectra of a mixture of [{(MesIm)2CH2}Pd(NCMe)2][PF6]2 
(black dots) and [{([MesIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (complex A red 
dots, complex B green dots). 
Scheme 3.7: Proposed equilibrium of IIIa in CH3CN. 
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To support the proposed equilibrium a 1H NMR spectrum of IIIa was performed in 
DMSO-d6 at room temperature and it was titrated with CD3CN. The 1H NMR 
spectrum of [{([MesIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 in DMSO-d6 at room temperature 
had broad signals, but was consistent with the pure IIIa sample previously recorded 
at 120 °C. The aromatic and methylene region of the 1H NMR spectra were 
monitored with the progressive titration of CD3CN into the solution. Two doublets 
were observed to appear both in the range of 7.85 – 7.95 ppm and 7.30 – 7.50 ppm 
(Figure 3.5, black dots). In addition, the integration ratio of the two methylene peaks 
between 6.20 – 6.60 ppm changed upon the addition of CD3CN. In the DMSO-d6 
solution the integration ratio is 1:1, however, with 435 µL of CD3CN added to the 
solution the peak at 6.5 ppm had increased in comparison to the peak at 6.2 ppm 
with a ratio of 1.6:1 (Figure 3.5, red dots). This supports the proposal above that the 
presence of acetonitrile affects the equilibrium with complex B only observed with 
CD3CN in solution. 
Figure 3.5: 1H NMR spectra of [{([MesIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (IIIa) in  
DMSO-d6 with titrated addition of CD3CN. Titrated volume shown on 
right. 
 
A NOESY NMR experiment was also recorded analysing the protons in exchange 
and protons that are close in distance to each other. In this case, cross peaks due 
0 µL 
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to chemical exchange (Figure 3.6, 3.7, blue) are opposite in phase to nOe 
crosspeaks (Figure 3.6–3.8, green). Analysis of the exchange peaks shows 
exchange between the CH2 peaks for complexes A and B of both the methylene 
linker and CH2CN ligand (Figure 3.6, 3.7 black dots); this indicates that the two 
complexes are in an equilibrium, which is slow on the NMR time scale at room 
temperature supporting what was described above. As expected, the aromatic 
mesityl peaks also exchange (Figure 3.7, red dots). From analysis of the nOe peaks 
it can be seen that the imidazol-2-ylidene ring proton resonances correlate with 
each other (Figure 3.7, green dots, Figure 3.9 a) in addition to the methylene linker 
(Figure 3.7, black dots, Figure 3.9 b). nOe interactions can be seen between the 
imidazol-2-ylidine and mesityl m-H peaks to the aliphatic mesityl peaks (Figure 3.8, 
Figure 3.9 c). In addition, a nOe correlation is observed between the mesityl o-CH3 
hydrogens and the CH2CN peaks consistent with a H···H distance of 2.69(4) Å 
observed in the X-ray crystal structure (Figure 3.9 d). 
 
Figure 3.6: NOESY NMR spectra of IIIa (blue peaks exchange peaks, green peaks 
nOe peaks, black dots methylene and CH2CN ligand CH2 signals) 
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Figure 3.8: NOESY NMR spectra of IIIa, partial aromatic and aliphatic correlation 
region (green peaks nOe peaks, red dots mesityl, green dots 
imidazolium resonances). 
Figure 3.7: NOESY NMR spectra of IIIa, aromatic and methylene region (blue 
peaks exchange peaks, green peaks nOe peaks, black dots methylene, 
red dots aromatic mesityl, green dots imidazolium resonances). 
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Figure 3.9: IIIa fragment highlighting nOe correlations. 
 
VT NMR studies were undertaken to elucidate the equilibrium behaviour of the 
proposed two complexes in solution. The characteristic CH2 peaks in the range of 
6.1–6.4 ppm do not coalesce indicating the presence of complexes A and B at all 
temperatures in a slow exchange on the NMR time scale. The ratio of complexes A 
and B are influenced by temperature, with a ratio at –10 °C of 1:2.7 while at 70 °C it 
is 1:1.3 (Figure 3.10, blue dots). This supports the presence of an equilibrium noted 
in the NOESY NMR spectra. At room temperature, the methylene bridge CH2 
protons are equivalent in both complex A and B, however, below 10 °C the peaks 
become separated consistent with the formation of an AB spin system for each 
complex (Figure 3.10, blue dots). This is consistent with the locking of the boat 
conformation of the bis(NHC) chelate rings.[16] 
 At room temperature, there are four m-H peaks consistent with both complex A and 
complex B having restricted motion, i.e. Ha and Hb were inequivalent by 1H NMR 
spectroscopy (Figure 3.11). When the solution is heated above room temperature, 
the aryl peaks coalesce indicating rapid N–C rotation rendering Ha equivalent to Hb 
(Figure 3.10, red and black dots). The peaks in the –0.5 to 1 ppm region correspond 
to the CH2CN ligands (Figure 3.10, green dots). When the temperature is –5 °C or 
below an AB spin system is observed consistent with the two protons becoming 
inequivalent due to restricted motion. At –15 °C, a third product is apparent, 
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evidenced by the presence of a third set of CH2CN peaks in the –0.5 to 1 ppm 
region.  
Figure 3.10: Overlay of the 1H NMR spectra of IIIa in CD3CN at various 
temperatures. 
 
Figure 3.11: IIIa fragment highlighting restricted motion. 
 
A DOSY NMR spectra was recorded at –40 °C to determine the diffusion coefficient 
of the third complex was inconclusive, which is likely due to increasing solvent 
viscosity and inability to resolve any differences in diffusion. Thus, the identity of the 
product formed is unclear and due to the difficulty in studying this product it was not 
pursued further. 
To understand the relationship between [{(MesIm)2CH2}Pd(CH2CN)2] (IIa) and 
[{([MesIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (IIIa) in their synthesis from 
[{(MesIm)2CH2}Pd(NCMe)2][PF6]2 (1a) [{([MesIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (IIIa) 
was reacted with an excess of NaOH at 60 °C for 24 h in CH3CN forming 
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40 °C  
25 °C  
10 °C  
–5 °C  
–15 °C  
–30 °C  
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[{(MesIm)2CH2}Pd(CH2CN)2] (IIa) in 75% yield. When IIa was reacted with 1 
equivalent of H[BF4] in CH3CN for 5 minutes, the product  
[{([MesIm]2CH2)Pd(µ-CH2CN)}2][BF4]2 (IIIa) was reformed (Scheme 3.8). This means 
that the formation of IIIa is likely favoured when there is insufficient NaOH in the 
reaction mixture to allow complete reactivity. This is consistent with the fact that 
when 6.3 equivalents of NaOH were reacted with 1a, IIa was observed as the sole 
product. However when 3.5 equivalents of NaOH was reacted with 1a, IIIa was 
observed as the sole product. 
Scheme 3.8: Interconversion between [{([MesIm]2CH2)Pd(µ-CH2CN)}2][X]2 (IIIa) and 
[{(MesIm)2CH2}Pd(CH2CN)2] (IIa). 
Similarly, upon the addition of excess H[BF4] to  
[{([MesIm]2CH2)Pd(µ-CH2CN)}2][BF4]2, [{(MesIm)2CH2}Pd(NCMe)2][PF6]2 1a was 
observed. 
Given the formation of both IIa and IIIa from 1a under similar conditions and the 
solution phase equilibrium of IIIa observed, the effect of the steric bulk of the 
bis(NHC) ligands was investigated by decreasing the steric bulk to a methyl 
substituent and increasing the steric bulk to a diisopropylphenyl substituent in 
comparison to the initially studied mesityl substituent.  
3.2.2 Synthesis of [{(MeIm)2CH2}Pd(CH2CN)2] (IIb): 
[{(MeIm)2CH2}Pd(NCMe)2][PF6]2, 1b was reacted with 9.4 equiv of NaOH in CH3CN 
at 60 °C for 24 h. [{(MeIm)2CH2}Pd(CH2CN)2] (IIb) was isolated (Scheme 3.9, Figure 
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3.12) The formation of IIb was supported by 1H and 13C NMR spectroscopy with 
resonances at 1.04 and –13.5 ppm respectively for the CH2 protons consistent with 
the formation of the CH2CN ligand. In addition, a crystal structure was also obtained, 
however, crystallisation was difficult due to the extreme low solubility of this complex 
in a suitable solvent to obtain crystals. As such, a cocrystallised derivative of IIb with 
K[PF6] was obtained (from a reaction attempted using KOH as a base). The metrics 
of the crystal structure of IIb is consistent with [{(MesIm)2CH2}Pd(CH2CN)2] with  
Pd–CNHC distances of 2.023(9) and 2.037(10) Å and Pd–CCH2CN distances of 
2.116(10) and 2.122(10) Å (Table 3.1). 
Scheme 3.9: Synthesis of [{(MeIm)2CH2}Pd(CH2CN)2] (IIb). 
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Figure 3.12: X-ray crystal structure of [{(MeIm)2CH2}Pd(CH2CN)2]·K[PF6] IIb. 
Thermal ellipsoids are shown at the 50% probability level. Left image 
K[PF6] molecule omitted for clarity, right image cocrystallised closest 
K[PF6] molecule shown in contact with IIb. All methyl hydrogen atoms 
removed for clarity. Selected bond lengths (Å) and angles (°): 
Pd(1)‒C(4) 2.023(9), Pd(1)‒C(1) 2.037(10), Pd(1)‒C(12) 2.116(10), 
Pd(1)‒C(10) 2.122(10), N(6)–K(1) 2.801(9), N(5)–K(1) 2.738(10), 
C(4)‒Pd(1)‒C(1) 85.4(4), C(4)‒Pd(1)‒C(12) 93.7(4), C(1)‒Pd(1)‒C(10) 
92.8(4), C(12)‒Pd(1)‒C(10) 87.5(4).  
 
During the synthesis of IIb an intermediate [{[(MeIm)2CH2]Pd(µ-OH)}2][PF6]2 was 
observed by 1H NMR spectroscopy and X-ray crystallography. 1b was reacted with 
NaOH in CD3CN at room temperature in a J. Young NMR tube yielding 
[{[(MeIm)2CH2]Pd(µ-OH)}2][PF6]2. This intermediate was detected as the sole 
intermediate by 1H NMR spectroscopy with no signals corresponding to 
 [{([MeIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 identified during the formation of  
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Figure 3.13: X-ray molecular structure of cation [{[(MeIm)2CH2]Pd(µ-OH)}2]2+. 
Thermal ellipsoids are shown at the 50% probability level. 2 [PF6]- 
counter ions a Et2O and a H2O lattice solvent molecules omitted for 
clarity. All methyl hydrogen atoms removed for clarity. Selected bond 
lengths (Å) and angles (°): Pd(1)–O(2) 2.074(2), Pd(1)–C(5) 
1.973(3), Pd(1)–C(1) 1.974(3), Pd(1)–O(1) 2.088(2),  
O(2)–Pd(1)–O(1) 78.15(9), C(5)–Pd(1)–O(2) 97.78(10),  
C(5)–Pd(1)–C(1) 84.92(11), C(5)–Pd(1)–O(1) 175.06(9),  
C(1)–Pd(1)–O(2) 174.63(10), C(1)–Pd(1)–O(1) 98.92(11),  
Pd(1)–O(2)–Pd(1) 87.42(11), Pd(1)–O(1)–Pd(1) 86.71(10). 
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[{(MeIm)2CH2Pd(CH2CN)2] (Figure 3.13). The crystal structure has the methyl 
substituents with a syn-orientations with respect to the central Pd2O2 ring with Pd–O 
bond distances of 2.074(2) and 2.088(2) Å and Pd–C distances of 1.973(3) and 
1.974(3) Å. This was consistent with the previously observed closely analogous 
methoxide dimer [{[(MeIm)2CH2]Pd(µ-OMe)}2][PF6]2 which had Pd–O bond distances 
of 2.058(2)–2.978(2) Å and Pd–C distances of 1.966(3) and 1.979(3) Å.[19] Due to 
the propensity for [{[(MeIm)2CH2]Pd(µ-OH)}2][PF6]2 to react further to form IIb 
isolation and further characterisation was not possible. 
[{([MeIm]2CH2)Pd(µ-CH2CN)}2][BF4]2 (IIIb) was synthesised by reacting 
[{(MeIm)2CH2}Pd(CH2CN)2] (IIb) with H[BF4] in acetonitrile to gain further 
understanding of the N-mesityl system. The low yield observed (3 %) is likely due to 
the low solubility of IIb and could possibly be increased with further reaction time, 
however, the reaction was not repeated due to time constraints (Scheme 3.10). 
Scheme 3.10: Synthesis of [{([MeIm]2CH2)Pd(µ-CH2CN)}2][BF4]2 (IIIb). 
 
The formation of IIIb was supported by 1H NMR spectroscopy in CD3CN with four 
inequivalent imidazol-2-ylidene peaks and two inequivalent CH3 substituents. This is 
consistent with two different trans donating ligands. There is a resonance at 1.29 
ppm consistent with the CH2 from the formation of the CH2CN ligand and two 
signals at 6.16 and 5.98 ppm consistent with the AB spin system of the methylene 
linker of the bis(NHC) ligand. 
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In contrast to the mesityl substituent, the 1H NMR spectrum of IIIb in CD3CN 
contains only one complex. To determine whether the complex observed was 
consistent with the formation of the previously discussed N-mesityl complexes A or 
B a DOSY NMR spectra was recorded of IIIb (Figure 3.14, red dots) with a capillary 
of [{(MeIm)2CH2}Pd(NCMe)2][PF6]2 (1b) (Figure 3.14, green dots). The capillary of 
1b in CD3CN was used as a standard that would not impact the 1H NMR spectrum 
of IIIb. Similar to the N-mesityl substituent, the molecular weight and thus diffusion 
coefficient of 1b was similar to that of the [{(MeIm)2CH2}Pd(µ-CH2CN)] fragment 
within complex IIIb. The DOSY NMR spectrum shows the diffusion coefficients of 1b 
and IIIb were found to be the same. This indicates that the species in solution had a 
similar molecular weight to 1b, i.e. only complex B is observed (Scheme 3.11). This 
may be consistent with the observation that only IIb was present in the reaction of 
1b with excess NaOH given the high level propensity for IIIb to dissociate in CH3CN.  
Figure 3.14: DOSY NMR spectra of a mixture of [{(MeIm)2CH2}Pd(NCMe)2][PF6]2  
(1b, green dots) and [{([MeIm]2CH2)Pd(µ-CH2CN)}2][BF4]2 (IIIb, red 
dots) 
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3.2.3 Synthesis of [{([DippIm]2CH2)Pd(µ-CH2CN)}2][PF6]2: 
 [{([DippIm]2CH2)Pd(NCMe)}2][PF6]2 (1c), Dipp = 2,6-diisopropylphenyl, was similarly 
reacted with NaOH in CH3CN at 60 °C for 24 h. Complex  
[{([DippIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (IIIc) was isolated while none of the 2:1 mono 
palladium complex was observed (Scheme 3.12, Figure 3.17). The formation of IIIc 
was supported by 1H and 13C NMR spectroscopy in DMSO-d6 with resonances at 
0.30 and –10.5 ppm respectively, consistent with the CH2 from the formation of the  
–CH2CN ligand.  
Scheme 3.12: Synthesis of [{([DippIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (IIIc). 
 
The 1H NMR spectrum was also recorded in CD3CN, which indicated the presence 
of two complexes in solution analogous to that discussed above for the N-mesityl 
IIIa system. Extensive spectroscopic analysis of the two complexes in solution was 
Scheme 3.11: Reaction of [{([MeIm]2CH2)Pd(µ-CH2CN)}2][BF4]2 in CD3CN as 
observed by a DOSY NMR spectra. 
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not performed due to the complicated overlapping nature of the resonances. A 
DOSY NMR spectrum was recorded of the sample indicating that the same 
equilibrium is present that was observed for IIIa (Scheme 3.13). Both the 
observation of the two diffusion rates and the large number of aromatic resonances 
supports the equilibrium proposed between complexes A and B (Figure 3.15 A trace 
contaminant was present in the NMR characterisation due to the difficulty to 
separate it from IIIc. This contaminant corresponds to another bis(NHC) complex 
and not 1c or IIc. 
Scheme 3.13: Proposed equilibrium of IIIc in NCMe. 
 
Figure 3.15: DOSY NMR spectra of IIIc. 
 
A VT 1H NMR was recorded of the sample from –40 °C to 70 °C. The characteristic 
methylene CH2 resonances in the range of 6.15–6.30 ppm do not coalesce 
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indicating the presence of complexes A and B at all temperatures in a slow 
exchange on the NMR time scale. With a varying ratio of complexes A and B the 
ratio of complexes A:B at –40 °C was 1:2 while at 70 °C it was 1.9:1 (Figure 3.16, 
blue dots). 
The methylene CH2 proton resonances of the bis(NHC) ligands between 6.15–6.30 
ppm are equivalent at all temperatures. This is in contrast to IIIa which appear with 
a AB spin system at low temperature (Figure 3.16, blue dots). Similarly, the 
resonances between 0–1 ppm corresponding with the CH2CN ligand do not observe 
an AB spin system at low temperatures in contrast to IIIa (Figure 3.16, green dots). 
In this case, there was no evidence that a third product was formed at low 
temperatures as was noted above for the analogous N-Mes system IIIa. 
The fact that the Dipp substituent did not appear with the same AB spin system as 
was observed with the Mes substituent for the CH2 peaks of the bis(NHC) ligand  
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Figure 3.16: Overlay of the 1H NMR spectra of IIIc in CD3CN at temperatures from  
–40 to 70 ° 
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Figure 3.17: X-ray molecular structure of cation [{([DippIm]2CH2)Pd(µ-CH2CN)}2]2+ 
of IIIc. Thermal ellipsoids are shown at the 50% probability level. 2 
[PF6]- counter ions and 2 Et2O lattice solvent molecules omitted for 
clarity. All diisopropylphenyl hydrogen atoms removed for clarity. 
Selected bond lengths (Å) and angles (°): Pd(1)‒N(5) 2.038(3), 
Pd(1)‒C(1) 2.065(3), Pd(1)‒C(4) 2.013(3), Pd(1)‒C(33) 2.126(3), 
N(5)‒C(32) 1.146(4), C(32)‒C(33) 1.433(4), N(5)‒Pd(1)‒C(1) 
91.82(10), N(5)‒Pd(1)‒C(33) 88.37(10), C(4)‒Pd(1)‒C(1) 88.28(11), 
C(4)‒Pd(1)‒C(33) 91.77(11), C(32)‒N(5)‒Pd(1) 164.9(2), 
C(32)‒C(33)‒Pd(1) 110.7(2), N(5)‒C(32)‒C(33) 175.3(3). 
was interesting due to the fact that the AB spin system is observed when solution 
phase fluctuation is restricted. This indicates that the steric hindrance of the mesityl 
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substituent for IIIa may be higher than that for the Dipp substituent of complex IIIc. 
The subsequent discussion of the comparison of the X-ray crystal structures of 
complexes IIIa and IIIc may account for this solution behaviour. 
A crystal structure of [{([DippIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (IIIc) was also obtained, 
containing metrics consistent with IIIa with Pd-CNHC distances of 2.065(3) and 
2.013(3) Å. The dimer has the same strained two CH2CN ligands with a Pd–N≡C 
bond angle of 164.9(2) ° (Figure 3.17). 
 
Figure 3.18: Spacefilling structure [{([DippIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (IIIc) with  
N-diisopropyl substituents in the foreground. 
[{(DippIm)2CH2}Pd(CH2CN)2] (IIc) was synthesised by reacting 
[{(DippIm)2CH2}Pd(NCMe)2][PF6]2 (1c) with NaOH in CH3CN for 48 h. The formation 
of the product was was supported by 1H and 13C NMR spectroscopy with 
resonances at 0.46 and –14.3 ppm respectively consistent with the CH2 moiety 
within the CH2CN ligand (Scheme 3.14). Unfortunately, due to the difficulty in 
acquiring large quantities of [{(DippIm)2CH2}Pd(CH2CN)2] a crystal structure could 
not be obtained. 
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Scheme 3.14: Synthesis of [{(DippIm)2CH2}Pd(CH2CN)2] (IIc). 
Analysis of the 1H and 13C NMR spectrum and Xray crystal structures of the NCMe, 
CH2CN and µ-CH2CN ligated complexes for the N-Me, Mes and Dipp substituent 
reveals a trend around the strain observed for these complexes (Table 3.1).  
The metrics of the crystal structures of the N-Mes substituted complexes 
[{(MesIm)2CH2}Pd(NCMe)2][PF6]2 (1a) and [{(MesIm)2CH2}Pd(CH2CN)2] (IIa) are 
very similar for both the Im/PdC2L2 dihedral angles and the distance of the CH2 from 
the PdC2L2 plane. The distance of the CH2 from the PdC2L2 plane is a measure of 
the intra ligand N-substituent strain across the face of the chelating system.[19] This 
is in contrast to [{([MesIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 which has a lower dihedral 
angle and distance of the CH2 from the PdC2L2 plane indicating higher strain on the 
molecule due to the steric influences from the second bis(NHC) ligand due to the 
dinuclear system. 
Similarly the complexes with N-Me substituents [{(MeIm)2CH2}Pd(NCMe)2][BF4]2 
(1b) and [{(MeIm)2CH2}Pd(CH2CN)2] (IIb) have similar metrics and thus have similar 
strain on the molecules. However, comparing the metrics for the crystal structures 
for [{(dippIm)2CH2}Pd(NCMe)2][PF6]2 (1c) and [{([dippIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 
(IIIc) it is important to note that although 1c has a more strained geometry than the 
N-Mes equivalent 1a the metrics of IIIc is close to that of 1c. This indicates the 
presence of the strain observed in IIIc is primarily due to the steric influences within 
the bis(NHC) ligand of the diisopropylphenyl substituent rather than the interligand 
steric hindrance (Figure 3.19). This is highlighted by analysis of the space filling 
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representation of IIIc which doesn’t appear to show an interaction between both 
bis(NHC) ligands (Figure 3.18). Despite the difference in the steric bulk of the 
ligands, the metrics of IIIa and IIIc are similar. 
Comparing the 1H and 13C NMR spectra of all the compounds synthesised the 
values are consistent with those described in Chapter 1 for bonding mode I and II 
with all 13C NMR resonances being in the region of –10.5 to –15.0 ppm. A trend 
emerges with IIa, IIIa, IIb and IIIc featuring an upfield 1H NMR shift for the CH2 
resonances. In addition, although it unclear why both complexes IIIb and IIIc display 
1H NMR downfield shifts in comparison to the corresponding II complex. The 13C 
NMR shift for the corresponding CH2 carbon shifts upfield. Interestingly, the 
opposite is true for the N-Mes substituent. 
Figure 3.19: Structural overlay of [{([DippIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (red) and 
[{([MesIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (black) crystal structures. For 
clarity one bis(NHC) ligand is removed. 
Comparing the steric bulk of the N-substituents a trend emerges around the 
selectivity between complex II and III (Figure 3.21, Table 3.1). Naota et al.[20] 
postulated that the dinuclear complexes of type III are intermediates in the N- to C-
bound isomerisation discussed in detail in the introduction. While all the reactions 
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were performed under similar equivalents of base, for N-Me only complex of IIb was 
observed, for N-Mes both complexes IIa and IIIa were observed while for N-Dipp 
only complex IIIc was observed after 24 h. Reacting 1c with NaOH for 48 h the 
specificity of the product changed, forming IIc exclusively. In addition, when excess 
NaOH was added to the N-Mes complex IIIa it was converted to IIa. This indicates 
that the dinuclear product is an intermediate in the formation of the mononuclear 
product with the larger sterically hindered N-substituent complexes having a higher 
transition state energy for the formation of the second deprotonated acetonitrile 
ligand. 
3.2.4 Synthesis of [{(MesIm)2CH2}Pd(NCR)2][PF6]2: 
Further work investigated increasing the scope of the reaction beyond acetonitrile to 
the more sterically hindered nitrile ligands to see whether the analogous  
α-deprotonated nitriles could be synthesised. 
[{(MesIm)2CH2}Pd(NCCH2CH3)2][PF6]2 (VI) was synthesised under analogous 
conditions to that previously published for the NCMe analogue 
[{(MesIm)2CH2}Pd(NCMe)2][PF6]2 (1a) (Scheme 3.15, Figure 3.22).[1] 
[{(MesIm)2CH2}PdBr2] was reacted with Na[PF6] in a 1:1 mixture of propionitrile and 
H2O at 90°C for 2 h forming the desired product. Unlike in the synthesis of 1a where 
CH3CN and H2O are miscible, propionitrile and H2O are immiscible and thus the 
reaction was stirred vigorously to afford a white solid in 42 % yield. The product 
Scheme 3.15: Synthesis of [{(MesIm)2CH2}Pd(NCCH2CH3)2][PF6]2 (VI). 
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identity was supported by both NMR spectroscopy and X-ray crystallography with 1H 
NMR resonances at 2.45 and 1.14 ppm assigned to the propionitrile protons 
consistent with the coordination of propionitrile. The Pd–CNHC distances of 1.983(4) 
and 1.992(4) Å are consistent with the previously reported 1a.[17]  
Figure 3.20: X-ray molecular structure of cation [{(MesIm)2CH2}Pd(NCCH2CH3)2]2+ 
of VI. Thermal ellipsoids are shown at the 50% probability level. 2 
[PF6]- counter ions and a propionitrile lattice solvent molecule omitted 
for clarity. All mesityl hydrogen atoms removed for clarity. Selected 
bond lengths (Å) and angles (°): Pd(1)‒N(5) 2.045(4), Pd(1)‒N(6) 
2.059(4), Pd(1)‒C(1) 1.983(4), Pd(1)‒C(4) 1.992(4), N(5)‒Pd(1)‒N(6) 
85.92(15), C(1)‒Pd(1)‒N(6) 93.22(16), C(1)‒Pd(1)‒C(4) 85.66(18), 
C(4)‒Pd(1)‒N(5) 95.24(16). 
Similarly [{(MesIm)2CH2}Pd(NCCH2CH2CH3)2][PF6]2 (VII) was synthesised under 
analogous conditions to those previously published for 
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[{(MesIm)2CH2}Pd(NCMe)2][PF6]2 (1a) (Scheme 3.16, Figure 3.21).[1] 
[{(MesIm)2CH2}PdBr2] was reacted with Na[PF6] in a 1:1 mixture of butyronitrile and 
H2O at 90°C for 2 h producing the desired product. As noted earlier, butyronitrile 
and H2O are immiscible and thus the reaction was stirred vigorously to prepare the 
desired product in 45 % yield. 
Scheme 3.16: Synthesis of [{(MesIm)2CH2}Pd(NCCH2CH2CH3)2][PF6]2 (VII). 
Complex: 1a[1, 17]  VI VII 
Pd-Ccarbene distance (Å) 1.983(4), 
1.984(4) 
1.983(4), 
1.992(4) 
1.969(6), 
1.986(6) 
Ccarbene-Pd-Ccarbene angle (°) 85.87(17) 85.66(18) 86.3(2) 
Ccarbene-N-R angle (°) 127.2(3), 
128.1(4) 
127.2(4), 
129.5(4) 
125.6(5), 
128.8(5) 
Av. distance from Im plane for  
CN-substituent and Pd (Å) 
0.045 0.0535 0.047 
Im/PdC2L2 dihedral angle (°) 35.92(14), 
37.7(2) 
33.88(16), 
37.63(16) 
32.0(2), 
37.50(19) 
Distance of CH2 from PdC2L2 plane (Å) 1.537(7) 1.448(7) 1.410(8) 
Table 3.2: Key crystallographic data for [{(MesIm)2CH2}Pd(NCMe)2][PF6]2 1a, 
[{(MesIm)2CH2}Pd(NCCH2CH3)2][PF6]2 VI and 
[{(MesIm)2CH2}Pd(NCCH2CH3)2][PF6]2 VII. 
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Figure 3.21: X-ray molecular structure of cation 
[{(MesIm)2CH2}Pd(NCCH2CH2CH3)2]2+ of VII. Thermal 
ellipsoids are shown at the 50% probability level. 2 [PF6]- 
counter ions and a propionitrile lattice solvent molecule 
omitted for clarity. All mesityl hydrogen atoms removed for 
clarity. Selected bond lengths (Å) and angles (°): Pd(1)‒N(5) 
2.060(5), Pd(1)‒N(6) 2.051(5), Pd(1)‒C(1) 1.969(6), 
Pd(1)‒C(4) 1.986(6), N(6)‒Pd(1)‒N(5) 85.68(19), 
C(1)‒Pd(1)‒N(6) 91.0(2), C(1)‒Pd(1)‒C(4) 86.3(2), 
C(4)‒Pd(1)‒N(5) 97.3(2). 
The formation of VII was supported by NMR spectroscopy and X-ray crystallography 
with 1H NMR resonances at 2.46, 1.56 and 0.96 ppm assigned to the butyronitrile 
protons consistent with the coordination of the butyronitrile ligand. The X-ray crystal 
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structure metrics were consistent with 1a and VI with Pd–CNHC distances of 1.969(6) 
and 1.986(6) Å. Analysis of the change in metrics of the X-ray crystal structures of 
1a, VI and VII it can be seen that with the increase in length of the nitrile ligand 
there is increased strain within the molecule. This is observed with a decreasing of 
the Im/PdC2L2 dihedral angle and distance of the CH2 from the PdC2L2 plane 
indicating a flattening of the bis(NHC) ligand to accommodate the increased steric 
bulk. 
The synthesis of the corresponding α-cyanocarbanion complexes was attempted in 
an effort to understand the effect of the steric bulk of the nitrile on the complexes 
formed Both VI and VII were treated with NaOH in the corresponding solvent in an 
attempt to form the desired α-cyanocarbanion complex, however, no reaction was 
observed.  
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3.3 Conclusion: 
Syntheses of [{(MesIm)2CH2}Pd(CH2CN)2] (IIa) and  
[{([MesIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (IIIa) were improved from the existing method 
developed in our group[4] by reacting [{(MesIm)2CH2}Pd(NCMe)2][PF6]2 (1a) with 
NaOH rather than NaOtBu. The use of NaOtBu led to an unintended side reaction, 
which was avoided by the former base, 3-aminocrotononitrile (IV) and 4-amino-2,6-
dimethylpyrimidine (V) were synthesised by reacting NaOtBu in CH3CN. Complex 
IIa and IIIa could be readily interconverted. Stirring IIIa with excess NaOH in CH3CN 
yielded IIa and IIa was treated with one equivalent of H[BF4] in CH3CN affording IIIa. 
The 1H NMR spectrum of IIIa in CD3CN shows an equilibrium that exists in solution. 
Through DOSY and NOESY NMR experiments it was suggested that an equilibrium 
between [{([MesIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 and 
[{(MesIm)2CH2}Pd(CH2CN)(NCMe)][PF6] in solution occurs, which is slow on the 
NMR time scale at room temperature. VT 1H NMR studies were performed to better 
understand the equilibrium at various temperatures. In each case, both complexes 
were present in solution at those temperatures utilised. When the solution was 
cooled below –15 °C a third product was also formed, however, the nature of this 
product was not determined due to the various products in solution. 
To better understand the impact of steric hindrance on the above reaction two other 
bis(NHC) ligands were chosen, N–Me and N–Dipp. [{(MeIm)2CH2}Pd(NCMe)2][PF6]2 
was reacted with NaOH in CH3CN yielding [{(MeIm)2CH2}Pd(CH2CN)2] exclusively. 
An intermediate [{([MeIm]2CH2)Pd(µ-OH)}2][PF6]2 was isolated which was the only 
intermediate observed when the reaction was performed on an NMR scale. 
[{(MeIm)2CH2}Pd(CH2CN)2] was also reacted with H[BF4] in CH3CN forming 
[{([MeIm]2CH2)Pd(µ-CH2CN)}2][BF4]2 in low yield. 
In comparison when [{(DippIm)2CH2}Pd(NCMe)2][PF6]2 was reacted with NaOH in 
CH3CN for 24 hours [{([DippIm]2CH2)Pd(µ-CH2CN)}2][BF4]2 (IIIc) was exclusively 
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formed. However, when the reaction was performed for 48 h 
[{(DippIm)2CH2}Pd(CH2CN)2] (IIc) was formed exclusively, this is due to the 
increased steric hindrance requiring longer reaction time for complete conversion. 
[{(MesIm)2CH2}Pd(NCCH2CH3)2][PF6]2 and 
[{(MesIm)2CH2}Pd(NCCH2CH2CH3)2][PF6]2 were synthesised by reacting 
[{(MesIm)2CH2}PdBr2] and Na[PF6] in a 1:1 mixture of H2O and the corresponding 
nitrile. However, reacting these complexes with NaOH did not yield the  
α-cyanocarbanion complexes, which were anticipated to provide more information 
regarding the impact of the steric bulk of the nitrile on the complex and to expand 
the range of nitrile coupling reactions discussed in Chapter 5.  
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3.4 Experimental: 
3.4.1 General Considerations: 
All air sensitive reactions were performed under an atmosphere of high purity argon 
using standard Schlenk techniques. NMR scale reactions were prepared in a dry 
glove box (Innovative Technologies) under a nitrogen atmosphere with J Young’s 
NMR tubes. Glassware was heated under vacuum and back-filled with argon to 
ensure the exclusion of oxygen and moisture in the reactions. The following 
chemicals were used as received: Na[PF6] (Aldrich), dibromomethane (Aldrich),  
2-methyl imidazole (Aldrich), Pd(OAc)2 (Precious Metals On-Line Pty Ltd.),  
2,4,6-trimethylaniline (Alfa Aesar), Glyoxal (VWR), [NH4]Cl (Chem Supply), 
Orthophosphoric acid (85 % of an aqueous solution, Ajax), tetrafluoroboric acid  
(50 % of an aqueous solution, Riedel-de Haen), 2,6-diisopropylaniline (Fluka). 
NaOH was purchased from Chem Supply and dried under vacuum at 200 °C. 
NaOtBu was synthesised by a previous student and sublimed at 200 °C. For air 
sensitive reactions anhydrous DMSO was purchased from Sigma-Aldrich and stored 
in an ampoule over 3 Å molecular sieves, anhydrous CH3CN was obtained by 
passage through an Innovative Technologies Solvent Purifier and stored in an 
ampoule over 3 Å molecular sieves. For air stable synthesis, solvents were of 
analytical grade and used as received. [{(MesIm)2CH2}Pd(NCMe)2][PF6]2[1] (1a), 
[{(MeIm)2CH2}Pd(NCMe)2][PF6]2[19] (1b), [{(dippIm)2CH2}Pd(NCMe)2][PF6]2[18] (1c) 
and [{(MesIm)2CH2}PdBr2][1] were all synthesised according to literature procedures. 
3.4.2 Instrumentation: 
NMR spectroscopic studies were carried out on a Bruker Avance 3 HD 400 MHz 
Wide Bore Spectrometer with a 5 mm BBFO probe at room temperature (293 K) 
unless otherwise stated or a Bruker Avance III HD 600 MHz spectrometer with a 5 
mm TCI-cyroprobe at 300 K, in DMSO-d6, CDCl3 or CD3CN. CDCl3 was used as 
received, whereas CD3CN and DMSO-d6 were used as received except in air 
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sensitive NMR spectroscopy where they were distilled over calcium hydride and 
stored over 3 Å molecular sieves. 1H NMR spectra were obtained at 399.58 or 
600.07 MHz while 13C NMR spectra were recorded at 100.47 or 150.89 MHz. 1H 
NMR spectra were referenced to the residual 1H resonance of the residual solvent 
peak while 13C NMR spectra were referenced to a deuterated 13C resonance. 
Elemental analyses were conducted by Dr. Thomas Rodemann at the Central 
Science Laboratory at the University of Tasmania using a Carlo Erba EA1108 
Elemental Analyser. 
EI-MS studies were conducted on an Agilent Technologies 6850 GC with a 5975C 
VL MSD. 
ESI-MS were conducted by Richard Wilson or Dr David Nichols at the Central 
Science Laboratory at the University of Tasmania using a LTQ-Orbitrap high 
resolution mass spectrometer (Thermo Fisher Scientific) by infusion at 5 µl/min 
using Positive mode electrospray ionisation, with a voltage of 4 kV applied. Full 
scan data (m/z range 150-2000) was aquired at a resolution of 60,000 and reported 
values for [M+H] or [M+Na] ions were based on the averaged spectrum of 20 
successive scans. 
X-ray crystallographic data for IIb and [{([MeIm]2CH2)Pd(µ-OH)}2][PF6]2 were 
collected at –173 °C on crystals mounted on a Hampton Scientific cryoloop at the 
MX1 or MX2 beamlines of the Australian Synchrotron.[21] Data completeness is 
limited by the single axis goniometer on the MX beamlines and the Australian 
synchrotron. Data for IIIa, IIIc, VI and VII were collected at –173 °C on crystals 
mounted on a Hampton Scientific cryoloop on a Bruker AXS D8 Quest with a Cu Kα 
source. The structures were solved by direct methods with SHELXT, refined using 
full-matrix least-squares routines against F2 with SHELXL-97,[22] and visualised 
using Olex2.[23] All non-hydrogen atoms were refined anisotropically. All hydrogen 
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atoms were placed in calculated positions and refined using a riding model with 
fixed C–H distances of 0.95 Å (sp2CH), 1.00 Å (sp3CH), 0.99 Å (CH2), 0.98 Å (CH3). 
The thermal parameters of all hydrogen atoms were estimated as Uiso(H) = 
1.2Ueq(C), except for CH3 where Uiso(H) = 1.5Ueq(C). Cif files available on request. 
3.4.3 Preparation of [{(MesIm)2CH2}Pd(CH2CN)2] (IIa): 
Method A: [{(MesIm)2CH2}Pd(NCMe)2][2PF6] (52.5 mg, 60.8 µmol) and NaOH  
(15.3 mg, 0.383 mmol) were combined in a predried Schlenk flask and then further 
dried under vacuum at 70 °C. CH3CN (5.0 mL) was then added to the solid and the 
solution was stirred at 60 °C for 24 h. The solvent was removed under vacuum and 
the product was recrystallised by vapour diffusion of diethyl ether into a near 
saturated solution of CH3CN. NMR spectroscopic analysis indicated that this 
compound was spectroscopically identical to equivalent data reported in the 
literature[4]. (quantitative yield, 48.6 mg) 
Method B: [{([MesIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (104 mg, 76.6 µmol) and NaOH 
(66.1 mg, 1.65 mmol) were combined in a predried Schlenk flask and further dried 
under vacuum at 70 °C. The solid was dissolved in CH3CN (5.0 mL) and stirred at  
60 °C for 24 h. The solution was cooled to room temperature and the CH3CN was 
removed under vacuum at 60 °C. The crude product was dissolved in H2O and the 
pure product was collected via vacuum filtration and dried under vacuum for 72 h to 
provide the product as an an off-white solid (75 % yield, 65.8 mg) 
1H NMR (400 MHz, CD3CN): δ 7.50 (2H, d, J = 2 Hz, ImH), 7.02 (4 H, s, m-CH), 
6.96 (2H, d, J = 2 Hz, ImH), 6.20 (2 H, bs, CH2), 2.32 (6H, s, p-Me), 2.06 (12 H, s,  
o-Me), 0.36 ppm (4H, bs, Pd-CH2). 
MP: 233 °C (dec) 
ESI-MS: m/z 588.2068 calculated for C29H36N7Pd+ (IIa + NH4) 588.2067 
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3.4.4 Preparation of [{([MesIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (IIIa): 
[{(MesIm)2CH2}Pd(NCMe)2][PF6]2 (71.1 mg, 82.4 µmol) and NaOH (11.4 mg,  
0.285 mmol) were combined in a predried Schlenk and then further dried under 
vacuum at 70 °C. CH3CN (5.0 mL) was then added to the solid and the solution was 
stirred at 60 °C for 24 h. The solvent was removed under vacuum and the product 
was recrystallised by vapour diffusion of diethyl ether into a near saturated solution 
of CH3CN. The product was washed with a small quantity of CH3CN. Only limited 
characterisation in CD3CN was possible due to the low solubility and dissociation of 
the complex. (45 % yield, 25.3 mg) 
1H NMR (400 MHz, CD3CN): δ (The complex dissociates partially in solution to form 
complex A and B in a 1.8:1 ratio) 7.62 (1H, d, J = 1.9 Hz, ImBH), 7.60 (1H, d, J =  
1.8 Hz, ImBH), 7.59 (2H, d, J = 1.8 Hz, ImAH) 7.56 (2H, d, J = 1.8 Hz, ImAH), 7.23 
(2H, bs, ArBH), 7.14 (1H, d, J = 2.0 Hz, ImBH) 7.11–7.12 (3H, m, ImBH & ArH), 7.09 
(2H, d, J = 1.9 Hz, ImAH), 7.06 (3H, s, ArAH & ArBH) 6.99 (2H, bs, ArAH), 6.82 (2H, 
bs, ArAH), 6.28 (2H, s, CBH2), 6.19 (4H, s, CAH2), 2.37 (9H, s, CBH3), 2.34 (3H, s, 
CBH3), 2.30 (6H, s, CBH3), 2.11 (12H, s, CAH3), 2.02 (12H, s, CAH3), 1.77–1.91 (12H, 
s, CAH3), 0.52 (4H, bs, CAH2CN), 0.06 ppm (2H, bs, CBH2CN). 
13C NMR (150 MHz, CD3CN): δ 172.5 (ImB-Pd), 168.5 (b, ImA-Pd), 160.2 (ImB-Pd), 
158.8 (b, ImA-Pd), 140.5 (ArBC), 140.0 (ArBC), 129.8 (ArAH), 129.7 (ArBH), 129.4 
(ArH), 129.1 (ArAH), 128.9 (ArAH), 124.8 (ImBH), 124.7 (ArH), 123.8 (ImAH), 123.0 
(ImAH & ImBH), 122.2 (ImBH), 122.1 (ImAH), 63.7 (CBH2), 63.5 (CAH2), 20.9 (CBH3), 
20.8 (CBH3), 20.7 (CBH3), 17.5 (b, CAH3), –12.3 (CBH2CN), –15.0 ppm (CAH2CN). 
1H NMR (400 MHz, DMSO-d6, 120 °C): δ 7.86 (2H, s, NCHCHN), 7.79 (2H, s, 
NCHCHN), 7.41 (2H, s, NCHCHN), 7.34 (2H, s, NCHCHN), 7.15 (4H, s, m-CH), 
6.89 (4H, s, m-CH), 6.44 (4H, s, NCH2N), 2.36 (6H, s, p-CH3), 2.28 (6H, s, p-CH3), 
2.04 (12H, s, o-CH3), 1.83 (12H, s, o-CH3), 0.31 ppm (4H, s, CH2CN). 
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13C NMR (100.47 MHz, DMSO-d6): δ 167.1 (Ar), 157.5 (Ar), 139.9 (Ar), 138.9 (Ar), 
136.1 (Ar), 135.7 (Ar), 135.5 (Ar), 135.1 (Ar), 134.7 (Ar), 134.3 (Ar), 133.1 (Ar), 
129.7 (m-CH), 129.3 (m-CH), 129.0 (m-CH), 128.5 (m-CH), 124.7 (NCHCHN), 
124.0 (NCHCHN), 123.3 (NCHCHN), 122.3 (NCHCHN), 62.9 (NCH2N), 21.1 (p-
CH3), 21.0 (p-CH3), 18.6 (o-CH3), 17.9 (o-CH3), 17.6 (o-CH3), 17.4 (o-CH3), –12.4 
ppm (CH2CN). 
ESI-MS: m/z 530.1512 calc. for PdN5C27H30 (M+ broken between Pd-N bonds) 
530.1531 
Elemental composition: Calculated: Pd2N10C54H60P2F12: C 47.98, N 10.36; H 4.47 
%; Found: C 48.04; N 11.01; H 4.70% 
MP: 194 °C (dec)  
3.4.5 Preparation of [{([MesIm]2CH2)Pd(µ-CH2CN)}2][BF4]2: 
[{(MesIm)2CH2}Pd(CH2CN)2] (61.8 mg, 0.108 mmol), H[BF4] (50 % in H2O, 13.8 µL, 
0.108 mmol) and CH3CN (5.0 mL) were combined in a round-bottom flask and 
stirred at room temperature for 5 min. The CH3CN was removed under vacuum and 
the solid was washed with H2O to provide a white solid with NMR spectroscopic 
analysis indicated that this compound was spectroscopically identical to equivalent 
data reported for the [PF6] analogue IIIa (97 % yield, 64.7 mg). 
1H NMR (400 MHz, CD3CN): δ 7.64-7.59 (4H, m, ImH), 7.57 (2H, d, J = 1.6 Hz, 
ImH), 7.23 (2H, bs, ArH), 7.14 (1H, d, J = 1.8 Hz, ImH), 7.12 (4H, s, ArH), 7.09 (2H, 
d, J = 1.7 Hz, ImH), 7.06 (3H, s, ArH), 6.99 (2H, bs, ArH), 6.83 (2H, bs, ArH), 6.29 
(2H, s, CH2), 6.20 (4H, s, CH2), 2.37 (9H, s, CH3), 2.34 (3H, s, CH3), 2.30 (6H, s, 
CH3), 2.106-2.12 (12H, m, CH3), 2.03 (12H, s, CH3), 1.78-1.89 (12H, s, CH3), 0.53 
(2H, bs, CH2CN), 0.08 ppm (2H, bs, CH2CN). 
 
Chapter 3 
98 
 
3.4.6 Preparation of 3-Aminocrotononitrile (IV) and  
4-Amino-2,6-dimethylpyrimidine (V):NaOtBu (61 mg, 0.635 mmol) and CH3CN 
(10 mL) were combined in a predried Schlenk flask and stirred at 70 °C for 16 h. 
The solid was filtered through a plug of celite® and the CH3CN was removed under 
vacuum. The products were separated via flash column chromatography eluting 
with 70% EtOAc/hexanes yielding IV as a 1:0.6 mixture of Z- & E-isomers (81.3 mg, 
0.990 mmol). 
1H NMR (400 MHz, CDCl3): δ 4.99 (2Ha, bs, NH2), 4.85 (2Hb, bs, NH2), 4.03 (1Hb, s, 
CH), 3.70 (1Ha, s, CH), 2.02 (3Hb, s, CH3), 1.86 ppm (3Ha, s, CH3).  
13C NMR (151 MHz, CDCl3): δ 162.3 (C-NH2), 161.7 (C-NH2), 122.0 (C≡N), 120.0 
(C≡N), 63.7 (CH), 61.6 (CH), 21.1 (CH3), 19.4 ppm (CH3).  
EI-MS: m/z 82 (M+) 
IR: 3327 (N-H), 2858 (C-H), 2781 (C-H), 2217 (C≡N), 1658 (C≡N/ C=C), 1652(C≡N/ 
C=C), 1612 (C≡N/ C=C), 1562, 1413, 1375, 1201, 945, 924, 874, 722 cm–1. 
The second product was eluted with 10% MeOH/CH2Cl2 to provide an off-white solid 
of V. (77.5 mg, 0.629 mmol) NMR spectroscopic analysis indicated that this 
compound was spectroscopically identical to equivalent data reported in the 
literature.[9]  
1H NMR (400 MHz, DMSO-d6): δ 6.07 (1H, s, CH), 2.25 (3H, s, CH3), 2.14 ppm (3H, 
s, CH3). 
3.4.7 Preparation of [{(MeIm)2CH2}Pd(CH2CN)2] (IIb): 
[{(MeIm)2CH2}Pd(NCMe)2][2PF6] (53.6 mg, 81.6 µmol) and NaOH (30.6 mg,  
0.765 mmol) were combined in a predried Schlenk flask and then further dried 
under vacuum at 70 °C. CH3CN (5.0 mL) was then added to the solid and the 
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solution was stirred at 60 °C for 24 h. The solvent was removed under vacuum and 
the product was recrystallised via slow evaporation of CH3CN. (76 % yield, 21.0 mg) 
1H NMR (400 MHz, CD3CN): δ 7.24 (2H, d, J = 1.7 Hz, ImH), 6.98 (2H, d, J = 1.7 
Hz, ImH), 6.08 (1H, d, J = 13.1 Hz, CH2), 5.84 (1H, d, J = 13.2 Hz, CH2), 3.77 (6H, 
s, CH3), 1.12 (2H, d, J = 13.5 Hz, CH2CN), 1.04 ppm (2H, d, J = 13.6 Hz, CH2CN). 
13C NMR (100.47 MHz, CD3CN): δ 180.0 (C-Pd), 130.3 (C≡N), 121.7 (ImH), 120.6 
(ImH), 63.1 (CH2), 36.8 (CH3), –13.5 ppm (CH2CN). 
ESI-MS: 322.0306 calculated for C13H16N6Pd+ (IIb – CH2CN) 322.0284 and 
381.0674 calculated for C13H19N6OPd+ (IIb + H3O+) 381.0655 
MP: 282 °C (dec) 
3.4.8 Preparation of [{([MeIm]2CH2)Pd(µ-CH2CN)}2][BF4]2 (IIb): 
[{(MeIm)2CH2Pd(CH2CN)2] (52.5 mg, 0.145 mmol), H[BF4] (50 % in H2O, 18.5 µL,  
0.147 mmol) and CH3CN (7 mL) were stirred in a round bottom flask at rt for  
10 minutes. The CH3CN was removed under vacuum and the solid was washed 
with water. The solid was redissolved in CH3CN, filtered and the CH3CN was 
removed under vacuum forming a white solid (3 % yield, 1.5 mg) 
1H NMR (600 MHz, CD3CN): δ 7.37 (1H, s, ImH), 7.33 (1H, s, ImH), 7.13 (1H, s, 
ImH), 7.08 (1H, s, ImH), 6.15 (1H, d, J = 13.4 Hz, CH2), 5.98 (1H, d, J = 13.0 Hz, 
CH2), 3.83 (3H, s, Me), 3.80 (3H, s, Me), 1.26–1.32 ppm (2H, m, CH2CN). 
13C NMR (150 MHz, CD3CN): δ 171.7 (Pd-C, found by HMBC), 161.1 (Pd-C, found 
by HMBC), 127.6 (C≡N, found by HMBC), 123.1 (ImH), 122.3 (ImH), 122.1 (ImH), 
121.1 (ImH), 62.9 (CH2), 37.3 (Me), 37.2 (Me), –14.1 (CH2CN) ppm. 
ESI-MS: 322.0297 calc for C22H28N10Pd22+ 322.0279 
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3.4.9 Preparation of [{([DippIm]2CH2)Pd(µ-CH2CN)}2][PF6]2 (IIIc): 
[{(dippIm)2CH2}Pd(NCMe)2][PF6]2 (0.107 g, 0.113 mmol) and NaOH (49 mg,  
1.23 mmol) were combined in a predried Schlenk flask and then further dried under 
vacuum at 70 °C. CH3CN (5.0 mL) was then added to the solid and the solution was 
stirred at 60 °C for 24 h. The solvent was removed under vacuum and the product 
was recrystallised by vapour diffusion of Et2O into a near saturated solution of 
CH3CN to provide colourless crystals (25 % yield, 21.2 mg) 
1H NMR (400 MHz, DMSO-d6): δ 7.88 (2H, d, J =2.0 Hz, ImH), 7.80 (2H, d, J = 1.8 
Hz, ImH), 7.72 (2H, t, J = 7.8 Hz, p-CH), 7.55 (4H, t, J = 1.7 Hz, ImH), 7.51 (4H, d,  
J = 7.8 Hz, m-CH), 7.29 (2H, t, J = 7.8 Hz, m-CH), 7.05 (4H, d, J = 7.7 Hz, p-H), 
6.45 (4H, s, CH2), 2.26 (8H, bs, iPr CH), 1.20 (12H, d, J = 6.8 Hz, iPr CH3), 1.05 
(12H, d, J = 6.7 Hz, iPr CH3), 1.00 (12H, d, J = 6.8 Hz, iPr CH3), 0.99 (12H, bs, iPr 
CH3), 0.30 ppm (4H, s, CH2CN). 
13C NMR (100.47 MHz, DMSO-d6): δ 167.4 (Pd-C), 154.9 (Pd-C), 145.0 (Ar), 135.4 
(Ar), 135.0 (Ar), 133.5 (C≡N), 131.5 (p-H), 130.6 (m-H), 127.7 (ImH), 126.5 (ImH), 
125.0 (m-H), 123.7 (p-H), 123.0 (ImH), 121.7 (ImH), 28.3 (iPr CH), 25.5 (iPr CH3), 
25.3 (iPr CH3), 23.5 (iPr CH3), 23.4 (iPr CH3), –10.5 ppm (CH2CN). 
MP: 218 °C (dec) 
Anal. Calc. for C66N10H84Pd2P2F12: C, 52.14; H, 5.57; N, 9.21; Found: C, 51.88; H, 
5.65; N, 8.82 % 
3.4.10 Preparation of [{(DippIm)2CH2}Pd(CH2CN)2] (IIc): 
[{(DippIm)2CH2}Pd(NCMe)2][PF6]2 (47.1 mg, 49.7 µmol) and NaOH (23 mg,  
0.575 mmol) were combined in a predried Schlenk flask and further dried under 
vacuum at 70 °C. To the CH3CN (5 mL) was added and the solution was stirred at  
60 °C for 48 hours. The CH3CN was removed under vacuum and the solid was 
washed with H2O isolating a white solid (91 % yield, 29.6 mg).  
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1H NMR (400 MHz, CD3CN): δ 7.53 (2H, d, J = 1.8 Hz, ImH), 7.51 (2H, t, J = 7.8 Hz, 
p-CH), 7.35 (4H, d, J = 7.8 Hz, m-CH), 7.09 (2H, d, J = 1.9 Hz, ImH), 6.21 (2H, s, 
CH2), 2.65 (4H, sep, J = 6.8 Hz, iPr CH), 1.30 (12H, d, J = 6.8 Hz, iPr CH3), 1.07 
(12H, d, J = 6.8 Hz, iPr CH3), 0.46ppm (4H, s, CH2CN). 
13C NMR (150 MHz, CD3CN): δ 179.5 (Pd-C), 145.6 (o-C), 136.1 (N-C), 130.0 (p-
CH), 129.3 (CN), 125.4 (ImH), 124.0 (m-CH), 120.2 (ImH), 63.1 (CH2), 28.1 (iPr 
CH), 24.5 (iPr CH3), 22.6 (iPr CH3), –14.3 ppm (CH2CN). 
ESI-MS: 614.2515 calculated for C33H42N5Pd+ (IIc – CH2CN) 614.2475 and 
673.2891 calculated for C35H47N6OPd+ (IIc + H3O+) 673.2846 
3.4.11 Preparation of [{(MesIm)2CH2}Pd(NCCH2CH3)2][PF6]2 (VI): 
[{(MesIm)2CH2}PdBr2] (0.142 g, 0.218 mmol) and NaPF6 (0.721 g, 4.30 mmol), H2O 
(10 mL) and propionitrile (10 mL) were combined in a round-bottom flask. This 
solution was stirred vigorously (800 rpm) and heated to 90 °C for 2 h. The solvents 
were removed via rotary evaporation. The solid was washed with water and 
recrystallization was achieved via layering of diethyl ether on a near saturated 
propionitrile solution (42 % yield, 81.9 mg). 
1H NMR (400 MHz, DMSO-d6): δ 8.00 (2H, d, J = 2.0 Hz, ImH), 7.58 (2H, d, J = 2.0 
Hz, ImH), 7.11 (4H, s, m-CH), 6.63 (2H, s, CH2), 2.45 (4H, q, J = 7.6 Hz, NCCH2), 
2.33 (6H, s, p-CH3), 2.07 (12H, s, o-CH3), 1.14 ppm (6H, t, J = 7.6 Hz, NCCH2CH3).  
13C NMR (100.47 MHz, DMSO-d6): δ 145.5 (Pd-C), 139.6 (Ar-C), 135.0 (Ar-C), 
134.6 (Ar-C), 129.5 (m-CH), 126.0 (ImH), 123.3 (ImH), 122.2 (N≡C), 62.8 (CH2), 
21.0 (p-CH3), 18.7 (o-CH3), 10.6 (NCCH2CH3), 10.4 ppm (NCCH2). 
Anal. Calc. for Pd1N6C31H38P2F12; C 41.79, N 9.43, H 4.30; Found: C 41.66, N 9.34, 
H 4.32%. 
MP: 225 °C (dec) 
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3.4.12 Preparation of [{(MesIm)2CH2}Pd(NCCH2CH2CH3)2][PF6]2 (VII): 
[{(MesIm)2CH2}PdBr2] (0.118 g, 0.181 mmol) and NaPF6 (0.595 g, 3.54 mmol), H2O 
(10 mL) and butyronitrile (10 mL) were combined in a round-bottom flask. This 
solution was stirred vigorously (800 rpm) and heated to 90 °C for 2 h. The solvents 
were removed via rotary evaporation. The solid was washed with water and 
recrystallised via layering of hexanes on a near saturated butyronitrile solution.  
(45 % yield, 74.8 mg). 
1H NMR (400 MHz, DMSO-d6): δ 8.01 (2H, d, J = 1.7 Hz, ImH), 7.60 (2H, d, J = 1.6 
Hz, ImH), 7.12 (4H, s, m-CH), 6.64 (2H, s, CH2), 2.46 (4H, t, J = 7.0, NCCH2), 2.33 
(6H, s, p-CH3), 2.07 (12H, s, o-CH3), 1.56 (4H, sex, J = 7.2 Hz, CH2CH2CH3), 0.96 
ppm (6H, t, J = 7.4 Hz, CH3). 
13C NMR (100.47 MHz, DMSO-d6): δ 145.5 (Pd–C), 139.6 (Ar–C), 135.0 (Ar–C), 
134.6 (o-C), 129.5 (m-CH), 126.0 (ImH), 123.3 (InH), 121.1 (N≡C), 62.8 (CH2), 21.0 
(p-CH3), 19.0 (CH2CH2CH3), 18.7 (o-CH3), 18.4 (NCCH2), 13.5 ppm (CH3). 
Anal Calc for Pd1N6C33H42P2F12: C 43.13, N 9.14, H 4.61; Found C 43.27, N 9.06, H 
4.48. 
MP: 176 °C (dec)  
Chapter 3 
103 
 
3.5 References: 
[1] M. G. Gardiner, W. A. Herrmann, C.-P. Reisinger, J. Schwarz, M. Spiegler, J. 
Organomet. Chem. 1999, 572, 239–247. 
[2] E. Drent, W. P. Mul, A. A. Smaardijk, in Encyclopedia of Polymer Science and 
Technology (Ed.: I. John Wiley & Sons), 2001. 
[3] P. D. Boyd, A. J. Edwards, M. G. Gardiner, C. C. Ho, M. H. Lemee-Cailleau, 
D. S. McGuinness, A. Riapanitra, J. W. Steed, D. N. Stringer, B. F. Yates, 
Angew. Chem. Int. Ed. 2010, 49, 6315–6318. 
[4] M. Tucker, Honours Thesis, University of Tasmania (Hobart Tasmania), 2014. 
[5] S. Chakraborty, Y. J. Patel, J. A. Krause, H. Guan, Angew. Chem. Int. Ed. 
2013, 52, 7523–7526. 
[6] F. G. Bordwell, Acc. Chem. Res. 1988, 21, 456–463. 
[7] R. G. Pearson, R. L. Dillon, J. Am. Chem. Soc. 1953, 75, 2439–2443. 
[8] K. Yoshizawa, S. Toyota, F. Toda, Green Chem. 2002, 4, 68–70. 
[9] I. R. Baxendale, S. V. Ley, J. Comb. Chem. 2005, 7, 483–489. 
[10] N. R. Smyrl, R. W. Smithwick, J. Heterocyclic Chem. 1982, 19, 493–496. 
[11] A. R. Ronzio, W. B. Cook, Org. Synth. 1944, 24, 6. 
[12] H. Takaya, T. Naota, S.-I. Murahashi, J. Am. Chem. Soc. 1998, 120, 4244–
4245. 
[13] J. Tehranchi, P. J. Donoghue, C. J. Cramer, W. B. Tolman, Eur. J. Inorg. 
Chem. 2013, 4077–4084. 
[14] D. M. Tellers, J. C. M. Ritter, R. G. Bergman, Inorg. Chem. 1999, 38, 4810–
4818. 
Chapter 3 
104 
 
[15] V. Y. Kukushkin, A. J. L. Pombeiro, Inorg. Chim. Acta 2005, 358, 1–21. 
[16] W. Herrmann, T. Scherg, S. Schneider, G. Frey, J. Schwarz, E. Herdtweck, 
Synlett. 2006, 2006, 2894–2907. 
[17] M. G. Gardiner, C. C. Ho, F. M. Mackay, D. S. McGuinness, M. Tucker, Dalton 
Trans. 2013, 42, 7447–7457. 
[18] A. Riapanitra, Masters Thesis, University of Tasmania (Hobart Tasmania), 
2009. 
[19] C. C. Ho, PhD Thesis, University of Tasmania (Hobart Tasmania), 2014. 
[20] a) T. Naota, A. Tannna, S. Kamuro, S.-I. Murahashi, J. Am. Chem. Soc. 2002, 
124, 6842–6843; b) T. Naota, A. Tannna, S. Kamuro, M. Hieda, K. Ogata, S. 
Murahashi, H. Takaya, Chem. Eur. J 2008, 14, 2482–2498. 
[21] T. M. McPhillips, S. E. McPhillips, H. J. Chiu, A. E. Cohen, A. M. Deacom, P. 
J. Ellis, E. Garman, A. Gonzalez, N. K. Sauter, R. P. Phizackerly, S. M. Soltis, 
P. Kuhn, Sychrotron Radiat. 2009, 9, 401. 
[22] G. M. Sheldrick, in SHELX97, Programs for Crystal Structure Analysis, 
Universität Göttingen: Germany, 1998. 
[23] O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard, H. Puschmann, 
J. Appl. Cryst. 2009, 42, 339–341. 
Chapter 4 
105 
 
Chapter 4: Synthesis of NHC Containing Pincer 
Complexes 
4.1 Introduction to NHC Containing Pincer Complexes: 
NHC based pincer complexes were first synthesised in 2001.[1] The vast majority of 
those synthesised since that time fall in two main classes: CEC and C^E^C 
complexes where E = C or N (Figure 4.1). The C^E^C complexes differ from the 
CEC complexes with the presence of a methylene linker leading to a characteristic 
C2 twisted conformation. The two wingtip NHCs for the methylene linked complex 
project out of the coordination plane in opposite directions (average imidazole-PdL4 
dihedral angle of 39 °[2]), while in comparison CEC complexes have a flat geometry 
(average imidazole-PdL4 dihedral angle of 2 °[3]).[4] The square planar geometry is 
distorted for CEC complexes with an average C–M–C angle 155(6) ° for the CCC 
complexes due to the strained 5 membered Pd–C–N–C–C ring. This is in contrast to 
the C^C^C species which have an average angle of 172(2) ° due to the 6 
membered Pd–C–N–C–C–C ring.[5] While a large portion of the CEC and C^E^C 
complexes are of group 10 metals the majority of those published have focussed on 
E = N complexes while the synthesis of few CCC and C^C^C species have been 
reported. This is with the exception of a body of work focusing on CCC platinum 
complexes which have potential applications as light-emitting complexes.[5]  
Figure 4.1: The two types of NHC containing pincer complexes: CEC and C^E^C 
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Pd CNC and C^N^C complexes are typically synthesised by reacting the NHC  
pro-ligand with Pd(OAc)2.[1, 6] However, the synthesis of CCC and C^C^C pincer 
complexes provide a more difficult reaction pathway due to the three C–H bond 
activations required. Initial reactions with Pd(OAc)2 failed to form the thee Pd–C 
bonds.[7] Since then, a number of synthetic pathways have been developed that 
allow for the synthesis of various CCC and C^C^C complexes. One method involves 
prefunctionalisation to the corresponding aryl bromide, which then reacts with the 
desired metal via oxidative addition[8] (Scheme 4.1, A). The second method involves 
the synthesis of a zirconium intermediate complex followed by the transmetallation 
Scheme 4.1: Various synthetic methods for group 10 NHC containing CCC and 
C^C^C pincer complexes 
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with the desired metal (Scheme 4.1, B).[9] In addition, a modified ligand with methyl 
substituents on the aryl ring was reacted with a mixture of Pd(OAc)2 and NaOAc 
yielding the desired complex (Scheme 4.1, C).[10] These complexes have also been 
synthesised by the reaction of free carbenes developed in situ with NiCl2 (Scheme 
4.1, D).[11] 
Various catalytic applications have been discovered for NHC containing pincer 
complexes including C-C bond formation through Mizoroki–Heck reactions[1, 12] and 
hydroamination.[13] Additionally these complexes have shown applications as photo 
sensitisers[14] and as light-emitting complexes.[15]  
The applications of NHC pincer complexes in the synthesis of α-cyanocarbanion 
compounds were explored due to their similarities to the POCOP complexes 
described by Guan and co-workers. [16] As NHC pincer complexes exhibited many of 
the key characteristics identified in the DFT calculations in Chapter 2 and due to the 
successful synthesis of [{(RIm)2CH2}Pd(CH2CN)2] complexes in Chapter 3 these 
complexes may observe the same reactivity. As NHCs represent established 
alternatives to phosphine ligands these complexes may provide enhanced or 
complementary reactivity to the related POCOP complexes. Pincers with the C^C^C 
and CCC motif contain a strong trans donor ligand at the active catalyst site, which 
DFT calculations suggest is crucial in lowering the activation energy of the reaction 
as discussed in Chapter 2. Pincers of type CEC contain the same flat geometry as 
the POCOP ligand, however, it is unclear whether this will affect the activation 
energy. It should also be noted that the charge on CNC complexes is different to 
POCOP complexes. As NHC pincer complexes have different geometry to the 
POCOP complexes it was unclear what effect the steric bulk of the N-substituent 
would have on the reactivity and, thus, ligands with different N-substituents were 
investigated. Complexes of the following type will be discussed in this Chapter: 
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1. The synthesis of [(CNCR)PdBr] from a published method and the reaction of 
this complex to form the –NCMe and –CH2CN analogues to test in the 
catalytic formation of β-hydroxynitriles. 
2. The synthesis of [(C^C^CR)PdBr] from a published method and the reaction 
of this to form the –NCMe analogue as well as attempts to form other 
potentially catalytically active analogues including –CH2CN and –OH 
complexes. 
3. A number of synthetic pathways were investigated for the formation of 
[(CCCR)PdBr] with a number of different ligands synthesised including the 
NCMe analogue. 
4. The use of the new synthetic method developed for the synthesis of 
[(CCCR)PdBr] was then extended to the other metals in group 10 as they 
may also show the same activity. 
Many of the complexes synthesised in this Chapter will be discussed again in 
Chapter 5 as they will be tested for their catalytic activity in the formation of  
β-hydroxynitriles.  
4.2 Results and Discussion: 
4.2.1 Synthesis of [(CNCiPr)Pd(CH2CN)][SbF6]: 
Complexes of the type [(CNCR)Pd(CH2CN)] were synthesised due to their structural 
similarities to [{2,6-(iPr2PO)2C6H3}Ni(CH2CN)][16] and as a comparison to the later 
synthesised [(CCCR)PdL] complexes due to its lack of a strong trans donation 
ligand. R = iPr was chosen due its small steric demand and its availability as there 
was pro-ligand available from a previous researcher. 
[(CNCiPr)PdBr]Br (VIII) was synthesised by reacting [(iPrImH)2Py]Br2 with Pd(OAc)2 
in DMSO under conditions analogous to those used by Crabtree and co-workers 
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(Scheme 4.2).[1] The product was purified via column chromatography and the 
formation of the desired product was supported by 1H NMR spectroscopy which was 
consistent with previous literature reports of the compound with loss of the 
characteristic downfield imidazolium C2 proton resonances at 10.38 ppm consistent 
with the formation of the Pd–C bonds.[17] 
Scheme 4.2: Synthesis of [(CNCiPr)PdBr]Br (VIII) 
 
[(CNCiPr)Pd(NCMe)][SbF6]2 (IX) was synthesised by reacting [(CNC
iPr)PdBr]Br with 
Ag[SbF6] in CH3CN. The complex was then purified via recrystallisation by vapour 
diffusion of Et2O into a solution in CH3CN giving the desired product in a 34 % yield 
(Scheme 4.3). The formation of the product was supported by 1H and 13C NMR 
spectroscopy. With signals in the 1H NMR spectrum at 2.08 ppm and 13C NMR 
spectrum 1.6 ppm consistent with the CH3 from the coordinated acetonitrile ligand. 
Analysis of the X-ray crystal structure reveals the bond lengths and angles are 
consistent with the previously published [(CNCiPr)Pd(NCMe)][PF6]2.[17] The complex 
has a flat geometry of the CNC ligand with the largest deviating from the least  
Scheme 4.3: Synthesis of [(CNCiPr)Pd(NCMe)][SbF6]2 (IX) 
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Figure 4.2: X-ray molecular structure of cation [(CNCiPr)Pd(NCMe)]2+ of IX. Thermal 
ellipsoids are shown at the 50% probability level. 2 [SbF6]- counter ions 
and a CH3CN lattice solvent molecule omitted for clarity. All isopropyl 
hydrogen atoms removed for clarity. Selected bond lengths (Å) and 
angles (°): Pd(1)–C(1) 2.040(4), Pd(1)–C(9) 2.031(4), Pd(1)–N(3) 
1.956(3), Pd(1)–N(6) 1.999(4), N(6)–C(18) 1.134(6), C(18)–C(19) 
1.450(6), N(3)–Pd(1)–N(6) 178.88(15), N(3)–Pd(1)–C(1) 79.24(15),  
N(3)–Pd(1)–C(9) 79.36(15), N(6)–Pd(1)–C(1) 100.70(15),  
N(6)–Pd(1)–C(9) 100.70(15), C(9)–Pd(1)–C(1) 158.60(16),  
C(18)–N(6)–Pd(1) 172.6(4), N(6)–C(18)–C(19) 179.5(5). 
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square plane being 0.046(4) Å for C(2) and imidazole-PdL4 dihedral angles of 
2.16(16) and 2.00(18) °. The complex observes a distorted square planar geometry, 
with the main deviation being a non-linear C–Pd–C angle (158.60(16) °) arising from 
the C2N2Pd 5-membered chelate rings (Figure 4.2). 
[(CNCiPr)Pd(NCMe)][SbF6]2 was then reacted with NaOH in CH3CN to synthesise 
the α-cyanocarbanion complex [(CNCiPr)Pd(CH2CN)][SbF6] (Scheme 4.4). The 
reaction was performed under analogous conditions to those described for the 
synthesis of the bis(NHC) complexes in Chapter 3. The formation of the desired 
complex was supported by the upfield shift of the 13C NMR resonance of the CH2 
protons of the CH2CN ligand (–10.0 ppm), which is consistent with similar 
complexes of bonding mode I discussed in Chapter 1. 
Scheme 4.4: Synthesis of [(CNCiPr)Pd(CH2CN)][SbF6] (X) 
 
Analysis of the X-ray crystal structure for X reveals similar bond distances to 
complex IX. [(CNCiPr)Pd(CH2CN)][SbF6] (X) has a flat CNC ligand geometry (largest 
deviation from the least square plane of 0.308(15) Å), small imidazole-PdL4 dihedral 
angles (2.19(16) & 2.01(18) °) and a distorted square planar geometry of the 
palladium (C(9)–Pd(1)–C(1) 156.9(4) °). One difference between IX and X is the 
elongation of the Pd(1)–N(3) bond length by 0.066 Å. This elongation is consistent 
with the increase in trans-donation effect from the change in ligation from an  
N–bound to C–bound donor ligand. 
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Figure 4.3: X-ray molecular structure of cation [(CNCiPr)Pd(CH2CN)]+ of X. Thermal 
ellipsoids are shown at the 50% probability level. 1 [SbF6]- counter ion 
molecule omitted for clarity. Disorder in one of the NHC rings and 
corresponding isopropyl substituent removed for clarity (N1B, C2B, 
C12B-C14B), discussed further below. All isopropyl hydrogen atoms 
removed for clarity. Selected bond lengths (Å) and angles (°):  
Pd(1)–N(3) 2.022(8), Pd(1)–C(1) 2.086(11), Pd(1)–C(9) 2.067(10), 
Pd(1)–C(18) 2.070(10), C(18)–C(19) 1.417(17), N(6)–C(19) 1.151(15),  
N(3)–Pd(1)–C(1) 77.9(4), N(3)–Pd(1)–C(9) 79.0(3), N(3)–Pd(1)–C(18) 
177.9(4), C(9)–Pd(1)–C(1) 156.9(4), C(9)–Pd(1)–C(18) 100.2(4), 
C(18)–Pd(1)–C(1) 102.9(4), C(19)–C(18)–Pd(1) 107.7(7),  
N(6)–C(19)–C(18) 177.3(12). 
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The CH2CN ligand has a C–C bond length of 1.417(17) Å, an N–C bond length of 
1.151(15) Å a Pd–C–C bond angle of 107.7(7) ° and a N–C–C angle of 177.3(12) °.  
These bond angles and distances are consistent with the dominant resonance form 
of CH2CN consistent with bonding mode I as discussed in Chapter 1 (Figure 4.3).  
The crystal structure of [(CNCiPr)Pd(CH2CN)][SbF6] included disorder in one of the 
NHC rings where there was some electron density above and below the plane. This 
was modelled with a refined ~0.56 occupancy for those modelled with continuous 
bonds and ~0.44 with dashed bonds. This disorder was modelled with isotropic 
atoms in this area as, although electron density was clearly observed, modelling this 
disorder anisotropically was not stable. (Figure 4.3, 4.4) 
Figure 4.4: X-ray molecular structure of cation [(CNCiPr)Pd(CH2CN)]+ of X. Ball and 
stick diagram showing disorder modelled for NHC ring (dashed bonds). 
 
4.2.2 Synthesis of [(C^C^CMe)Pd(NCMe)][SbF6]: 
[(C^C^CR)PdL] complexes were synthesised as the central aryl carbon’s strong 
trans donating ability make them strong candidates as catalysts. Although these 
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Scheme 4.6: Synthesis of [2,6-(MeImHCH2)2-1-BrPh]Br2 (XII). 
complexes do not have the same flat geometry to [{2,6-(iPr2PO)2C6H3}Ni(CH2CN)] it 
is unclear whether this geometry is crucial for catalysis. Given successful previous 
work by Crabtree and co-workers synthesising [(C^C^CMe)PdBr] this was chosen as 
the desired backbone.[8] 
2,6-(BrCH2)2-1-BrPh was synthesised by reacting bromo-m-xylene with  
N-bromosuccinimide in CCl4 while irradiated with a 23 W compact fluorescent light 
bulb. [18] The desired product was isolated in a 28 % yield. No reaction was observed 
in the absence of visible light irradation and when the reaction was attempted with a 
benzoyl peroxide catalyst a complex mixture of products were formed. The 1H NMR 
spectrum of the product was consistent with that previously reported for the target 
compound with resonances at 4.65 ppm consistent with the CH2 signal from the 
downfield shift due to coupling of the Br.[19]  
Scheme 4.5: Synthesis of 2,6-(BrCH2)2-1-BrPh (XI). 
 
[2,6-(MeImHCH2)2-1-BrPh]Br2 was then synthesised from the tribromide XI by 
reaction with 1-methylimidazole in 1,4-dioxane for 2 h in a 83 % yield.[8] The 1H 
NMR spectrum of the product was consistent with that previously reported for the 
compound with a C2 proton resonance at 9.21 ppm consistent with the formation of 
hν 
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the imidazolium.[8]  
[(C^C^CMe)PdBr] was synthesised in a 27 % yield by reacting  
[2,6-(MeImHCH2)2-1-BrPh]Br2 with Pd(dba)2 and Na2CO3 in DMSO following a 
modified literature procedure replacing Pd2(dba)3 with the more accessible 
Pd(dba)2.[8] The reaction was also performed using Pd2(dba)3·CHCl3 however, the 
yield observed was comparable. The 1H NMR spectrum of XIII was consistent with 
that previously reported[8] with the characteristic loss of the imidazolium resonances 
at 9.21 ppm due to the newly formed Pd–C bonds. 
Scheme 4.7: Synthesis of [(C^C^CMe)PdBr] (XIII). 
 
[(C^C^CMe)Pd(NCMe)][SbF6] was subsequently synthesised by reacting 
[(C^C^CMe)PdBr] with Ag[SbF6] in CH3CN in a 77% yield (Scheme 4.8). The 
formation of the product was supported by the presence of resonances in the 1H & 
13C NMR spectrum at 2.09 and 1.77 ppm respectively consistent with the CH3 group 
of the acetonitrile ligand. The X-ray crystal structure of the product indicates a 
Scheme 4.8: Synthesis of [(C^C^CMe)Pd(NCMe)][SbF6] (XIV) 
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Figure 4.5: X-ray molecular structure of cation [(C^C^CMe)Pd(NCMe)]+ of XIV. 
Thermal ellipsoids are shown at the 50% probability level. 1 [SbF6]- 
counter ion and an CH3CN solvent molecule omitted for clarity. All 
methyl hydrogen atoms removed for clarity. Selected bond lengths (Å) 
and angles (°): Pd(1)–N(5) 2.103(5), Pd(1)–C(1) 2.040(6), Pd(1)–C(5) 
2.007(6), Pd(1)–C(12) 2.031(6), N(5)–C(17) 1.134(7), C(17)–C(18) 
1.465(8), C(1)–Pd(1)–N(5) 92.4(2), C(5)–Pd(1)–C(1) 87.3(2),  
C(5)–Pd(1)–C(12) 86.5(2), C(12)–Pd(1)–N(5) 93.9(2),  
C(12)–Pd(1)–C(1) 173.7(2), N(5)–C(17)–C(18) 178.0(7),  
C(17)–N(5)–Pd(1) 176.2(5). 
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twisted geometry of the C^C^C ligand consistent with the corresponding Br complex 
with NHC ring-PdL4 dihedral angles of 39.17(19) and 40.3(2) ° (Figure 4.6).[8] The 
C(1)–Pd(1)–C(12) angle of 173.7(2) ° is closer to the ideal linear angle in 
comparison to the CNC analogue due to the presence of the methylene linker 
creating the 6-membered C4NPd chelate ring. The Pd–N bond length for XIV is 
2.103(5) Å in contrast to 1.99(4) Å for [(CNCiPr)Pd(NCMe)][SbF6]2 and is consistent 
with the stronger trans donation of the central aryl carbon of the C^C^C ligand 
(Figure 4.5). 
Figure 4.6: Side on view of the molecular structure of cation [(C^C^CMe)Pd(NCMe)]+ 
of XIV highlighting the twisted geometry of the NHC rings-PdL4 dihedral 
angle. 
 
The synthesis of [(C^C^CMe)Pd(CH2CN)] was attempted by the reaction of XIV with 
NaOH in CH3CN, however various products were observed by 1H NMR 
spectroscopy and were inseparable by chromatography or crystallisation. Given the 
difficulty in the formation of the CH2CN complex, the synthesis of 
[(C^C^CMe)Pd(OH)] was attempted as it may feature the same reactivity given the 
OH-ligated complex was observed as an intermediate in the formation of 
[{(MeIm)2CH2}Pd(CH2CN)2]. The synthesis of [(C^C^CMe)Pd(OH)] was attempted 
following a method developed for a PdPCP complex.[20] [(C^C^CMe)PdBr] was 
reacted with AgNO3 in THF yielding [(C^C^CMe)Pd(ONO2)] which was then reacted 
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with NaOH in THF to provide [(C^C^CMe)Pd(OH)]. However, due to difficulties in 
purification it was unclear whether the desired product was formed. 
4.2.3 Synthesis Attempt for CCC Complex Using Unsubstituted Ligand: 
[(CCCR)PdL] complexes were synthesised as these have the same geometry and 
trans donating ability as [{2,6-(iPr2PO)2C6H3}Ni(CH2CN)] and thus may find useful 
applications in catalysis. 
As discussed at the start of this Chapter, very few successful synthetic methods 
have been established for complexes of the type [(CCC)ML]. When the CCC pro-
ligand [1,3-(RImH)2Ph]X2 was treated with Pd(OAc)2 the product formed contained 
only two of the Pd–C bonds as assigned by NMR spectroscopy.[7] Successful 
synthetic pathways for complexes of the type CCC have involved the use of a 
zirconium transmetallation reagent before treating the solution with the desired 
metal salt.[9] This is in contrast to complexes of the type C^C^C which are commonly 
synthesised by the use of a brominated aryl ligand allowing oxidative addition of 
palladium(0) (as discussed in 4.2.2).[8] Another report claims to have made the 
complex, however, no experimental information or characterisation was provided.[21] 
 However, the same synthetic pathway cannot be used for the synthesis of the CCC 
complexes as was used for XII. One of the intermediates in the synthesis of the pro-
ligand for XII is 2,6-(BrCH2)2-1-BrPh and with the absense of the methylene linker in 
the CCC pro-ligand the specificity for the addition of imidazole cannot be achieved 
for a tribromobenzene (i.e. X1=X2=Br). Thus an alternative method was required. 
Initially the 3x C–H activation pathway was attempted, i.e. X1 = H, X2 = Br (Scheme 
Scheme 4.9: Retrosynthetic analysis for the synthesis of the CCC pro-ligands. 
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4.9). 
1,3-Im2Ph was synthesised following a modified published procedure.[22] Imidazole 
was reacted with 1,3-dibromobenzene in DMSO in the presence of K2CO3 and CuO 
and was purified by eluting on a silica plug in a 44 % yield (Scheme 4.10). The 
product was spectroscopically consistent to the literature.[23]  
Scheme 4.10: Synthesis of 1,3-Im2Ph (XV). 
 
From this compound [1,3-(MeImH)2Ph]I2 (XVIa) and [1,3-(nBuImH)2Ph]Br2 (XVIb) 
could both be synthesised under very similar conditions in a pressure tube. The 
NMR spectroscopic data for these compounds were consistent with the literature 
with the presence of downfield 1H NMR resonances at 9.88 for XVIa and 11.33 ppm 
for XVIb consistent with the formation of the imidazolium C2-protons (Scheme 
4.11).[23-24] 
Scheme 4.11: Synthesis of [1,3-(MeImH)2Ph]I2 (XVIa) and [1,3-(nBuImH)2Ph]Br2 
(XVIb). 
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A number of reactions were attempted with XVIa and XVIb to synthesise the desired 
[(CCCR)PdX] complex. Initially, the ligand XVIa was treated with Pd(OAc)2 under 
identical conditions for the synthesis of complex VIII. The 1H NMR spectrum 
indicated a mixture of products were formed. The crude product was then treated 
with Ag[SbF6] in acetonitrile and a crystal structure of the product was obtained. The 
crystal structure shows a binuclear palladium complex with two bridging NHC 
ligands. Each palladium also has one water and one DMSO ligand. The DMSO is 
likely to be present from the Pd(OAc)2 reaction while the water may have been 
present from the subsequent reaction in acetonitrile or during the recrystallisation 
process. The Pd–C bond distances between 2.038(8) – 2.055(8) Å are consistent 
with the Pd–C distances for the NHC ring distances observed for 
[(C^C^CMe)Pd(NCMe)][SbF6] (Figure 4.7). Similar Cu, Ag and Au metallated 
complexes have previously been synthesised due to their application in 
photoluminescence.[25] 
The formation of this product indicates the lack of the desired three C–H 
deprotonation and metalation steps as expected. [1,3-(nBuImH)2Ph]Br2 (XVIb) was 
treated with Pd(OAc)2 giving a mixture of products by 1H NMR spectroscopy. 
Attempting this reaction again with the addition NaOAc also yielding an inseparable 
mixture. XVIb was also treated with Ag2O in CH2Cl2 in an attempt to form the silver 
salt intermediate before treating with [PdBr2(COD)]. However, an inseparable 
mixture was formed and further reaction with NaOAc to promote the formation of the 
complex did not give the desired result.  
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To try to replicate the successfully synthesised CCC complex using Zr(NMe2)4 an 
alternative zirconium transmetallation agent was used which would have synthetic 
advantages due to its lower cost.[9] Zr(NEt2)4[26] was treated with both XVIa and XVIb 
Figure 4.7: X-ray molecular structure of the product formed from the reaction of  
[1,3-(MeImH)2Ph]I2 (XVIa) and Pd(OAc)2. Thermal ellipsoids are shown 
at the 50% probability level. 4 [SbF6]- counter ions modelled, 1 of these 
modelled via solvent mask, omitted for clarity. 4 DMSO solvent 
molecule omitted for clarity. All ligated DMSO hydrogen atoms and 
methyl hydrogen atoms removed for clarity. Selected bond lengths (Å) 
and angles (°): Pd–S 2.215(2) – 2.225(2), Pd–O 2.057(7) – 2.059(6), 
Pd(1)–C(1) 2.055(8), Pd(1)–C(15) 2.043(9), Pd(2)–C(10) 2.042(8), 
Pd(2)–C(24) 2.038(8), O–Pd–S 175.73(19) – 177.7(2), C–Pd–S 
89.7(2) – 90.6(3), C–Pd–O 90.1(3) – 90.3(3), C–Pd–S 89.0(2) – 
89.6(2), C–Pd–O 89.4(3) – 91.1(3), C–Pd–C 177.8(3) – 179.3(4). 
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however none of the desired complex was observed. Due to the high cost of 
Zr(NMe2)4 and the low atom economy of the formation of [(CCCR)PdX], an 
alternative method was further investigated. 
4.2.4 Attempted Synthesis of CCC Complex using Triflate Functionality on 
Central Carbon: 
Due to the difficulty in synthesising [(CCCR)PdX] using the 3 x C–H activation 
pathway an alternative synthesis method was needed. Thus the use of an X1 = OTf 
substituent while X2 = Br (Scheme 4.9) would allow synthesis by the oxidative 
addition pathway pioneered by Crabtree’s work for the C^C^C complex. 
 2,6-Dibromophenol was synthesised by the reaction of phenol with  
N-bromosuccinimide in the presence of diisopropylamine following a modified 
literature procedure.[27] In addition to the formation of 2,6-dibromophenol in a 67 % 
yield, 2,4,6-tribromophenol was also observed by 1H NMR spectroscopy. The 1H 
NMR spectrum was consistent with that previously reported (Scheme 4.12).[27] 
2,6-Dibromophenol was treated with imidazole in the presence of a CuO catalyst 
however, various products were observed in an inseparable mixture. This was in 
contrast to a previous literature report which successfully coupled imidazole to 2-
bromophenol using a copper catalyst.[27] To prevent unwanted side reactions 2,6-
dibromophenol was protected with a benzyl protecting group by treating it with 
benzylchloride and a catalytic quantity of NaI forming the desired product in 94 % 
yield (Scheme 4.13).[29] The formation of 2,6-Br2-1-OBnPh was supported by 1H 
Scheme 4.12: Synthesis of 2,6-dibromophenol (XVII). 
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NMR spectroscopy with resonances equivalent to that published in the literature 
including those at 5.06 ppm consistent with the CH2 benzyl protons.[29] 
Initial coupling reactions to form 2,6-Im2-1-OBnPh followed the identical synthetic 
method used for XV by treating 2,6-Br2-1-OBnPh with imidazole in the presence of a 
CuO catalyst. However, 1H NMR spectroscopy indicated the intermediate  
2-Br-6-Im-1-OBnPh was synthesised. To promote complete conversion the more 
reactive CuI and Cu2O were used as coupling catalysts. Both have been used for 
similar couplings previously.[30] 2,6-Br2-1-OBnPh and imidazole were heated in 
DMSO in the presence of CuI and Cu2O and K2CO3 yielding both 2,6-Im2-1-OBnPh 
(XIXa) and 2,6-Im2-1-OHPh (XIXb) which were separated on a basic alumina plug 
(Scheme 4.14). 1H and 13C NMR, IR spectroscopy and mass spectrometry 
supported the formation of XIXa with 1H NMR resonances at 8.03, 7.58 and 7.44 
ppm consistent with the imidazole resonances supporting coupling of the two 
imidazoles. XIXb displayed 1H NMR resonances at 8.21, 7.48, 6.89 ppm consistent 
with the imidazole resonances and absence of the signal at 5.32 ppm for the benzyl 
protons. The formation of XIXb is possibly due to a copper mediated debenzylation 
reaction. 
Scheme 4.13: Synthesis of 2,6-Br2-1-OBnPh (XVIII). 
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Scheme 4.14: Synthesis of 2,6-Im2-1-OBnPh (XIXa) and 2,6-Im2-1-OHPh (XIXb). 
 
The benzyl protected product 2,6-Im2-1-OBnPh was then converted to the alcohol 
by the reaction of XIXa with 10 % Pd/C in a H2 atmosphere yielding XIXb (Scheme 
4.15). 
Scheme 4.15: Synthesis of 2,6-Im2-1-OHPh (XIXb) from XIXa. 
The last two steps to form the desired ligand involved the triflation and methylation 
of XIXa or XIXb and these steps could occur in either order. For the desired 
formation of the triflate, XIXb was treated with triflic anhydride with various bases in 
CH2Cl2. Similarly, N-methylation of both XIXa and XIXb were attempted with CH3I in 
toluene. Both are described together below in Table 4.1. As neither the triflation nor 
the N-methylation reaction proceeded, the formation of desired triflate based CCC 
pro-ligand became unfeasible and thus an alternative ligand pathway was pursued 
for the synthesis of [(CCCR)PdBr]. 
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Reaction Conditions Product Formed 
XIXb + Tf2O + Pyridine 
+ CH2Cl2 
No triflate formed, likely protonated imidazolium as shifts 
are consistent with XIXb + HCl 
XIXb + Tf2O + DMAP + 
CH2Cl2 
Product unclear, impossible to separate from DMAP 
XIXb + Tf2O + NaH + 
CH2Cl2 
No triflate formed, ESI-MS indicated major ion 227 i.e. 
protonated product 
XIXb + CH3I + Toluene,  
62 h, 110 °C 
Mixture of products, unclear whether correct product was 
formed.  
XIXa + CH3I + Toluene,  
24 h, 110 °C 
Mixture of products, unclear whether correct product was 
formed. 
Table 4.1: Synthesis attempts for the formation of the desired triflate CCC  
pro-ligand. 
4.2.5 Synthesis of [2,6-(ImHR)21-BrPh]X2: 
Due to the difficulty in synthesising the desired ligand with a triflate functionality on 
the central carbon, an alternative synthetic method was sought. Strassner and co-
workers treated 1,2-dibromo-4,5-difluorobenzene with imidazole and K2CO3 in DMF 
yielding (3,4-dibromo-1,2-phenylene)bisimidazole. This intermediate was 
successfully treated with MeBr to form the desired imidazolium salt (Scheme 
4.16).[31] 
Scheme 4.16: Synthesis of (3,4-dibromo-1,2-phenylene)bisimidazole by Strassner 
and co-workers.[31] 
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Given the success of Strassner and co-workers and their ability to synthesise the 
desired imidazolium salt a mixed halide synthesis method was pursued where X1 = 
Br and X2 = F (Scheme 4.9). Anticipating the same results could be used to achieve 
selective addition of imidazole, 1-bromo-2,6-difluorobenzene was used as a starting 
material for the synthesis of the pro-ligand (Scheme 4.9).  
1-Bromo-2,6-difluorobenzene was treated with imidazole and K2CO3 in DMF giving 
2,6-Im2-1-BrPh in 88 % yield (Scheme 4.17). The formation of the product was 
supported by NMR spectroscopy with 1H NMR resonances at 7.70, 7.23 and 7.16 
ppm consistent with the imidazole protons and the formation of the product. This 
yield is higher than that observed for the synthesis of 1,3-Im2Ph (XV, 44 %). In 
addition, this method does not require a CuO catalyst and thus the use of  
1,3-difluorobenzene may be a better synthetic method for XV but this was not 
attempted due to time constraints. 
Scheme 4.17: Synthesis of 2,6-Im2-1-BrPh (XX). 
 
The desired ligands can then easily be synthesised from XX under varying 
conditions. 2,6-Im2-1-BrPh was treated with iodomethane or 1-bromobutane in 
toluene yielding the desired corresponding ligands [2,6-(MeImH)2-1-BrPh]I2 (XXIa) 
and [2,6-(nBuImH)2-1-BrPh]Br2 (XXIb) (Scheme 4.18). The formation of these 
ligands were supported by 1H and 13C NMR spectroscopy with 1H NMR resonances 
at 9.61 and 9.73 ppm respectively consistent with the formation of the C2 proton 
imidazolium. An X-ray crystal structure was obtained for both ligands with a Br–C 
bond length of 1.884(7) Å for XXIa and 1.890(2) Å for XXIb (Figure 4.8 and 4.9).  
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Scheme 4.18: Synthesis of [2,6-(MeImH)2-1-BrPh]I2 (XXIa) and  
[2,6-(nBuImH)2-1-BrPh]Br2 (XXIb) 
 
Figure 4.8: X-ray molecular structure of cation [2,6-(ImHCH3)2-1-BrPh]2+ of XXIa. 
Thermal ellipsoids are shown at the 50% probability level. two I- 
counter anions and all methyl hydrogen atoms omitted for clarity. 
Selected bond length (Å): Br(1)–C(4) 1.884(7). 
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Figure 4.9: X-ray molecular structure of cation [2,6-(nBuImH)2-1-BrPh]2+ of XXIb. 
Thermal ellipsoids are shown at the 50% probability level. two Br– 
counter anion and a methanol lattice solvent molecule omitted for 
clarity. All nbutyl hydrogen atoms omitted for clarity. Selected bond 
length (Å): Br(1)–C(9) 1.890(2). 
 
For the N-adamantyl ligand [2,6-(AdImH)21-BrPh]Br2, the synthesis was more 
difficult due to the increased steric hindrance of the N-substituent in comparison to 
XXIb. Following the method used for the synthesis of the analogous ligand without 
the 1-Br substituent,[32] solid 2,6-Im2-1-BrPh XX and 1-bromoadamantane were 
stirred at 170 °C for 24 hours forming the desired ligand in 7 % yield. This was 
compared to a 77 % yield recorded for the analogue without the 1-Br substituent 
under identical conditions.[32] The yield was increased slightly to 11 % when the 
reaction was stirred at 170 °C for 48 hours. Perhaps, the increased steric hinrance 
or electron withdrawing effects of the Br-substituent makes2,6-Im2-1-BrPh more 
stable than 1,3-Im2Ph and, thus, less reactive. In addition, 1-bromoadamantane was 
observed to sublime and crystallise on the side of the pressure tube during the 
reaction and, although steps were taken to minimise this, it may have reduced the 
yield (Scheme 4.19, Figure 4.10). 
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Scheme 4.19: Synthesis of [2,6-(AdImH)21-BrPh]Br2 (XXIc). 
 
Analysis of the three pro-ligands indicates XXIc in comparison to the other ligands 
has an increase in the C–Br distance and the distance from the Ph plane of the Br 
substituent. This is likely due to the increased steric demand of the N-adamantyl 
substituents forcing the Br to sit slightly out of plane and may also contribute to the 
Figure 4.10: X-ray molecular structure of cation [2,6-(AdImH)21-BrPh]2+ of XXIc. 
Thermal ellipsoids are shown at the 50% probability level. Only one of 
the two XXIc cations in the asymmetric unit is displayed for clarity. two 
Br– counter anions and a Et2O lattice solvent molecule omitted for 
clarity. All N-adamantyl hydrogen atoms omitted for clarity. Selected 
bond length (Å): Br–C 1.909(5), 1.922(5). 
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lower yield of XXIc observed (Table 4.2). 
 
Table 4.2: Comparison of the strain on the Br substituent for the three pro-ligands 
XXIa-c. 
 
4.2.6 Synthesis of [(CCCR)Pd(NCMe)][SbF6]: 
The synthesis of complexes of the type [(CCCR)PdBr] followed a modified procedure 
for the synthesis of the equivalent [(C^C^CMe)PdBr] complex developed by Crabtree 
and co-workers.[8]  
[2,6-(MeImH)21-BrPh]I2 was treated with Pd(dba)2 and Na2CO3 in DMSO in an 
attempt to synthesise the complex [(CCCMe)PdX], X=Br/I. Due to the poor solubility 
of the final product, the multiple species observed by 1H NMR spectroscopy and the 
difficulty in purification the focus moved on to [(CCCnBu)PdBr] which had previously 
been synthesised using a zirconium transfer agent.[9b] 
[2,6-(nBuImH)21-BrPh]Br2 was treated with Pd(dba)2 and Na2CO3 in DMSO giving 
N-substituent N-Me N-Butyl N-Adamantyl 
C-Br distance (Å) 1.884(7) 1.890(2) 1.909(5), 
1.922(5) 
Distance from Ph plane to the Br 
substituent (Å) 
0.0811(12) 0.104(4) 0.425(10), 
0.433(9) 
Scheme 4.20: Synthesis of [CCCnBuPdBr] (XXIIa). 
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[(CCCnBu)PdBr], spectroscopically identical to that previously published (Scheme 
4.20).[9b] Although the yield was slightly lower than the previously published method 
(26 % vs 40 %) the better atom economy, air stable starting materials and the 
advantage of not having to use an expensive zirconium transfer agent makes this 
synthesis method superior. 
  
Figure 4.11: X-ray molecular structure of [(CCCnBu)PdBr] XXIIa. Thermal ellipsoids 
are shown at the 50% probability level. All nbutyl hydrogen atoms 
removed for clarity. Selected bond lengths (Å) and angles (°):  
Pd(1)–Br(1) 2.4979(10), Pd(1)–C(1) 2.058(7), Pd(1)–C(4) 1.940(7), 
Pd(1)–C(10) 2.054(7), C(1)–Pd(1)–Br(1) 101.48(19), C(4)–Pd(1)–Br(1) 
177.5(2), C(4)–Pd(1)–C(1) 78.2(3), C(4)–Pd(1)–C(10) 78.5(3),  
C(10)–Pd(1)–Br(1) 101.78(18), C(10)–Pd(1)–C(1) 156.7(3). 
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The crystal structure of XXIIa is consistent with similar CCC metal complexes.[15] 
The imidazolium rings, aryl and palladium square planar ligand plane are all on the 
same plane with the palladium having a distorted square planar geometry. The 
C(1)–Pd(1)–C(10) angle is 156.7(3) ° due to the 5 membered PdC3N ring which is 
comparable to the angle observed for [(CNCiPr)Pd(NCMe)][SbF6]2 (IX) (158.60(16) 
°). In addition the dihedral angle of the imidazolium to palladium ligand plane are 
3.7(3) and 5.2(3) ° slightly higher than those observed for IX (2.19(16) and 2.01(18) 
°) (Figure 4.11). 
The oxidative addition intermediate prior to the NHC coordination was trapped in an 
attempt to learn more about the synthesis of [(CCCnBu)PdBr] due to the moderate 
yield for the synthesis of the complex. 
The first attempt to isolate the oxidative addition intermediate yielded unexpected 
results. [2,6-(nBuImH)2-1-BrPh]Br2 was treated with Pd(dba)2 in DMSO and the 
solution was stirred at room temperature for 19 h, however, to remove the DMSO 
the solution was heated to 140 °C. Upon characterisation of the product the 1H and 
13C NMR spectroscopy, X-ray crystal structure and ESI-MS were all consistent with 
the formation [(3-(nBuImH)-1-(nBuImPdBr3)Ph)] (XXIII) (Scheme 4.21, Figure 4.10). 
The 1H NMR spectrum had inequivalent N-butyl chains and an imidazolium C2 
proton resonance remaining at 9.96 ppm supporting one Pd–NHC bond. In addition, 
a ESI-MS with a m/z of 588.9617 was consistent with the proposed product with the 
loss of a Br atom. Due to the low solubility of XXIII and a high number of 
Scheme 4.21: Synthesis of [(3-(nBuImH)-1-(nBuImPdBr3)Ph)] (XXIII). 
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inequivalent peaks, incomplete 13C NMR spectroscopy characterisation was 
possible. The crystal structure had large thermal ellipsoids due to larger R1  
(10.39 %) and Rint (8.41 %) factors as the crystals obtained were small  
(20x 10x 10 µm) and were collected on the MX2 beamline at the Australian 
Synchrotron. The Pd–Br distances of between 2.4337(14)–2.4848(14) Å are 
consistent with [(3-(cyImH)-1-(cyImPdBr3)Py)] of 2.429–2.483 Å with a C–Pd 
distance of 1.994(9) Å longer than 1.957 Å observed for the literature compound.[17] 
Figure 4.12: X-ray molecular structure of [(3-(nBuImH)-1-(nBuImPdBr3)Ph)] XXIII. 
Thermal ellipsoids are shown at the 50% probability level. All n-butyl 
hydrogen atoms removed for clarity. Selected bond lengths (Å) and 
angles (°): Pd(1)–Br(1) 2.4337(14), Pd(1)–Br(2) 2.4542(14),  
Pd(1)–Br(3) 2.4848(14), Pd(1)–C(1) 1.994(9), Br(1)–Pd(1)–Br(3) 
92.17(5), Br(2)–Pd(1)–Br(3) 92.18(5), C(1)–Pd(1)–Br(1) 87.3(3), 
C(1)–Pd(1)–Br(2) 88.9(3). 
 
A postulated mechanism for the formation of XXIII began with the anticipated 
oxidative addition of Pd(0) to the C–Br to an aryl bond. As the solution was heated 
during the removal of the DMSO, this heat facilitated the coordination of the NHC 
Chapter 4 
134 
 
carbon to the palladium and the decoordination of the Pd–C to aryl bond yielding 
XXIII (Scheme 4.22). 
Scheme 4.22: Proposed mechanism for the synthesis of  
[(3-(nBuImH)-1-(nBuImPdBr3)Ph)] (XXIII). 
 
 The reaction was repeated in acetonitrile as this polar solvent could be removed at 
room temperature and would hopefully trap the desired oxidative addition 
intermediate. [2,6-(nBuImH)21-BrPh]Br2 was treated with Pd(dba)2 in CH3CN and 
the solution was stirred at room temperature for 17 hours. The expected oxidative 
addition product [(2,6-(nBuImH)2Ph)PdBr3] was isolated. The identity of the product 
was supported by 1H NMR spectroscopy with the presence of the C2 proton 
imidazolium resonance at 9.67 ppm and symmetrical nBu substituent. In addition, 
the 13C NMR spectroscopy, ESI-MS and X-ray crystallography all supported the 
Scheme 4.23: Synthesis of [(2,6-(nBuImH)2Ph)PdBr3] (XXIV). 
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formation of XXIV. The Pd–Br bond lengths of 2.4370(12) and 2.5499(18) Å and 
Pd–C bond length of 1.991(14) Å are consistent with those observed with XXIII. 
With a yield of 18 % for the isolation of XXIV, the reaction of this isolated product 
with Na2CO3 will not lead to an increase in the yield of [(CCC
nBu)PdBr] as the one 
step reaction described previously had a yield of 26 % (XXIIa) (Scheme 4.23). 
 
Figure 4.13: X-ray molecular structure of [(2,6-(nBuImH)2Ph)PdBr3] XXIV. Thermal 
ellipsoids are shown at the 50% probability level. All n-butyl hydrogen 
atoms removed for clarity. Disorder in n-butyl chain (C10B and C11B) 
omitted for clarity, see cif for details. Selected bond lengths (Å) and 
angles (°): Pd(1)–Br(1) 2.4370(12), Pd(1)–Br(2) 2.5499(18),  
Pd(1)–C(4) 1.991(14), Br(1)–Pd(1)–Br(1) 173.61(8), Br(1)–Pd(1)–Br(2) 
93.19(4), 93.20(4), C(4)–Pd(1)–Br(1) 86.80(4), 86.81(4). 
[(CCCnBu)PdBr] XXIIa was treated with Ag[SbF6] in acetonitrile to form the desired 
acetonitrile complex [(CCCnBu)Pd(NCMe)][SbF6] (XXIIIa, Scheme 4.24). This was 
supported by X-ray crystallography and 1H NMR spectroscopy with a peak at 2.10 
ppm consistent with the coordination of an acetonitrile ligand. 
Chapter 4 
136 
 
Figure 4.12: X-ray molecular structure of cation [(CCCnBu)Pd(NCMe)]+ of XXVa. 
Thermal ellipsoids are shown at the 50% probability level. Only one 
complex shown for clarity, [SbF6]- counter ion omitted for clarity. All 
N-butyl hydrogen atoms removed for clarity. Selected bond lengths 
(Å) and angles (°): Pd–N 2.101(4), 2.103(4), Pd–CNHC  
2.043(4) – 2.059(4), Pd–Caryl 1.943(4), 1.951(4), N≡C 1.132(6), 
1.141(6), C–Cα 1.454(6), 1.468(7), CNHC–Pd–N  
100.69(16) – 102.73(16), Caryl–Pd–N 177.43(16), 178.53(15),  
Caryl–Pd–CNHC 77.98(18) – 78.62(17), CNHC–Pd–CNHC 156.80(17), 
156.23(17), C≡N–Pd 176.1(4), 177.0(4), N≡C–Cα 178.3(6), 178.7(5). 
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[(CCCnBu)Pd(NCMe)][SbF6] has similar bond angles and distances to 
[(CCCnBu)PdBr] with a Pd–N distance bond of 2.101(4) and 2.103 (4) Å consistent 
with the Pd–N distance observed for [(C^C^CMe)Pd(NCMe)][SbF6]. 
Only two NHC containing CCC complexes with adamantyl N-substituents have 
previously been recorded, both of which are iridium complexes. A nNHC-nNHC 
(normal NHC-normalNHC) iridium complex was observed for a benzimidazole 
based ligand with a square pyramidal geometry.[33] Similarly a mixed nNHC-aNHC 
(normalNHC-abnormal NHC) iridium complex was observed with an octahedral 
geometry under similar reaction conditions.[32] While normal NHC complexes bond 
via the C2 carbon, with increased steric bulk or substitution, coordination can occur 
via the C4 carbon and are classed as abnormal carbenes.[34]  
[2,6-(AdImH)21-BrPh]Br2 was treated with Pd(dba)2 and Na2CO3 in DMSO. Due to a 
range of products being observed by 1H NMR spectroscopy and difficulty in 
separating the compounds at this stage the crude reaction product was treated with 
Ag[SbF6] in CH3CN. Despite difficulties in separating the products, two different 
pincer complexes were observed by X-ray crystallography. These are the first 
examples of metal containing CCC complexes with adamantyl N-substituents in 
distorted square planar geometries (Scheme 4.25). 
Scheme 4.24: Synthesis of [(CCCnBu)Pd(NCMe)][SbF6] (XXVa). 
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 [(CCCAd)Pd(NCMe)][SbF6], one of the products observed is the expected product, 
consistent with that observed for [(CCCnBu)Pd(NCMe)][SbF6]. However, the X-ray 
crystallographic data indicates the complex is highly strained. Additionally, there is a 
disorder of the NCMe ligand below and above the plane with distances of the 
nitrogen from the PdL3 plane of 0.802814(18) and 0.662617(15) Å (Figure 4.15). 
The spacefill diagram highlights the strain in [(CCCAd)Pd(NCMe)][SbF6] (Figure 
4.17). The strain can be observed through the elongated Pd–N bond of 2.14(5) and 
2.18(4) Å compared to 2.101(4) and 2.103(4) Å for XXIIIa, a distorted Caryl–Pd–N 
angle (168.7(3), 170.5(3) °) and Pd–N≡C angle (159.5(6), 162.7(7) °) (Scheme 4.25, 
Figure 4.16, Table 4.3). 
 
 
 
Figure 4.15: X-ray molecular structure of cation [(CCCAd)Pd(NCMe)]+ showing 
distortion and disorder of NCMe ligand from the palladium ligand 
plane. 
 
Scheme 4.25: Synthesis of [(CCCAd)Pd(NCMe)][SbF6] and 
[(CCCaAd)Pd(NCMe)][SbF6]. 
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Figure 4.16: X-ray molecular structure of [(CCCAd)Pd(NCMe)]+. Thermal ellipsoids 
are shown at the 50% probability level. [SbF6]- counter ion and NCMe 
ligand disorder (N(3B), C(18B), C(19B)) omitted for clarity, see cif for 
details. All adamantyl hydrogen atoms removed for clarity except for 
that with a close distance to N(3A). Selected bond lengths (Å) and 
angles (°): Pd(1)–C(1) 2.11(2), Pd(1)–C(4) 1.91(2), Pd(1)–N(3) 2.14(5), 
2.18(4), N(3)–C(18) 1.15(7), 1.20(6), C(18)–C(19) 1.45(10), 1.49(6), 
C(1)–Pd(1)–C(1) 157.0(8), C(1)–Pd(1)–N(3) 100.7(4), 100.9(4),  
C(4)–Pd(1)–C(1) 78.5(4), C(4)–Pd(1)–N(3) 159.2(13), 161.2(14), 
C(18)–N(3)–Pd(1) 157(4), 172(5), N(3)–C(18)–C(19) 167(5), 180(7). 
The X-ray crystal structure data has poor data quality (R1 = 16.02 % Rint = 7.51 %) 
this is partially due to the difficulty to model a partial acetonitrile molecule in the 
lattice and large thermal motion of the adamantyl ligands (Figure 4.16). 
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The second product observed was [(CCCaAd)Pd(NCMe)][SbF6]. This is consistent 
with the previously reported product for the identical ligand on iridium.[32] As has 
been previously reported for bis(NHC) complexes the reason for the formation of 
mixed normalNHC-abnormalNHC complexes is due to the increased steric 
hindrance effectively blocking the attack on the normal carbon with the abnormal 
carbene proton becoming the next most acidic proton for attack.[35] Analysis of the 
X-ray crystal structure data indicates that the product, while more strained than the 
n-butyl substituent is less strained than [(CCCAd)Pd(NCMe)][SbF6] (Scheme 4.25, 
Figure 4.18, Table 4.3). 
Analysis of Table 4.3 shows both [(CCCAd)Pd(NCMe)][SbF6] and 
[(CCCaAd)Pd(NCMe)][SbF6] have a distorted –NCMe ligand while 
[(CCCaAd)Pd(NCMe)][SbF6] has alleviated some of the steric strain as the adamantyl 
ligand is pointing away from the –NCMe coordination area. 
Figure 4.17: Spacefill diagram of [(CCCAd)Pd(NCMe)][SbF6] showing steric 
hindrance of adamantyl substituent on the NCMe ligand, one NCMe 
ligand shown for clarity. 
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Figure 4.18: X-ray molecular structure of cation [(CCCaAd)Pd(NCMe)]+. Thermal 
ellipsoids are shown at the 50% probability level. Only one of the 
three [(CCCaAd)Pd(NCMe)]+ complexes in the asymmetric unit is 
displayed, two DBU co-crystallisation molecules, two [SbF6]- counter 
ion and a CH3CN solvent molecule omitted for clarity. All adamantyl 
hydrogen atoms removed for clarity. Selected bond lengths (Å) and 
angles (°): Pd(1)–N(5) 2.094(7), 2.095(6), Pd(1)–C(1) 2.026(7), 
2.033(7), Pd(1)–C(4) 1.925(8), Pd(1)–C(10) 2.082(8), 2.091(7),  
N(5)–C(33) 1.138(10), 1.144(10), C(33)–C(34) 1.448(12), 1.453(11),  
C(1)–Pd(1)–N(5) 91.2(3), 92.0(3), C(1)–Pd(1)–C(10) 158.0(3), 
158.4(3), C(4)–Pd(1)–N(5) 168.7(3), 170.5(3), C(4)–Pd(1)–C(1) 
79.4(3), C(4)–Pd(1)–C(10) 79.0(3), 78.7(3), C(10)–Pd(1)–N(5) 
109.4(3), 110.7(3), C(33)–N(5)–Pd(1) 159.5(6), 162.7(7),  
N(5)–C(33)–C(34) 177.4(9), 177.5(10). 
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Complex [(CCCnBu)Pd(NCMe)][SbF6] [(CCCAd)Pd(NCMe)][SbF6] [(CCCaAd)Pd(NCMe)][SbF6] 
Pd–CNHC distance 2.043(4) - 2.059(4) 2.11(2) 2.026(7), 2.033(7) (abnormal), 
2.082(8), 2.091(7) (normal) 
Pd–Caryl distance 2.056(4), 2.059(4) 1.91(2) 1.925(8) 
Pd–N distance 2.101(4), 2.103(4) 2.14(5), 2.18(4) 2.094(7), 2.095(6) 
Caryl–Pd–N angle 177.43(16), 178.53(15) 159.2(13), 161.2(14) 168.7(3), 170.5(3) 
Pd–N≡C angle 176.1(4), 177.0(4) 157(4), 172(5), 159.5(6), 162.7(7) 
N≡C–C angle 178.3(6), 178.7(5) 167(5), 180(7) 177.4(9), 177.5(10) 
Distance of N from Pd C–C–C plane 0.006, 0.052 0.66(6), 0.81(6) 0.061(16), 0.261(15) 
Table 4.3: Various X-ray crystallographic data for the complexes of type [(CCCR)Pd(NCMe)][SbF6]. 
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The X-ray crystal structure data for [(CCCaAd)Pd(NCMe)][SbF6] shows strain in the 
NCMe ligand with C(4)–Pd(1)–N(5) angles of 168.7(3) and 170.5(3) ° and C(33)–
N(5)–Pd(1) angles of 159.5(6) and 162.7(7) °. This is distorted from the near linear 
angles observed for [(CCCnBu)Pd(NCMe)][SbF6]. (Figure 4.18) 
4.2.7 Synthesis of [(CCCnBu)PdL] Complexes: 
The synthesis of various complexes of the type [(CCCnBu)PdL] were attempted from 
XXIIa that were seen as potential catalysts for the formation of β-hydroxynitriles. 
Given the success of Guan and co-workers, initial work focussed in the synthesis of 
the CH2CN complexes. 
The synthesis of [(CCCnBu)Pd(CH2CN)] was attempted by treating 
[(CCCnBu)Pd(NCMe)][SbF6] with NaOH in CH3CN, however, various products were 
observed. [(CCCnBu)Pd(CN)Pd(CCCnBu)] was isolated from this reaction mixture. 
This product is likely the result of the decomposition of the –NCMe ligand by C–C 
activation, similar to previous reactivity as outined in Chapter 1.[36] 
The X-ray crystal structure of [(CCCnBu)Pd(CN)Pd(CCCnBu)] is modelled with a C 
and N atom with half occupancy for the CN ligand as the complex was modelled 
with half a molecule occupying an asymmetric unit (Figure 4.19). The Pd(1)-
N(5)/C(21) bond length is 2.064(9) Å, with a N(5)–C(21) 1.122(19) Å bond length 
consistent with a CN triple bond. 
The synthesis of [(CCCnBu)Pd(CH2CN)] was also attempted by treating 
[(CCCnBu)Pd(NCMe)] with [LiN(SiMe3)2] in THF following a synthetic method 
described by Guan et al.[16] However, 1H NMR spectroscopic analysis showed that a 
number of products were formed and separation was not possible. 
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Similarly, [(CCCnBu)PdBr] was also treated with a solution of nBuLi and CH3CN in 
THF in an attempt to yield [(CCCnBu)Pd(CH2CN)] following a previously published 
method.[16] However, although one major product was observed by 1H NMR 
Figure 4.19: X-ray molecular structure of [(CCCnBu)Pd(CN)Pd(CCCnBu)]. Thermal 
ellipsoids are shown at the 50% probability level. [SbF6]- counter ion 
omitted for clarity. All n-butyl hydrogen atoms removed for clarity. 
Selected bond lengths (Å) and angles (°): Pd(1)–C(1) 2.050(10), 
Pd(1)–C(4) 1.971(9), Pd(1)–C(10) 2.039(12), Pd(1)–N(5)/C(21) 
2.064(9), N(5)/C(21)–N(5)/C(21) 1.122(19), C(1)–Pd(1)–N(5)/C(21) 
101.9(4), C(4)–Pd(1)–C(1) 77.3(4), C(4)–Pd(1)–C(10) 77.7(5),  
C(4)–Pd(1)–N(5)/C(21) 179.1(4), C(10)–Pd(1)–C(1) 155.0(5),  
C(10)–Pd(1)–N(5)/C(21) 103.1(5), N(5)/C(21)–N(5)/C(21)–Pd(1) 
178.1(19). 
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spectroscopy, there were no peaks in the –1 to 1 ppm region consistent with the 
formation of a –CH2CN ligand. 
Given the difficulty in preparing [(CCCnBu)Pd(CH2CN)], synthesis of 
[(CCCnBu)Pd(OH)] was attempted as it may exhibit similar catalytic activity as 
outlined previously. [(CCCnBu)PdBr] was treated with AgNO3 in THF yielding 
[(CCCnBu)Pd(ONO2)] which was supported by 1H and 13C NMR spectroscopy 
(Scheme 4.26). 
Scheme 4.26: Synthesis of [(CCCnBu)Pd(ONO2)] (XXVI) 
 
When [(CCCnBu)Pd(ONO2)] was treated with NaOH in THF an unexpected product 
was observed. The workup required the use of dichloromethane due to the 
insolubility of the product in other solvents, however both the X-ray crystal structure 
and 1H NMR spectroscopic analysis indicate that the product was [(CCCnBu)PdCl].[9b] 
The formation of this product is likely due to the reaction of the initial hydroxide 
product with the dichloromethane in solution (Scheme 4.27). 
Scheme 4.27: Synthesis of [(CCCnBu)PdCl] (XXIIb). 
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The crystal structure of [(CCCnBu)PdCl] exhibits the same flat geometry of 
[(CCCnBu)PdBr] with similar bond distances and angles with a Pd–Cl distance of 
2.4123(17) Å (Figure 4.20). 
Figure 4.20: X-ray molecular structure of [(CCCnBu)PdCl] XXIIb. Thermal ellipsoids 
are shown at the 50 % probability level. All n-butyl hydrogen atoms 
removed for clarity. Selected bond lengths (Å) and angles (°):  
Pd(1)–Cl(1) 2.4123(17), Pd(1)–C(1) 2.067(6), Pd(1)–C(4) 1.941(7), 
Pd(1)–C(10) 2.064(6), C(1)–Pd(1)–Cl(1) 101.46(19), C(4)–Pd(1)–Cl(1) 
179.0(2), C(4)–Pd(1)–C(1) 78.3(3), C(4)–Pd(1)–C(10) 78.2(3),  
C(10)–Pd(1)–Cl(1) 102.12(19), C(10)–Pd(1)–C(1) 156.4(3). 
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Synthesis of the cyanoacetate complex [(CCCnBu)Pd(O2CCH2CN)] was also 
attempted as a potential pre-catalyst for the synthesis of β-hydroxynitriles. Previous 
work has shown that cyanoacetate ligands decarboxylate under catalytically 
relevant conditions making them candidates for the formation of  
α-cyanocarbanions.[37] 
[NaO2CCH2CN] was synthesised by treating 2-cyanoacetic acid with NaOtBu in 
ethanol.[37b] [AgO2CCH2CN] was then synthesised by treating [NaO2CCH2CN] with 
AgNO3 in H2O. The low yield of 5 % observed is likely due to the decomposition of 
the final product via decarboxylation (Scheme 4.28). XXVIII was treated with 
[(CCCnBu)PdBr] in an attempt to form [(CCCnBu)Pd(O2CCH2CN)], however, no 
reaction was observed. 
Scheme 4.28: Synthesis of [NaO2CCH2CN] (XXVII) and [AgO2CCH2CN] (XXVIII). 
 
4.2.8 Synthesis of Other [(CCCnBu)M(NCMe)][SbF6] Group 10 Metal Complexes: 
To extend the scope of the synthesis of [(CCCnBu)PdBr] beyond palladium and to 
generate a larger range of catalysts, the synthesis of equivalent complexes of 
platinum and nickel was attempted. This was also of particular interest due to the 
applications of platinum CCC complexes as light emitting complexes.[9b, 15] When the 
ligand [2,6-(nBuImH)21-BrPh]Br2 was treated with [Pt(PPh3)4] and Na2CO3 in DMSO 
a mixture of products was obtained which were inseparable by column 
chromatography. Thus, the synthesis of the platinum complex was not pursued 
further due to time constraints. 
[(CCCnBu)NiCl] was synthesised by treating [2,6-(nBuImH)21-BrPh]Br2 with 
[Ni(COD)2] and Na2CO3 in DMSO in a 20 % yield. The reaction was initially 
performed in a J. Youngs tube, by monitoring the reaction by 1H NMR spectroscopy 
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an optimum heating regime could be determined. This meant the solution was 
heated at 25 °C for 3 h followed by 180 °C for 18 h giving a complete loss of the 
imidazolium proton signal at 9.73 ppm. The X-ray crystal structure was consistent 
with the formation of [(CCCnBu)NiCl] however NMR spectroscopic analysis was 
unclear due to similar 1H and 13C NMR shifts for both [(CCCnBu)NiCl] and 
[(CCCnBu)NiBr].[9b] Elemental analysis also supported the formation of [(CCCnBu)NiCl] 
exclusively. The change in the co-ligand from the expected Br to Cl is likely to have 
occurred in the workup when dichloromethane was used as a solvent for purification 
via column chromatography (Scheme 4.29). 
Scheme 4.29: Synthesis of [(CCCnBu)NiCl] (XXIIc). 
 
The crystal structure of XXIIc has shorter bond distances including the metal in 
comparison to [(CCCnBu)PdCl] with a Ni(1)–Cl(1) distance of 2.2520(7) Å, Ni(1) to 
NHC bound C distance of 1.960(3) and 1.968(3)Å and a Ni(1)–C(4) distance of 
1.862(3) Å (Figure 4.21). 
Scheme 4.30: Synthesis of [(CCCnBu)Ni(NCMe)][SbF6] (XXVb) 
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[(CCCnBu)Ni(NCMe)][SbF6] was synthesised by treating [(CCC
nBu)NiCl] with Ag[SbF6] 
in CH3CN in a 37 % yield. The formation of the product was supported by 1H and  
 
Figure 4.21: X-ray molecular structure of [(CCCnBu)NiCl] XXIIc. Thermal ellipsoids 
are shown at the 50% probability level. All n-butyl hydrogen atoms 
removed for clarity. Selected bond lengths (Å) and angles (°):  
Ni(1)–Cl(1) 2.2520(7), Ni(1)–C(10) 1.968(3), Ni(1)–C(4) 1.862(3), 
Ni(1)–C(1) 1.960(3), C(10)–Ni(1)–Cl(1) 99.54(8), C(4)–Ni(1)–Cl(1) 
177.31(9), C(4)–Ni(1)–C(10) 80.61(12), C(4)–Ni(1)–C(1) 79.68(11), 
C(1)–Ni(1)–Cl(1) 100.09(8), C(1)–Ni(1)–C(10) 160.26(11).  
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Figure 4.22: X-ray molecular structure of cation [(CCCnBu)Ni(NCMe)]+ of XXVb. 
Thermal ellipsoids are shown at the 50% probability level. Only one of 
the two [(CCCnBu)Ni(NCMe)] complexes in the asymmetric unit is 
displayed, [SbF6]– counter ion omitted for clarity. All n-butyl hydrogen 
atoms removed for clarity. Selected bond lengths (Å) and angles (°): 
Ni–N 1.906(4), 1.916(4), Ni–CNHC 1.938(5) – 1.951(5), Ni–Caryl 
1.854(5), 1.866(5), N≡C 1.126(6), 1.141(6), C–Cα 1.465(7), 1.469(7), 
N–Ni–CNHC 98.88(18) – 101.04(18), CNHC–Ni–CNHC 159.84(19), 
160.3(2), Caryl–Ni–CNHC 79.7(2) – 80.7(2), C≡N–Ni 176.4(4), 177.9(4), 
N≡C–Cα 177.7(6), 178.3(6). 
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13C NMR spectroscopy with 1H NMR resonances at 2.12 ppm consistent with the 
CH3 from the coordination of the NCMe ligand. The bond distances and angles are 
consistent with XXIIc with Ni(1)–N(5) bond lengths of 1.906(4) and 1.926(4) Å 
(Scheme 4.30, Figure 4.22). 
In an attempt to synthesise the α-cyano carbanion, [(CCCnBu)Ni(NCMe)][SbF6] was 
reacted with  [LiN(SiMe3)2] in THF following a previously published method for the 
synthesis of [{2,6-(iPr2PO)2C6H3}Ni(CH2CN)].[16] However the 1H NMR spectrum of 
the product did not indicate the presence of a –CH2CN ligand. Due to time 
constraints of the PhD project this was not pursued further.  
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4.3 Conclusion: 
A range of CEC and C^C^C complexes were synthesised as target catalysts and 
pre-catalysts for the synthesis of β-hydroxynitriles which is discussed in Chapter 5. 
The desired CNC palladium complex [(CNCiPr)Pd(CH2CN)][SbF6] (X) was 
synthesised from the corresponding NCMe ligated complex IX using analogous 
reaction conditions to that designed in Chapter 3 for the corresponding bis(NHC) 
complexes. The C^C^C complex [(C^C^CMe)Pd(NCMe)][SbF6] (XIV) was 
successfully prepared by modifying a previously reported synthesis of the 
corresponding Br complex.[8] Attempts to access other catalytically useful 
complexes with the corresponding hydroxide and CH2CN ligand were not fruitful. 
A number of different approaches were explored for the synthesis of the CCC 
complex. The first strategy used ligands [1,3-{(R)ImH}2Ph]X2 (XVIa and XVIb) in an 
attempt to form the desired palladium complex. However, due to the need for the 
deprotonation of three C–H bonds this synthetic pathway was not successful. Thus 
an alternative method was investigated based on that used for [(C^C^CMe)PdBr] 
utilising an oxidative addition pathway. The initial pathway focused on the synthesis 
of the corresponding ligand using a OTf on the central aryl carbon but was unfruitful 
due to difficulties in methylating or forming the desired triflate from either XIXa or 
XIXb. 
An alternative synthetic method for the desired CCC ligand was developed using  
2-bromo-1,3-difluorobenzene allowing oxidative addition on the aryl carbon. The 
desired pro-ligands XXIa and XXIb were prepared by reacting XX with the 
corresponding alkyl halide in toluene while the more sterically hindered adamantyl 
ligand XXIc was synthesised by reacting XX with bromoadamantane neat, albeit in 
a low yield. [(CCCnBu)PdBr] (XXIIa) was successfully obtained from the 
corresponding ligand XXIb in a good yield providing an alternative synthetic 
pathway to that previously developed by Hollis and co-workers.[9b] This new 
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synthesis method has higher atom efficiency, uses air stable starting materials and 
avoids the zirconium transfer reagent which makes this method advantagous 
despite the lower yield under minimally optimised conditions. Oxidative addition 
intermediate XXIV was isolated in similar yields to the final product and thus a 
stepwise synthesis method would not prove fruitful to increase the yield of the 
reaction. A number of catalytically relevant related complexes were prepared. 
[(CCCnBu)Pd(NCMe)][SbF6] (XXVa) was synthesised from [(CCC
nBu)PdBr] XXIIa, 
however attempted formation of the CH2CN, OH and O2CCH2CN ligated complexes 
were not successful. 
 [2,6-(AdImH)21-BrPh]Br2 XXIc was similarly treated with Pd(dba)2 in an attempt to 
form the desired palladium complex. Both [(CCCAd)Pd(NCMe)][SbF6] and 
[(CCCaAd)Pd(NCMe)][SbF6] were observed which are the first square planar metal 
complexes with a CCC adamantyl ligand. The geometry observed for the 
nNHC/nNHC isomer was highly distorted due to the steric hindrance of the 
adamantyl group.  
[(CCCnBu)NiCl] (XXIIc) was synthesised by treating the corresponding ligand XXIb 
with [Ni(COD)2]. Again providing a viable alternative to that previously reported by 
Hollis and co-workers.[9b] The Cl ligand forms via exchange in CH2Cl2 during the 
workup, XXVb was prepared by the reaction of XXIIc with Ag[SbF6] in CH3CN.  
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4.4 Experimental: 
4.4.1 General Considerations: 
All air sensitive reactions were performed under an atmosphere of high purity argon 
using standard Schlenk techniques. NMR scale reactions were prepared in a dry 
glove box (Innovative Technologies) under a nitrogen atmosphere with J. Young’s 
NMR tubes. Glassware was heated under vacuum and back-filled with argon to 
ensure the exclusion of oxygen and moisture in the reactions. [(iPrIm)2Py]Br2[38] was 
obtained from Dr David S. McGuinness. The following chemicals were used as 
received: Ag[SbF6] (Sigma Aldrich), N-bromosuccinimide (Sigma Aldrich),  
1,3-dibromobenzene (Combi-Blocks), 2-bromo-m-xylene (Combi-Blocks)  
1-bromoadamantane (Combi-Blocks), imidazole (Koch-light), nBuLi (1.6 M in 
hexanes, Aldrich), Li(NSiMe3)2 (1.0 M in THF, Aldrich), Cu2O (Aldrich), CuO (BDH), 
NaI (BDH), MeI (BDH), MgSO4 (Scharlau), CuI (Merck), Pd(OAc)2 (Precious Metals 
On-Line Pty Ltd.), phenol (Griffin), HCl (36 % of an aqueous solution, RCI Labscan), 
benzyl chloride (Hopkin & Williams), 2-cyanoacetic acid (Acros Organics), AgNO3 
(Chem Supply), 1-bromobutane (Fluka), and diisopropylamine (Fluka). Na2CO3 was 
purchased from Ajax, dried under vacuum at 200 °C and stored in a vacuum 
desiccator. NaOH was purchased from Chem Supply and dried under vacuum at 
200 °C. K2CO3 was purchased from Strem and stored in an oven 150 °C. For air 
sensitive reactions anhydrous DMSO was purchased from Sigma-Aldrich and stored 
in an ampoule over 3 Å molecular sieves, anhydrous CH3CN was obtained by 
passage through an Innovative Technologies Solvent Purifier and stored in an 
ampoule over 3 Å molecular sieves. All other anhydrous solvents were obtained by 
passage through an Innovative Technologies Solvent Purifier and stored in an 
ampoule over a mirror of sodium. For air stable synthesis, solvents were of 
analytical grade and used as received. LiNEt2,[39] Zr(NEt2)4,[26] Pd(dba)2,[40] 
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Pd2(dba)3.CHCl3[40] and [Ni(COD)2][41] were all synthesised according to literature 
procedure. 
4.4.2 Instrumentation: 
NMR spectroscopic studies were carried out on a 400 MHz Bruker Avance 3 HD  
400 MHz Wide Bore Spectrometer with a 5 mm BBFO probe at room temperature 
(298 K) or 120 °C where stated or a 600 MHz Bruker Avance III HD 600 MHz 
spectrometer with a 5 mm TCI-cyroprobe at 300 K, in DMSO-d6, CDCl3 or CD3CN. 
CD3Cl3 was used as received, whereas CD3CN and DMSO-d6 were used as 
received except in air sensitive NMR spectroscopy where they were distilled over 
calcium hydride and stored over 3 Å molecular sieves. 1H NMR spectra were 
obtained at 399.58 or 600.07 MHz while 13C NMR spectra were recorded at 100.47 
or 150.89 MHz. 1H NMR spectra were referenced to the residual 1H resonance of 
the residual solvent peak while 13C NMR spectra were referenced to a deuterated 
13C resonance, assignments were supported by COSY, HSQC and HMBC NMR 
spectra.  
Elemental analyses were conducted by Dr. Thomas Rodemann at the Central 
Science Laboratory at the University of Tasmania using a Carlo Erba EA1108 
Elemental Analyser. 
ESI-MS were conducted by Richard Wilson at the Central Science Laboratory at the 
University of Tasmania using a LTQ-Orbitrap high resolution mass spectrometer 
(Thermo Fisher Scientific) by infusion at 5 µl/min using Positive mode electrospray 
ionisation, with a voltage of 4 kV applied. Full scan data (m/z range 150-2000) was 
aquired at a resolution of 60,000 and reported values for [M+H] or [M+Na] ions were 
based on the averaged spectrum of 20 successive scans. 
X-ray crystallography data for XXIII, XXIV and [(CCCaAd)Pd(NCMe)][SbF6] were 
collected at -173 °C on crystals mounted on a Hampton Scientific cryoloop at the 
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MX1 or MX2 beamlines of the Australian Synchrotron.[42] Data completeness is 
limited by the single axis goniometer on the MX beamlines and the Australian 
synchrotron. Data for IX, X, XIV, reaction of XVIa and Pd(OAc)2, XXIa, XXIb, XXIc, 
XXIIa, XXVa, [(CCCAd)Pd(NCMe)][SbF6], [(CCC
nBu)Pd(CN)Pd(CCCnBu)], XXIIb, 
XXIIc and XXVb were collected at -173 °C on crystals mounted on a Hampton 
Scientific cryoloop on a Bruker AXS D8 Quest with a Cu Kα source. The structures 
were solved by direct methods with SHELXT, refined using full-matrix least-squares 
routines against F2 with SHELXL-97,[43] and visualised using Olex2.[44] All non-
hydrogen atoms were refined anisotropically. All hydrogen atoms were placed in 
calculated positions and refined using a riding model with fixed C–H distances of 
0.95 Å (sp2CH), 1.00 Å (sp3CH), 0.99 Å (CH2), 0.98 Å (CH3). The thermal 
parameters of all hydrogen atoms were estimated as Uiso(H) = 1.2Ueq(C), except for 
CH3 where Uiso(H) = 1.5Ueq(C). Cif files available on request. 
4.4.3: Preparation of [(CNCiPr)PdBr]Br (VIII): 
The synthesis followed a modified published procedure.[1] [(iPrIm)2Py]Br2 (0.2100 g, 
0.459 mmol) and Pd(OAc)2 (0.1085 g, 0.483 mmol) were combined in a predried 
Schlenk flask and further dried under vacuum at 70 °C. DMSO (5 mL) was then 
added and the solution was stirred at room temperature for 3 h and then heated to 
50 °C for 18 h and 160 °C for 1 h. DMSO was removed under reduced pressure at 
160 °C. A column was run of the product, first eluting with CH2Cl2 then 10 % MeOH 
in CH2Cl2. The product was recrystallised by vapour diffusion of Et2O onto a near 
saturated solution of MeOH forming an orange solid (20 % yield, 51.6 mg). NMR 
spectroscopic analysis indicated that this compound was spectroscopically identical 
to equivalent data reported in the literature.[17]  
1H NMR (400 MHz, DMSO-d6): δ 8.59 (1H, t, J = 8.2 Hz, p-CH), 8.54 (2H, d, J =  
2.2 Hz, ImH), 8.02 (2H, d, J = 8.2 Hz, m-CH), 7.98 (2H, d, J = 2.2 Hz, ImH), 5.79 
(2H, sep, J = 6.7 Hz, iPr CH), 1.46 ppm (12H, d, J = 6.8 Hz, iPr CH3). 
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13C NMR (100.47 MHz, DMSO-d6): δ 165.2 (C-Pd), 150.7 (o-C), 147.0 (p-CH), 
120.8 (ImH), 119.3 (ImH), 109.2 (m-CH), 52.5 (iPr CH), 22.8 ppm (iPr CH3). 
M.P.: 182 °C (dec) 
4.4.4 Preparation of [(CNCiPr)Pd(NCMe)][SbF6]2 (IX): 
[(CNCiPr)PdBr]Br (51.6 mg, 91.9 µmol), Ag[SbF6] (72.6 mg, 0.211 mmol) and CH3CN 
(8 mL) were combined in a round bottom flask and allowed to stir at room 
temperature for 17 h with the exclusion of light. The solution was filtered through a 
plug of celite® and the solvent was removed under vacuum. The product was then 
recrystallised with the vapour diffusion of diethyl ether onto a near saturated solution 
in acetonitrile (34 % yield, 28.5 mg). 
1H NMR (400 MHz, DMSO-d6): δ 8.62 (1H, t, J = 8.2 Hz, p-CH), 8.55 (2H, d, J =  
1.6 Hz, ImH), 8.06 (2H, d, J = 1.6 Hz, ImH), 8.01 (2H, d, J = 8.2 Hz, m-CH), 4.70–
4.73 (2H, m, iPr CH), 2.08 (6H, s, NCCH3), 1.53 ppm (12H, d, J = 6.6 Hz, iPr CH3). 
13C NMR (100.47 MHz, DMSO-d6): δ 164.4 (Pd-C), 151.4 (o-C), 148.0 (p-CH), 
120.9 (ImH), 119.8 (ImH), 118.6 (NC), 109.6 (m-CH), 52.3 (iPr CH), 23.0 (iPr CH3), 
1.6 ppm (NCCH3). 
M.P.: 276 °C (dec) 
4.4.5 Preparation of [(CNCiPr)Pd(CH2CN)][SbF6] (X): 
[(CNCiPr)Pd(NCMe)][SbF6]2 (27.2 mg, 29.7 µmol) and NaOH (14.5 mg, 0.363 mmol) 
were combined in a predried Schlenk flask which was further dried under vacuum. 
To this CH3CN (5 mL) was added and they were allowed to stir at 60 °C for 18 h. 
The solvent was removed under reduced pressure. The product was recrystallised 
via vapour diffusion of Et2O into a near saturated solution in CH3CN. (44 % yield, 
8.9 mg) 
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1H NMR (400 MHz, DMSO-d6): δ 8.52–8.54 (3H, m, ImH & m-CH), 7.98–8.00 (4H, 
m, ImH & p-CH), 4.74 (2H, sep, J = 6.64 Hz, iPr CH), 2.12 (2H, s, PdCH2), 1.54 ppm 
(12H, d, J = 6.64 Hz, iPr CH3). 
13C NMR (100.47 MHz, DMSO-d6): δ 170.2 (Pd-CIm), 149.7 (o-C), 146.7 (m-CH), 
126.6 (C≡N), 120.9 (ImH), 119.5 (ImH), 109.1 (p-CH), 52.8 (iPr CH), 23.3 (iPr CH3), 
–10.0 ppm (Pd-CH2). 
M.P.: 216 °C (dec) 
4.4.6 Preparation of 2,6-(CH2Br)2-1-BrPh (XI): 
Synthesis followed a modified published procedure.[18] 2-bromo-m-xylene (3.0 mL, 
22.5 mmol), N-bromosuccinimide (8.99 g, 50.5 mmol) and CCl4 (25 mL) were 
combined in a round bottom flask and stirred at reflux overnight irradiated by a 23 W 
compact fluorescent light bulb. The solution was cooled to room temperature and 
filtered. The solvent was removed under vacuum from the filtrate and the product 
was recrystallised from hot hexanes giving XI as a white solid (28 % yield, 2.161 g). 
NMR spectroscopic analysis indicated that this compound was spectroscopically 
identical to equivalent data reported in the literature.[19]  
1H NMR (400 MHz, CDCl3): δ 7.42 (2H, d, J = 7.6 Hz, m-CH), 7.29 (1H, t, J = 7.6 
Hz, p-CH), 4.65 ppm (4H, s, CH2). 
4.4.7 Preparation of [2,6-(MeImHCH2)2-1-BrPh]Br2 (XII): 
Synthesis followed a modified published procedure.[8] 2,6-(CH2Br)2-1-BrPh (0.360 g, 
1.05 mmol), 1-methylimidazole (280 µL, 3.51 mmol) and 1,4-dioxane (15 mL) were 
combined in a round bottom flask and stirred at 100 °C for 2 h. The solution was 
cooled to room temperature and the product was collected via vacuum filtration and 
washed with 1,4-dioxane and Et2O giving a white powder (83 % yield, 0.4394 g). 
NMR spectroscopic analysis indicated that this compound was spectroscopically 
identical to equivalent data reported in the literature.[8]  
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1H NMR (400 MHz, DMSO): δ 9.21 (2H, s, ImH), 7.78 (2H, s, ImH), 7.76 (2H, s, 
ImH), 7.55 (1H, t, J = 7.6 Hz, p-CH), 7.38 (2H, d, J = 7.7 Hz, m-CH), 5.58 (4H, s, 
CH2), 3.89 ppm (6H, s, CH3). 
4.4.8 Preparation of [(C^C^CMe)PdBr] (XIII): 
Synthesis followed a modified published procedure.[8] [2,6-(MeImHCH2)2-1-BrPh]Br2 
(1.104 g, 2.18x10 mmol), Pd(dba)2 (1.256 g, 2.78 mmol) and Na2CO3 (0.939 g,  
8.86 mmol) were combined in a predried Schlenk flask and further dried under 
vacuum. These were dissolved in DMSO (30 mL) and the solution was stirred at 
room temperature for 6 h. The solution was then heated to 125 °C 17 h. The 
solution was cooled to room temperature, brine (270 mL) was added and it was 
separated with CH2Cl2 (3x100 mL). The organic layers were combined, washed with 
brine, dried with MgSO4, filtered and the solvent was removed under vacuum. The 
product was purified via column chromatography, first eluting with CH2Cl2 followed 
by 40 % acetone/60 % CH2Cl2 forming the desired product as a white powder  
(27 % yield, 0.268 g) NMR spectroscopic analysis indicated that this compound was 
spectroscopically identical to equivalent data reported in the literature.[8] 
1H NMR (400 MHz, CDCl3): δ 7.01 (2H, d, J = 7.4 Hz, m-CH), 6.97 (2H, d, J =  
1.6 Hz, ImH), 6.89 (1H, t, J = 7.3 Hz, p-CH), 6.72 (2H, d, J = 1.6 Hz, ImH), 5.47 (2H, 
d, J = 13.6 Hz, CH2), 4.65 (2H, d, J = 13.7 Hz, CH2), 4.09 (6H, s, CH3). 
4.4.9 Preparation of [(C^C^CMe)Pd(NCMe)][SbF6] (XIV): 
[(C^C^CMe)PdBr] (0.268 g, 0.594 mmol), Ag[SbF6] (0.233 g, 0.679 mmol) and 
CH3CN (5 mL) were combined in a round bottom flask and stirred for 2 h at room 
temperature with the exclusion of light. The solution was filtered through a celite® 
plug and the solvent was evaporated under reduced pressure. The product was 
then recrystallised via vapour diffusion of Et2O into a near saturated solution in 
CH3CN giving colourless crystals (77 % yield, 0.297 g) 
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1H NMR (600 MHz, DMSO-d6): δ 7.53 (2H, d, J = 1.38 Hz, ImH), 7.26 (2H, s, ImH), 
7.01 (2H, d, J = 7.38 Hz, m-CH), 6.86 (1H, t, J = 7.32 Hz, p-CH), 5.23 (2H, s, CH2), 
4.99 (2H, s, CH2), 3.83 (6H, s, N-CH3), 2.09 ppm (3H, s, NCCH3). 
13C NMR (150 MHz, DMSO-d6): δ 175.5 (Im-Pd), 144.4 (Ph-Pd), 141.4 (o-C), 125.9 
(m-CH), 123.4 (p-CH), 122.4 (Im), 121.8 (Im), 118.5 (NCCH3), 57.2 (CH2), 37.3  
(N-CH3), 1.7 ppm (NCCH3). 
M.P.: 168 °C (dec). 
Anal. Calc. for C18N5H20PdSbF6.NCMe: C, 34.83; H, 3.36; N, 12.19; Found: C, 
34.72; H, 3.22; N, 12.10 %. 
4.4.10 Preparation of 1,3-Im2Ph (XV): 
The synthesis followed a modified published procedure.[22] 1,3-dibromobenzene  
(2.00 mL, 16.5 mmol), imidazole (2.847 g, 41.8 mmol), K2CO3 (5.728 g, 41.4 mmol), 
CuO (0.156 g, 1.95 mmol) and DMSO (25 mL) were combined in a round bottom 
flask and allowed to stir at 150 °C for 48 h. The reaction was confirmed to have 
been completed by TLC. The DMSO was removed under vacuum at 150 °C. The 
product was then eluted through a plug of silica with 10% MeOH in CH2Cl2. The 
product was recrystallised via slow evaporation of MeOH yielding a light yellow 
solid. NMR spectroscopic analysis indicated that this compound was 
spectroscopically identical to equivalent data reported in the literature.[23] (44 % 
yield, 1.539 g). 
1H NMR (400 MHz, CDCl3): δ 7.88 (2H, s, ImH), 7.57 (1H, t, J = 8.0 Hz, Ph5H), 7.41 
(1H, d, J = 1.8 Hz, Ph2H), 7.37 (2H, dd, J = 8.0, 2.0 Hz, Ph4&6H), 7.30 (2H, s, ImH), 
7.19 ppm (2H, s, ImH). 
13C NMR (100.47 MHz, CDCl3): δ 138.8 (Ph1&3), 135.6 (ImH), 131.6 (Ph5H), 131.0 
(ImH), 120.2 (Ph4&6H), 118.2 (ImH), 114.6 (Ph2H) ppm. 
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4.4.11 Preparation of [1,3-(MeImH)2Ph]I2 (XVIa): 
1,3-Im2Ph (0.445 g, 2.12 mmol), CH3I (1.25 mL, 20.1 mmol) and THF (5.0 mL) were 
combined in a pressure tube and stirred at reflux for 18 h. The white solid was 
collected via vacuum filtration and washed with both THF and Et2O (91 % yield, 
0.953 g). NMR spectroscopic analysis indicated that this compound was 
spectroscopically identical to equivalent data reported in the literature.[23] 
1H NMR (400 MHz, DMSO-d6): δ 9.88 (2H, s, ImH), 8.38 (2H, s, ArH), 8.31 (1H, s, 
ArH), 8.03 (2H, s, ArH), 7.97-8.01 (3H, m, ArH), 4.00 ppm (6H, s, CH3). 
4.4.12 Preparation of [1,3-(nBuImH)2Ph]Br2 (XVIb): 
The synthesis followed a modified published procedure.[15] 1,3-Im2Ph (0.483 g,  
2.30 mmol), 1-bromobutane (1.00 mL, 9.25 mmol) and CH3CN (9 mL) were 
combined in a pressure tube and allowed to reflux for 68 h. The CH3CN was 
removed under vacuum and the solution was dissolved in acetone. The solid was 
collected via vacuum filtration and washed with acetone, Et2O and toluene forming 
an off white solid (64 % yield, 0.835 g). NMR spectroscopic analysis indicated that 
this compound was spectroscopically identical to equivalent data reported in the 
literature.[24] 
1H NMR (400 MHz, DMSO-d6): δ 11.33 (2H, s, ImH), 9.05 (2H, s, ArH), 8.95 (1H, s, 
ArH), 8.30 (2H, d, J = 8.0 Hz, ArH), 7.60-7.67 (3H, m, ArH), 4.45 (4H, t, J = 7.2 Hz, 
N-CH2), 2.01 (4H, p, J = 7.4 Hz, N-CH2CH2), 1.42 (4H, sex, J = 7.4 Hz,  
N-CH2CH2CH2), 0.97 ppm (6H, t, J = 7.3 Hz, N-CH2CH2CH2CH3). 
4.4.13 Preparation of 2,6-Br21-OHPh (XVII): 
The synthesis followed a modified published procedure.[27] Phenol (3.088 g,  
32.81 mmol) and CH2Cl2 (20 mL) were combined in a round bottom flask. To this 
NN’-diisopropylamine (0.88 mL, 6.28 mmol) was added. N-Bromosuccinimide 
(11.48 g, 64.6 mmol) and CH2Cl2 (300 mL) were combined and added via a 
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dropping funnel over 1 h. The solution was then stirred at rt for 1 h and the reaction 
was confirmed to be completed by TLC. The solution was then acidified by the 
addition of HCl (50 mL, 1 molL–1) and the organic layer was separated, washed with 
H2O (100 mL), dried with MgSO4 and filtered. The solvent was removed under 
reduced pressure. The product was then filtered through a plug of silica with 
hexanes yielding a white solid. (67 % yield, 5.542 g). NMR spectroscopic analysis 
indicated that this compound was spectroscopically identical to equivalent data 
reported in the literature.[27] 
1H NMR (400MHz, CDCl3): δ 7.44 (2H, d, J = 8.0 Hz, m-CH), 6.70 (1H, t, J = 8.0 Hz, 
p-CH), 5.89 ppm (1H, s, OH). 
4.4.14 Preparation of 2,6-Br21-OBnPh (XVIII): 
The synthesis followed a modified published procedure.[29] 2,6-Br21-OHPh (5.542 g, 
22.0 mmol), benzyl chloride (2.60 mL, 22.6 mmol), K2CO3 (4.565 g, 33.0 mmol), NaI 
(0.398 g, 2.65 mmol) and CH3CN (30 mL) were combined in a round bottom flask 
with a reflux condenser attached and allowed to reflux for 5 h. At this time a TLC 
was run to confirm that reaction was complete. The solution was cooled to room 
temperature and H2O (100 mL) was added to the solution. The product was 
extracted with Et2O (3x 100 mL). The organic layer was washed with brine  
(100 mL), dried with MgSO4 and filtered. The Et2O was removed under rotary 
evaporation and filtered through a plug of silica with hexanes giving XVIII as a white 
solid (94 % yield, 7.038 g). NMR spectroscopic analysis indicated that this 
compound was spectroscopically identical to equivalent data reported in the 
literature.[29]  
1H NMR (400 MHz, CDCl3): δ 7.64 (2H, d, J = 6.9 Hz, BnH), 7.55 (2H, d, J = 8.0 Hz, 
Ph3,5H), 7.37-7.46 (3H, m, BnH), 6.91 (1H, t, J = 8.0 Hz, Ph4H), 5.06 ppm (2H, s, 
CH2). 
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4.4.15 Preparation of 2,6-Im21-OBnPh (XIXa) and 2,6-Im21-OHPh (XIXb): 
The synthesis followed a modified published procedure.[30] 2,6-Br21-OBnPh  
(6.390 g, 18.7 mmol), Imidazole (7.674 g, 0.113 mol), CuI (3.424 g, 4.77 mmol), 
Cu2O (0.678 g, 4.75 mmol) and K2CO3 (15.614 g, 0.113 mol) were combined evenly 
in three predried Schlenk flasks and then further dried under vacuum. DMSO  
(60 mL) was added and the solution was heated to 150 °C for 4 days. The DMSO 
was removed under vacuum at 140 °C. The solid was dissolved in EtOAc and 
filtered through celite®. The solvent was removed under vacuum and the compound 
was purified via filtration through a basic plug of alumina first washing with CH2Cl2, 
then 10% MeOH in CH2Cl2 giving XIXa as a brown solid (45 % yield, 2.689 g). 
1H NMR (400 MHz, DMSO-d6, 120 °C): δ 8.03 (2H, s, ImH), 7.58 (2H, s, ImH), 7.44 
(2H, s, ImH), 7.18 (2H, d, J = 7.8 Hz, p-CH), 7.00 (10H, s, Ph), 6.60 (1H, t, J =  
7.8 Hz, m-CH), 5.32 ppm (2H, bs, O-CH2). 
13C NMR (100.47 MHz, DMSO-d6): δ 153.3 (Ar), 137.9 (b, ImH), 135.7 (b, ImH), 
129.1 (Ar), 127.9 (Ph), 123.7 (p-CH), 122.2 (b, Ph), 120.5 (b, ImH), 115.8 (Ar), 
112.1 (m-CH), 50.0 ppm (O-CH2). 
ESI-MS: m/z 316 (M+) calc for C19H16N4O 316 
IR (nujol mull): 2951 (C-H), 2948 (C-H), 2923 (C-H), 2853 (C-H), 1721, 1454 (C-H), 
1377, 1216 (C-O-C), 722 cm-1. 
MP: 156 °C (dec) 
XIXb was isolated by washing the basic alumina plug with MeOH as a purple solid 
(22 % yield, 0.926 g). 
1H NMR (400 MHz, DMSO-d6): δ 8.21 (2H, s, ImH), 7.48 (2H, s, ImH), 6.94 (2H, d,  
J = 7.7 Hz, m-CH), 6.89 (2H, s, ImH), 5.96 ppm (1H, t, J = 8.2 Hz, p-CH).  
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13C NMR (100.47 MHz, DMSO-d6): δ 158.3 (O-C), 137.8 (ImH), 128.7 (o-C), 127.2 
(ImH), 122.1 (m-CH), 120.1 (ImH), 105.5 ppm (p-CH). 
ESI-MS: m/z 226.08514 calc for C12H10N4O 226.08546 
IR: 3312 (OH), 3117 (CH), 3030 (CH), 2927 (CH), 1503, 1325, 1064, 827, 743 cm-1. 
M.P.: 72 °C (dec) 
4.4.16 Preparation of 2,6-Im2-1-OHPh (XIXb): 
2,6-Im21-OBnPh (2.689 g, 8.50 mmol), 10 % Pd/C (92.4 mg, 0.868 mmol), EtOAc  
(35 mL) and EtOH (35 mL) were combined in a 2-neck round bottom flask under a 
balloon of H2. The solution was stirred for 16 h and filtered through celite®. The 
solvent was removed under vacuum with the product crystallising out of the crude 
oil (50 % yield, 0.954 g) NMR spectroscopic analysis indicated that this compound 
was spectroscopically identical to that synthesised in 4.3.15. 
4.4.17 Preparation of 2,6-Im21-BrPh (XX): 
This experiment followed a modified published procedure.[31]  
2-Bromo-1,3-difluorobenzene (1.0 mL, 8.86 mmol), Imidazole (1.852 g, 27.2 mmol), 
K2CO3 (7.43 g, 53.8 mmol) and DMF (40 mL) were combined in a round bottom 
flask and was stirred at 140 °C for 43 h. The DMF was removed under reduced 
pressure at 140 °C yielding an orange powder. The solid was dissolved in H2O  
(75 mL) and extracted with CH2Cl2 (3x 75 mL). The organic layers were combined, 
washed with brine (20 mL) and dried with MgSO4. The solution was filtered through 
a scintered glass funnel and the CH2Cl2 removed under vacuum. The crude product 
was then recrystallised via layering of hexanes onto a near saturated solution in 
CH2Cl2 forming colourless crystals (88 % yield, 2.248 g) 
1H NMR (400 MHz, CDCl3): δ 7.70 (2H, s, ImH), 7.56 (1H, t, J = 8.4 MHz, p-CH), 
7.45 (2H, d, J = 8.0 MHz, m-CH), 7.23 (2H, s, ImH), 7.16 ppm (2H, s, ImH). 
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13C NMR (100.47 MHz, CDCl3): δ 138.7 (C-N), 137.5 (ImH), 129.8 (ImH), 128.9  
(p-CH), 128.5 (m-CH), 120.5 (ImH), 119.4 ppm (C-Br). 
ESI-MS: m/z 288.00100 calculated for C12H9N4Br 288.0106 
IR: 3120 (C-H), 3101 (C-H), 1610 (C=C), 1600 (C=C), 1498 (C=C), 1483 (C=C), 
1312, 1298, 1249, 1106, 1065, 1059, 1001, 880, 814, 798, 771, 746, 725, 690, 652 
cm–1. 
MP: 118 – 130 °C 
4.4.18 Preparation of [2,6-(MeImH)21-BrPh]I2 (XXIa): 
2,6-Im21-BrPh (107.8 mg, 0.373 mmol), CH3I (150 μL, 2.40 mmol) and toluene  
(5 mL) were combined in a pressure tube and stirred at reflux for 17 h. The solution 
was then cooled to room temperature, the solvent was decanted off and the solid 
was dissolved in MeOH and recrystallised via vapour diffusion of Et2O into a near 
saturated solution in MeOH giving a light yellow solid (81 % yield, 173.9 mg). 
1H NMR (400 MHz, DMSO-d6): δ 9.61 (2H, s, ImH), 8.05–8.08 (6H, m, 2 x ImH and 
m-CH), 7.95–7.99 (1H, m, p-CH), 4.02 ppm (6H, s, CH3). 
13C NMR (150 MHz, DMSO-d6): δ 138.6 (ImH), 136.0 (o-C), 131.6 (m-CH), 130.7  
(p-CH), 124.7 (ImH), 124.5 (ImH), 119.1 (C-Br), 36.9 ppm (CH3). 
IR: 3067 (C-H), 2959 (C-H), 2872 (C-H), 1567 (C=C), 1547 (C=C), 1470 (C=C), 
1273, 1221, 1174, 1117, 1107, 1075, 837, 804, 712 cm–1. 
MP: 242 °C (dec) 
ESI-MS: m/z 160.0222 calculated for C14H15N4Br2+ 160.0224 
4.4.19 Preparation of [2,6-(nBuImH)21-BrPh]Br2 (XXIb): 
2,6-Im21-BrPh (1.289 g, 4.46 mmol), 1-bromobutane (2.6 mL, 24 mmol) and toluene 
(15 mL) were combined a pressure tube and heated to 120 °C for 24 h. The solution 
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was cooled to room temperature and the solvent was removed under reduced 
pressure. Recrystallisation the desired product was achieved by layering Et2O on a 
near saturated solution of [2,6-(nBuImH)21-BrPh]Br2 in CH2Cl2 yielding a white 
powder (48 % yield, 1.203 g). 
1H NMR (400 MHz, DMSO-d6): δ 9.73 (2H, d, J = 6.0 Hz, ImH), 8.16 (2H, d, J =  
1.4 MHz, ImH), 8.12-8.13 (4H, m, ImH & m-CH), 7.99 (1H, t, J = 8.0 MHz, p-CH), 
4.35 (4H, t, J = 7.1 MHz, NCH2), 1.89 (4H, p, J = 7.3 MHz, NCH2CH2), 1.33 (4H, 
sex, J = 7.5 MHz, NCH2CH2CH2), 0.95 ppm (6H, t, J = 7.4 MHz, NCH2CH2CH2CH3). 
13C NMR (150 MHz, DMSO-d6): δ 138.1 (ImH), 136.0 (o-C), 131.7 (m-CH), 130.6  
(p-CH), 124.8 (ImH), 123.5 (ImH), 119.3 (C-Br), 49.7 (NCH2), 31.7 (NCH2CH2), 19.2 
(NCH2CH2CH2), 13.8 ppm (NCH2CH2CH2CH3).  
ESI-MS: m/z 202.0694 calculated for C20N4H27Br2+ 202.0694 
IR: 3064 (C-H), 2962 (C-H), 2869 (C-H), 1567 (C=C), 1547 (C=C), 1470 (C=C), 
1273, 1219, 1173, 1107, 1075, 839, 802, 712 cm–1. 
MP: 214-220 °C. 
4.4.20 Preparation of [2,6-(AdImH)21-BrPh]Br2 (XXIc): 
2,6-Im21-BrPh (0.503 g, 1.74 mmol) and 1-bromoadamantane (3.78 g, 17.6 mmol) 
were combined in a screw cap vial and stirred at 170 °C for 48 h. The solution was 
cooled to room temperature and the solid was washed with THF to remove the 
excess 1-bromoadamantane. The solid was recrystallised via layering of Et2O onto 
a near saturated solution in MeOH forming an off-white solid (11 % yield, 0.140 g) 
1H NMR (600 MHz, CDCl3): δ 10.78 (2H, s, ImH), 8.16 (2H, s, ImH), 7.84 (2H, d, J = 
8.0 Hz, m-CH), 7.69 (1H, t, J = 8.0 Hz, p-CH), 7.54 (2H, s, ImH) 2.30-2.31 (6H, m, 
Ad CH), 2.24 (12H, d, J = 2.2 Hz, Ad CH2), 1.75 ppm (12H, s, Ad CH2). 
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13C NMR (150 MHz, CDCl3): δ 136.8 (ImH), 135.2 (o-C), 130.7 (m-CH), 130.1 (p-
CH), 124.3 (ImH), 120.6 (C-Br confirmed by HMBC), 118.5 (ImH), 61.9 (N-C), 42.9 
(Ad CH2), 35.2 (Ad CH2), 29.5 (Ad CH) 
ESI-MS: m/z 280.1161 calculated for C32N4H39Br2+ 280.1162 
4.4.21 Preparation of [(CCCnBu)PdBr] (XXIIa): 
The experiment followed a modified published procedure.[8]  
[2,6-(nBuImH)21-BrPh]Br2 (1.001 g, 1.78 mmol) and [Pd(dba)2] (1.042 g,  
1.81 mmol) were combined in a predried Schlenk flask and further dried under 
vacuum at approx. 70 °C. To this DMSO (20 mL) was added and this was allowed 
to stir at room temperature for 2 h. Na2CO3 (0.767 g, 7.23 mmol) was added and the 
solution was heated to 120 °C for 19 h. The DMSO was removed under vacuum at 
140 °C and the solid was dissolved in CH2Cl2 and filtered through a plug of celite®. 
The solvent was removed under vacuum and the dba was removed via dissolving in 
Et2O and filtering. The solid was collected and was purified via column 
chromatography with an eluent of CH2Cl2 yielding the desire complex as an off-
white solid (26 % yield, 0.237 g). NMR spectroscopic analysis indicated that this 
compound was spectroscopically identical to equivalent data reported in the 
literature.[9b] 
1H NMR (400 MHz, CDCl3): δ 7.34 (2H, d, J = 1.8 Hz, ImH) 7.15 (1H, t, J = 7.8 Hz,  
p-CH), 6.93 (2H, d, J = 1.8 Hz, ImH), 6.90 (2H, d, J = 7.8 Hz, m-CH), 4.79 (4H, t, J = 
7.3 Hz, N-CH2), 1.90 (4H, p, J = 7.5 Hz, N-CH2CH2), 1.50 (4H, sex, J = 7.5 Hz,  
N-CH2CH2CH2), 0.99 ppm (6H, t, J = 7.4 Hz, N-CH2CH2CH2CH3). 
13C NMR (150 MHz, CDCl3): 177.2 (Im-Pd), 146.1 (o-C), 144.5 (Pd-C), 124.9 (p-
CH), 119.9 (ImH), 114.2 (ImH), 107.9 (m-CH), 49.6 (N-CH2), 33.8 (N-CH2CH2), 19.8  
(N-CH2CH2CH2), 13.9 ppm (N-CH2CH2CH2CH3). 
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4.4.22 Preparation of [(3-(nBuImaH),1-(nBuImbPdBr3)Ph)] (XXIII):  
[2,6-(nBuImH)21-BrPh]Br2 (0.1035 g, 0.214 mmol) and [Pd(dba)2] (0.1040 g,  
0.181 mmol), were combined in a predried Schlenk flask and further dried under 
vacuum. To this DMSO (5 mL) was added and the solution was stirred at room 
temperature for 19 h. The DMSO was removed under vacuum at 140 °C. The solid 
was dissolved in MeOH and filtered through a plug of celite®. The MeOH was 
removed under vacuum and the solid was washed with Et2O. The solid was 
recrystallised via vapour diffusion of Et2O into a near saturated solution in MeOH 
yielding orange crystals. (17 % yield, 24.3 mg). Incomplete NMR spectroscopic 
characterisation was possible due to low solubility. 
1H NMR (600 MHz, DMSO-d6): δ 9.96 (1H, s, C2aH), 8.37-8.45 (2H, m, ImaH & 
ArH), 8.12 (1H, s, ImaH), 7.95 (2H, s, ArH), 7.90 (1H, s, ImbH), 7.77 (1H, bs, ImbH), 
4.51 (2H, t, J = 7.4 Hz, Nb-CH2), 4.28 (2H, t, J = 7.2 Hz, Na-CH2), 2.07 (2H, p, J = 
7.5 Hz, Nb-CH2CH2), 1.91 (2H, p, J = 7.4 Hz, Na-CH2CH2), 1.41-1.44 (2H, m, Nb-
CH2CH2CH2), 1.36 (2H, sex, J = 7.5 Hz, Na-CH2CH2CH2), 0.99 (3H, t, J = 7.4 Hz,  
Nb-CH2CH2CH2CH3), 0.95 ppm (3H, t, J = 7.4 Hz, Na-CH2CH2CH2CH3). 
13C NMR (150 MHz, DMSO-d6): δ 141.1 (Imb-Pd, found by HMBC), 140.7 (ArC), 
136.0 (C2aH), 135.4 (ArC, found by HMBC), 131.5 (ArC), 126.1 (126.1, found by 
HSQC), 124.6 (ImbH), 124.2 (ImbH, found by HSQC), 124.1 (ArC), 121.5 (ImaH), 
51.1 (Nb-CH2), 49.8 (Na-CH2), 31.7 (Nb-CH2CH2), 31.5 (Na-CH2CH2), 19.8  
(Nb-CH2CH2CH2), 19.3 (Na-CH2CH2CH2), 14.1 (Nb-CH2CH2CH2CH3), 13.8 ppm  
(Na-CH2CH2CH2CH3).  
ESI-MS: m/z calc for PdN4C20H27Br2 (M+-Br as consistent with other literature 
reports[43]): 588.9611. Found: 588.9617. 
MP: 214 °C (dec) 
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4.4.23 Preparation of [(2,6-(nBuImH)2Ph)PdBr3] (XXIV): 
[2,6-(nBuImH)21-BrPh]Br2 (0.103 g, 0.182 mmol) and Pd(dba)2 (0.106 g, 0.184 
mmol) were combined in a predried Schlenk flask and further dried under vacuum. 
To this CH3CN (5 mL) was added and the solution was stirred at 25 °C for 17 h. The 
CH3CN was removed under vacuum at 25 °C and the solid was washed with Et2O, 
dissolved in CH2Cl2 and filtered through a plug of celite®. The solid was 
recrystallised via layering of Et2O onto a solution in CH2Cl2 giving orange crystals 
(18 % yield, 22.1 mg). 
1H NMR (400 MHz, DMSO-d6): δ 9.67 (2H, s, ImH), 8.38 (2H, s, ImH), 8.04 (2H, s, 
ImH), 7.47 (2H, d, J = 7.8 Hz, m-CH), 7.32 (1H, t, J = 7.8 Hz, p-CH), 4.32 (4H, t, J = 
6.9 Hz, N-CH2), 1.88 (4H, p, J = 7.2 Hz, N-CH2CH2), 1.37 (4H, sex, J = 7.5 Hz,  
N-CH2CH2CH2), 0.93 ppm (6H, t, J = 7.3 Hz, N-CH2CH2CH2CH3). 
13C NMR (150 MHz, DMSO-d6): δ 141.3 (o-C), 136.8 (ImH), 136.0 (Pd-C, found in 
HMBC), 126.3 (p-CH), 125.8 (m-CH), 124.3 (ImH), 122.3 (ImH), 49.3 (N-CH2), 32.0 
(N-CH2CH2), 19.3 (N-CH2CH2CH2), 13.8 ppm (N-CH2CH2CH2CH3). 
ESI-MS: m/z 588.9617 calculated for C20H27Br2N4Pd (M+-Br as consistent with other 
literature reports[43]) 588.9611. 
MP: 186 – 192 °C 
4.4.24 Preparation of [(CCCnBu)Pd(NCMe)][SbF6] (XXVa): 
[(CCCnBu)PdBr] (0.140 g, 0.276 mmol), Ag[SbF6] (0.112 g, 0.326 mmol) and CH3CN 
(10 mL) were combined in a round-bottom flask and stirred at room temperature for 
2.5 h with the exclusion of light. The solution was filtered through a plug of celite® 
and the solvent was removed under vacuum. The product was recrystallised by 
vapour diffusion of Et2O into a near saturated solution in CH3CN forming white 
needles (67 % yield, 0.130 g). 
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1H NMR (400 MHz, DMSO-d6): δ 8.12 (2H, s, ImH), 7.59 (2H, s, ImH), 7.25 (3H, s, 
ArH), 4.26 (4H, t, J = 6.5 Hz, N-CH2), 2.10 (3H, s, NCCH3), 1.83 (4H, p, J = 7.4 Hz, 
N-CH2CH2), 1.33 (4H, sex, J = 7.4 Hz, N-CH2CH2CH2), 0.94 ppm (6H, t, J = 7.4 Hz, 
CH3). 
13C NMR (150 MHz, DMSO-d6): δ 175.3 (Im-Pd), 146.0 (Ar), 139.7 (Ar, found by 
HMBC), 126.7 (ArH), 121.9 (ImH), 118.7 (NCCH3), 116.9 (ImH), 109.8 (ArH), 49.1  
(N-CH2), 33.0 (N-CH2CH2), 19.5 (N-CH2CH2CH2) 14.0 (CH3), 1.65 ppm (NCCH3). 
MP: 228 °C (dec) 
Anal. Calc. for C22N5H28PdSbF6: C, 37.50; H, 4.00: N,9.94; Found: C, 37.52; 
H,3.98; N, 9.81 % 
4.4.25 Preparation of [(CCCnBu)Pd(ONO2)] (XXVI): 
[(CCCnBu)PdBr] (0.0390 g, 76.8 µmol), AgNO3 (0.0212 g, 12.5 mmol) and THF  
(7 mL) were combined in a round-bottom flask and stirred at room temperature for 
48 h. The THF was removed under vacuum and the solid was dissolved in CH3CN 
and filtered through a plug of celite®. The CH3CN was removed under vacuum and 
the product was used crudely in the following reaction. 
1H NMR (400 MHz, CDCl3): δ 7.35 (2H, d, J = 1.8 Hz, ImH), 7.14 (1H, t, J = 8.0 Hz, 
p-CH), 6.94 (2H, d, J = 1.8 Hz, ImH), 6.87 (2H, d, J = 8.0 Hz, m-CH), 4.18 (4H, t, J = 
7.3 Hz, N-CH2), 1.86 (4H, p, J = 7.5 Hz, N-CH2CH2), 1.41-1.47 (4H, m,  
N-CH2CH2CH2), 0.98 ppm (6H, t, J = 7.4 Hz, N-CH2CH2CH2CH3). 
13C NMR (150 MHz, CDCl3): δ 175.7 (Im-Pd), 144.4 (o-C), 139.4 (Pd-C), 123.7  
(p-CH), 118.0 (Im-H), 112.8 (Im-H), 106.4 (m-CH), 48.1 (N-CH2), 31.6 (N-CH2CH2), 
17.9 (N-CH2CH2CH2), 11.8 ppm (N-CH2CH2CH2CH3). 
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4.4.26 Preparation of [(CCCnBu)PdCl] (XXIIb): 
[(CCCnBu)Pd(ONO2)] (76.8 µmol), NaOH (0.0686g, 1.72 mmol) and THF (5 mL) 
were sonicated for 5 h. The THF was removed under vacuum. The solid was 
dissolved in CH2Cl2 and filtered through a plug of celite®. The CH2Cl2 was removed 
under vacuum yielding the desired crude product (quantitative yield, 38.8 mg). NMR 
spectroscopic analysis indicated that this compound was spectroscopically identical 
to equivalent data reported in the literature.[9b] 
1H NMR (400 MHz, CDCl3): δ 7.35 (d, 2H, J = 2.0 Hz, ImH), 7.14 (t, 1H, J = 7.8 Hz, 
p-CH), 6.93 (d, 2H, J = 2.0 Hz, ImH), 6.90 (d, 2H, J = 7.8 Hz, m-CH), 4.73 (t, 4H, J = 
7.3 Hz, N-CH2), 1.90 (p, 4H, J = 7.5 Hz, N-CH2CH2), 1.49 (sex, 4H, J = 7.6 Hz,  
N-CH2CH2CH2) 0.99 ppm (t, 6H, J = 7.4 Hz, N-CH2CH2CH2CH3). 
13C NMR (150 MHz, CDCl3): δ 177.2 (Pd-Im), 146.2 (o-C), 144.6 (Pd-C), 124.9  
(p-CH), 119.9 (ImH), 114.1 (ImH), 107.9 (m-CH), 49.7 (N-CH2), 33.8 (N-CH2CH2), 
19.8 (N-CH2CH2CH2), 13.9 ppm (N-CH2CH2CH2CH3). 
4.4.27 Preparation of [NaO2CCH2CN] (XXVII): 
The experimental followed a modified published procedure.[37b] 2-cyanoacetic acid 
(3.422 g, 40.2 mmol) and EtOH (40 mL), were combined in a 2 neck round bottom 
flask. To this NaOtBu (3.866 g, 40.2 mmol) dissolved in EtOH (80 mL) was added 
via a pressure equalising dropping funnel over 30 min. The solution was then stirred 
for a further 1 h at room temperature. The volume was then reduced to approx. 20 
mL via rotary evaporation and Et2O (50 mL) was added. The solid was collected via 
vacuum filtration and washed with Et2O (2x 10 mL) and EtOH (2x 5 mL). The 
desired product was dried under vacuum giving a white powder (91 % yield,  
3.924 g). NMR spectroscopic analysis indicated that this compound was 
spectroscopically identical to equivalent data reported in the literature.[37b] CH2 
resonances were invisible in the 1H and 13C NMR spectrum due to H-D exchange. 
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13C NMR (100.47 MHz, D2O): 170.1 (COO-), 117.9 ppm (C≡N). 
4.4.28 Preparation of [AgO2CCH2CN] (XXVIII): 
[NaO2CCH2CN] (0.228 g, 2.13 mmol) and H2O (10 mL) were combined in a conical 
flask and separately AgNO3 (0.342 g, 2.01 mmol) was dissolved in H2O (4 mL) and 
added to the solution of [NaO2CCH2CN]. This solution was stirred at room 
temperature for 1 h with the exclusion of light. The solution was collected via 
vacuum filtration and was dried under vacuum yielding a grey solid (5 % yield,  
19.6 mg). 
4.4.29 Preparation of [(CCCnBu)NiCl] (XXIIc): 
[2,6-(nBuImH)21-BrPh]Br2 (0.2136 g, 0.379 mmol) and [Ni(COD)2] (0.108 g,  
0.393 mmol) were added to a predried Schlenk and further dried under vacuum. 
The solid was dissolved in DMSO (5 mL) and stirred at room temperature for 3 h. 
The Na2CO3 (0.154 g, 1.46 mmol) was added and the solution was heated to 180 
C for 18 h. The solution was cooled to room temperature and the DMSO was 
removed under vacuum at 140 °C. The solid was dissolved in CH2Cl2 and filtered 
through a plug of celite®. The solvent was removed under vacuum and a column 
was then run of the product eluting with CH2Cl2 giving the desired product as orange 
crystals (20 % yield, 31.0 mg). NMR spectroscopic analysis indicated that this 
compound was spectroscopically identical to equivalent data reported in the 
literature.[9b] 
1H NMR (400 MHz, CDCl3): δ 7.24 (2H, bs, ArH), 7.04 (1H, t, J = 7.4 Hz, p-CH) 6.80 
(2H, bs, ArH), 6.71 (2H, bs, ArH), 4.66 (4H, bs, N-CH2), 1.88 (4H, bs, N-CH2CH2), 
1.40-1.52 (4H, m, N-CH2CH2CH2), 0.99 ppm (6H, t, J = 7.0 Hz, N-CH2CH2CH2CH3). 
Anal. Calc. for C20N4H25NiCl: C, 57.80; H, 6.06: N, 13.48; Found: C, 57.30; H, 6.31; 
N, 13.14 % 
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4.4.30 Preparation of [(CCCnBu)Ni(NCMe)][SbF6] (XXVb): 
[(CCCnBu)NiCl] (20.3 mg, 48.8 µmol), Ag[SbF6] (17.7 mg, 51.5 µmol) and CH3CN  
(5 mL) were combined in a round bottom flask and stirred at room temperature for 
22 h with the exclusion of light. The solution was filtered through a plug of celite® 
and the CH3CN was removed under vacuum. The solid was recrystallised via 
vapour diffusion of diethyl ether into a near saturated solution in CH3CN yielding red 
needles (37 % yield, 11.8 mg). 
1H NMR (600 MHz, DMSO-d6): δ 7.97 (2H, d, J = 1.8 Hz, ImH), 7.44 (2H, d, J =  
1.7 Hz, ImH), 7.11 (1H, t, J = 7.7 Hz, p-CH), 7.01 (2H, d, J = 7.7 Hz, m-CH), 4.10 
(4H, t, J = 7.0 Hz, N-CH2), 2.12 (3H, s, NCCH3), 1.80 (4H, p, J = 7.2 Hz, NCH2CH2), 
1.33 (4H, sep, J = 7.4 Hz, NCH2CH2CH2), 0.96 ppm (6H, t, J = 7.4 Hz, 
NCH2CH2CH2CH3) 
13C NMR (150 MHz, DMSO-d6): δ 171.6 (C2), 147.1 (o-C), 141.8 (Ni-C), 126.5  
(p-CH), 123.0 (ImH), 119.4 (NCCH3), 115.9 (ImH), 108.4 (m-CH), 48.3 (N-CH2), 
33.0 (N-CH2CH2), 19.4 (N-CH2CH2CH2), 13.9 (N-CH2CH2CH2CH3), 1.7 ppm 
(NCCH3). 
MP: 196–224 °C 
Anal. Calc. for C22N5H28NiSbF6: C, 40.22; H, 4.30: N, 10.66; Found: C, 40.02; H, 
4.10; N, 10.34 %  
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Chapter 5: Catalytic Synthesis of β-Hydroxynitriles 
5.1 Introduction: 
The synthesis of 3-hydroxy-3-phenylpropionitrile was first achieved under base-free 
conditions by Guan and co-workers using [{2,6-(iPr2PO)2C6H3}Ni(CH2CN)] (1) low 
catalyst loadings at room temperature (discussed in more detail in Chapters 1.4.4 
and 2, Scheme 5.1).[1] Prior to this, similar reactions were achieved with a Ni(PNP) 
catalyst (2) in the presence of the base DBU at 45 °C. Longer reaction times and 
higher catalyst loadings were required in comparison to catalyst 1. Notably, the 
equivalent Ni(PNP)CH2CN complex did not react.[2] 
 
 
The formation of 3-hydroxy-3-phenylpropionitrile has previously been observed in 
the presence of DBU without a transition metal catalyst, albeit in a low yield.[2] While 
many reports investigating the synthesis of β-hydroxy and β-aminonitriles using 
transition metal catalysts undertook a background reaction, these reactions 
contained only the organic compound and solvent. But they had not considered the 
fact that the catalyst precursors used featured basic ligands such as –CH2CN,  
–OMe or –OAc {e.g. [Rh(OMe)(cod)]2, Pd(OAc)2}.[1, 3] Therefore, to make sure that 
the catalytic reactions performed were the result of the proposed complex, the 
reaction should have also been reported with the corresponding transition metal 
precursor. 
Scheme 5.1: Synthesis of various β-hydroxynitriles via Ni(POCOP) and Ni(PNP) 
catalysts. 
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5.2 Results and Discussion: 
For the synthesis of 3-hydroxy-3-phenylpropionitrile from benzaldehyde various 
catalysts were employed. Where possible –CH2CN ligated complexes were used in 
the reaction. However, in some cases, due to the difficulty in isolating the M–CH2CN 
complex the M–NCMe complex was used. In these instances, NaOH was added as 
an external base due to requirement for the formation of the active –NCCH2 catalyst 
in situ as determined by DFT calculations (Chapter 2.1.1, Table 5.1 & 5.2). When 
the reactions were attempted at room temperature no reaction was observed. 
Subsequent reactions were performed at 60 °C as this was consistent with the 
temperature employed for the synthesis of CH2CN complexes from their 
corresponding NCMe complex outlined in Chapter 3. 
As noted in Chapter 2 the synthesis of [{2,6-(iPr2PO)2C6H3}Ni(CH2CN)] (1) was not 
possible. Consequently, the related [{2,6-(iPr2PO)2C6H3}Ni(NCMe)][SbF6] I was 
used in the presence of NaOH for benchmarking purchases. 
As discussed in Chapter 2 the characteristics of the Ni(POCOP) catalyst that 
promoted the desired reactivity were determined by the DFT calculations:  
a) The C-bound CH2CN isomer is not the active catalyst instead the N-bound  
–NCCH2 ligated complex is the active catalyst. 
b) The trans donor effect of the phenyl ring is important in lowering the energy 
of the transition state of the intramolecular isomerisation and the  
5-coordinate transition state. 
Due to the presence of the 5-coordinate transition state, increasing the steric bulk to 
[{2,6-(tBu2PO)2C6H3}Ni(CH2CN)] prevents the reaction from proceeding. 
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Control reactions were performed by treating benzaldehyde with substoichiometric 
quantities of NaOH in acetonitrile. Preliminary screening revealed that when the 
reaction was performed at 25 °C no reaction occurred (Table 5.1, entry 2). However, 
when the reaction temperature was raised to 60 °C, 3-hydroxy-3-phenylpropionitrile 
was formed in a 20 % yield with a 9 % loading of NaOH and 42 % yield (12 % 
NaOH loading) (Table 5.1, entries 3 & 4). The yield of this reaction was lower than 
that observed by Guan and co-workers using catalyst 1 at 25 °C in the absence of 
base (Table 5.1, entries 5 & 6). While the formation of  
3-hydroxy-3-phenylpropionitrile in the presence of NaOH was perhaps not 
unexpected, the relatively high yield obtained was somewhat surprising. Indeed, it 
Table 5.1: Background reactions for the synthesis of 3-hydroxy-3-phenylpropionitrile 
from benzaldehyde. Yields determined by GC with the aid of a calibrated 
internal standard. †Yield determined by NMR spectroscopy with the aid of 
an internal standard. 
 
 Catalyst Catalyst 
(mol %) 
Base 
(mol %) 
Temp 
(°C) 
Time 
(h) 
Yield 
(%)  
1 none 0 0 60 24 0 
2 none 0 5 25 20 0 
3† none 0 9 60 24 20 
4† none 0 12 60 24 42 
5[1] [{2,6-(iPr2PO)2C6H3}Ni(CH2CN)] 
(1) (lit) 
1 0 25 6 91 
6[1] [{2,6-(iPr2PO)2C6H3}Ni(CH2CN)] 
(1) (lit) 
0.01 0 25 72 83 
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has been reported that the synthesis of 3-hydroxy-3-phenylpropionitrile can be 
promoted by DBU in a 13 % yield at 60 °C.[2]  
When benzaldehyde was treated with one equivalent of NaOH in acetonitrile a 
number of products were formed (Scheme 5.3). With the exception of sodium 
benzoate, the yields of all products were determined by NMR spectroscopy. The 
formation of sodium benzoate is likely due to the Cannizzaro reaction.[4] This 
product is most commonly observed in concentrated solutions in H2O, and, thus, the 
formation of this product from a reaction in a dilute CH3CN solution was surprising. 
The other three products observed are both (E)- and (Z)-cinnamonitrile and 3-
phenylpentanedinitrile. The formation of (E)- and (Z)-cinnamonitrile both involve the 
addition of an acetonitrile to benzaldehyde while 3-phenylpentanedinitrile involves 
the addition of two acetonitrile molecules to benzaldehyde (Scheme 5.3).  
Scheme 5.3: Synthesis of various products from a 1:1 mixture of benzaldehyde and 
NaOH. 
 
A possible mechanism for the synthesis of (E)- and (Z)-cinnamonitrile and  
3-phenylpentanedinitrile may involve the intermediate  
3-hydroxy-3-phenylpropionitrile, which was observed when the reaction was 
performed with a catalytic amount of NaOH (Scheme 5.4). 
The benchmarking reactions were performed by treating benzaldehyde with  
[{2,6-(iPr2PO)2C6H3}Ni(NCMe)][SbF6] (I) as a catalyst in CH3CN. When the reaction 
was performed in the absence of NaOH no reaction was observed (Table 5.2, entry 
1). Similarly, when the reaction was performed with NaOH at room temperature no 
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reaction was observed (Table 5.2, entry 2). However, heating the reaction mixture at 
60 °C gave a yield of 35 % (Table 5.2, entry 3). This is comparable to results 
obtained in the absence of the catalyst indicating that this was due to the 
background reaction. 
A range of different complexes were screened in an attempt to find an effective 
catalyst which had the best activity in the synthesis of  
3-hydroxy-3-phenylpropionitrile. No reaction occurred when the bis(NHC) catalysts 
[{(MesIm)2CH2}Pd(CH2CN)2] (IIa), [{(MeIm)2CH2}Pd(CH2CN)2] (IIb), and 
[{(MesIm)2CH2}Pd(µ-CH2CN)2][PF6]2 (IIIa) were used (Table 5.2, entries 4 – 6). It is 
unclear why these complexes are not active in catalysis. The POCOP catalyst has 
one active site and these systems potentially have two. Thus, complexes were 
synthesised which had a geometry closer to the POCOP catalyst consistent with the 
DFT calculations performed. 
 
Scheme 5.4: Possible mechanism for the synthesis of (E)- and (Z)-cinnamonitrile 
and 3-phenylpentanedinitrile from the reaction observed when 
benzaldehyde was treated with one equivalent of NaOH. 
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Table 5.2: Synthesis of 3-hydroxy-3-phenylpropionitrile from benzaldehyde. Yields 
determined by GC with the aid of a calibrated internal standard. †Yield 
determined by NMR spectroscopy with the aid of an internal standard. 
*reaction as previous mixture heated ^the solution was stirred at rt for 24 
h followed by 60 °C for 24 h, * uncalibrated yield, □ benzoic acid was 
observed instead, ǂ DBU used instead of NaOH, # NaO2CCH2CN used 
instead of NaOH. 
 
 
 
 
 
 
 Catalyst Cat. 
load. 
(mol 
%) 
Base 
load. 
(mol 
%) 
Temp 
(°C) 
Time 
(h) 
Con. 
(%) 
Yield 
(%)  
1 [{2,6-(iPr2PO)2C6H3}Ni(NCMe)] 
[SbF6] (I) 
4.91 0 rt/60^ 48 0 0 
2 [{2,6-(iPr2PO)2C6H3}Ni(NCMe)] 
[SbF6] (I) 
4.91 5 25 22 0 0 
3* [{2,6-(iPr2PO)2C6H3}Ni(NCMe)] 
[SbF6] (I) 
4.91 5 60 24 43 35* 
4† [{(MesIm)2CH2}Pd(CH2CN)2] (IIa) 4.1 0 60 24 0 0 
5 [{([MesIm]2CH2)Pd(µ-CH2CN)}2] 
[PF6]2 (IIIa) 
2.5 0 60 24 0 0 
6 [{(MeIm)2CH2}Pd(CH2CN)2] (IIb) 5.3 0 60 24 0 0□ 
7 [(CNCiPr)Pd(CH2CN)][SbF6] (X) 4.90 0 rt/60^ 48 0 0 
8 [(C^C^CMe)Pd(NCMe)][SbF6] (XIV) 5.1 5 rt/60^ 48 0 0 
9 [(CCCnBu)Pd(NCMe)][SbF6] (XXVa) 4.9 10 rt 20 0 0 
10† [(CCCnBu)Pd(NCMe)][SbF6] (XXVa) 5.4 22 60 24  40 
11 [(CCCnBu)Pd(NCMe)][SbF6] (XXVa) 5.0 5.0ǂ rt/60^ 48 0 0 
12 [(CCCnBu)Pd(NCMe)][SbF6] (XXVa) 5.2 5.61# rt/60^ 48 0 0 
13† [(CCCnBu)Ni(NCMe)][SbF6] (XXVb) 4.8 13 60 24 0 0 
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As discussed in Chapter 4 a group of complexes of the type CEC and C^E^C were 
synthesised due to their structural similarities to POCOP complexes and the ability 
to tailor both the electronic and steric properties of the complex independently. 
Complexes of the type CNC exhibit the same flat ligand skeleton geometry as 
POCOP complexes, but do not have the same trans donating ability as the C atom 
of the POCOP complex, which was shown to be crucial using DFT. Unfortunately, 
the reaction of complex [(CNCiPr)Pd(CH2CN)][SbF6] (X) with benzaldehyde in 
acetonitrile did not yield any product (Table 5.2, entry 7). 
Complexes of the type C^C^C were also tested in catalysis. They exhibit the same 
trans donation of a central aryl carbon as the POCOP ligand, however, the twisted 
geometry created by the methylene linker (discussed in Chapter 4) may affect that 
catalysis. When the reaction was catalysed by [(C^C^CMe)Pd(NCMe)][SbF6] (XIV) in 
the presence of a catalytic amount of NaOH in CH3CN no reaction was observed 
(Table 5.2, entry 8). Unfortunately, the corresponding –CH2CN or –OH complex, 
which may have displayed better reactivity could not be synthesised. 
The CCC complex exhibits the desired trans donating ability and flat geometry, 
which is similar to the POCOP complex. The reaction of benzaldehyde was 
catalysed by [(CCCnBu)Pd(NCMe)][SbF6] (XXVa) in the presence of a catalytic 
amount of NaOH in CH3CN, however, the yield was comparable to the background 
reaction, which indicates that the catalyst did not facilitate this reaction (Table 5.2, 
entry 10). The reaction was also attempted using XXVa and two alternative bases 
due to their increased solubility in CH3CN. Specifically benzaldehyde was treated 
with XXVa and DBU, however no reactivity was observed (Table 5.2, entry 11). 
Similarly, NaO2CCH2CN was also used as the acetate may decarboxylate on the 
metal to form the desired –CH2CN complex in situ (Table 5.2, entry 12). 
Unfortunately, this was also not successful. 
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As the previous work by Guan and co-workers focussed on a nickel catalyst, the 
transformation was also attempted by treating benzaldehyde with 
[(CCCnBu)Ni(NCMe)][SbF6] (XXVb) and NaOH. However, no reaction was observed 
(Table 5.2, entry 13). 
5.3 Conclusion: 
A significant background reaction was observed when treating benzaldehyde with a 
catalytic amount of NaOH in CH3CN yielding 3-hydroxy-3-phenylpropionitrile. 
When the reaction was performed using a 1:1 mixture of NaOH and benzaldehyde 
in CH3CN, a number of products were formed, including sodium benzoate. This 
compound is the likely result of a Cannizzaro reaction. In addition, (E)- and (Z)-
cinnamonitrile and 3-phenylpentanedinitrile were obtained. 
Various bis(NHC) and NHC containing CNC –CH2CN complexes were tested in 
catalysis. Unfortunately, in all cases, no reaction was observed. NHC-containing 
CCC and C^C^C pincer –NCMe complexes in the presence of NaOH were tested in 
catalysis, however, only the background reaction was observed. While no desired 
reactivity was observed for any of the catalysts screened, those described in 
Chapter 4 to likely have the best success i.e. the –CH2CN ligated CCC and C^C^C 
complexes could not be synthesised. Therefore, if these complexes could be 
prepared in future they may facilitate the desired transformation.  
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5.4 Experimental: 
5.4.1 General Considerations: 
All air sensitive reactions were performed under an atmosphere of high purity argon 
using standard Schlenk techniques. Catalysis reactions were prepared in a dry 
glove box (Innovative Technologies or MBraun) under a nitrogen atmosphere in a  
4 mL scintillation vial. Glassware was heated under vacuum and back-filled with 
argon to ensure the exclusion of oxygen and moisture in the reactions. NaOH was 
purchased from Chem Supply and dried under vacuum at 200 °C. Benzaldehyde 
and tridecane were purchased from Sigma Aldrich dried with MgSO4 and distilled. 
For air sensitive reactions anhydrous CH3CN was obtained by passage through an 
Innovative Technologies Solvent Purifier and stored in an ampoule over 3 Å 
molecular sieves.  
5.4.2 Instrumentation: 
NMR spectroscopic studies were carried out on a 400 MHz Bruker Avance 3 HD  
400 MHz Wide Bore Spectrometer with a 5 mm BBFO probe at room temperature 
(293 K) or a 600 MHz Bruker Avance III HD 600 MHz spectrometer with a 5 mm  
TCI-cyroprobeat 300 K, in CDCl3. CDCl3 was used as received. 1H NMR spectra 
were obtained at 399.58 or 600.07 MHz. 1H NMR spectra were referenced to the 
residual 1H resonance of the residual solvent peak. 
GC-FID studies were conducted on a Shimadzu GC-2014. 
GC-MS studies were conducted on an Agilent Technologies 6850 GC with a 5975C 
VL MSD. 
5.4.3 Synthesis of β-hydroxynitriles and other by-products: 
For GC analysed reactions: Benzaldehyde (25.5 µL, 2.50x10–4 mol), catalyst 
(1.25x10–5 mol), NaOH (0.5 mg, 1.25x10-5 mol), tridecane (15.2 µL, 6.25x10–5 mol) 
and CH3CN (3.0 mL) were combined in a scintillation vial under an atmosphere of 
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N2. The solution was stirred at 60 °C for 24 h. it was cooled to room temperature 
and a 300 µL aliquot was taken for GC-FID analysis and where relevant GC-MS 
analysis. The yield was calculated using a calibrated internal standard (tridecane). 
For 1H NMR spectra analysed reactions: Benzaldehyde (25.5 µL, 2.50x10–4 mol), 
catalyst (1.25x10–5 mol), NaOH (0.5 mg, 1.25x10-5 mol) and CH3CN (3.0 mL) were 
combined in a scintillation vial under an atmosphere of N2. The solution was stirred 
at 60 °C for 24 h. it was cooled to room temperature and the CH3CN was removed 
under vacuum the solid was dissolved in a solution of 1,3,5-trioxane (2.50x10–4 mol) 
in CDCl3 (0.4 mL). The yield of 3-hydroxy-3-phenylpropionitrile was then calculated 
by 1H NMR analysis of the reaction mixture using an internal standard  
(1,3,5-trioxane).[5] 
For 1:1 benzaldehyde:NaOH reaction: Benzaldehyde (25.5 µL, 2.50x10–4 mol), 
NaOH (10.0 mg, 2.50x10–4 mol) and CH3CN (3.0 mL) were combined in a 
scintillation vial under an atmosphere of N2. The solution was stirred at 60 °C for  
24 h. it was cooled to room temperature and the CH3CN was removed under 
vacuum the solid was dissolved in a solution of 1,3,5-trioxane (2.50x10–4 mol) in 
CDCl3 (0.4 mL). The yield was then calculated by 1H NMR spectra analysis with 
comparison of the integration ratio of 1,3,5-trioxane and the integrations of (E)-[6] 
and (Z)-cinnamonitrile[7] and 3-phenylpentanedinitrile.[8] To determine the yield of 
sodium benzoate the CDCl3 was removed under vacuum, the solid was washed with 
CH2Cl2, and dissolved in MeOH. The MeOH was removed under vacuum yielding 
sodium benzoate. This allowed the isolated yield of sodium benzoate to be 
determined. 
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